| |
Disclosures: Nothing to disclose - 08/10/2023
CURRICULUM VITAE CURRICULUM VITAE LEONARD WARTOFSKY, M.D. Date of Birth: July 14, 1937 Birthplace: New York, NY USA Citizenship: USA Permanent residence: USA Address and Contact Information: Office: Leonard Wartofsky, MD MedStar Health Research Institute (Department of Medicine) Washington Hospital Center East Building 4120 110 Irving Street, N.W. Washington, DC 20010-2975 Telephone: 202-215-5900 Email: leonard.wartofsky@medstar.net Home: 2 Farmington Court Chevy Chase, Maryland 20815 Telephone: 301-654-5900 Revised: November 2023 CURRICULUM VITAELEONARD WARTOFSKY, M.D. | | | | | | | EDUCATION: | | | George Washington University | 1955‑1959 B.S. (Zoology) | | George Washington University | 1959-1961 M.S. (Anatomy) | | George Washington University School of Medicine | 1960-1964 M.D.(Cum Laude) | | George Washington University | 1993-1995 MPH (Honors) | | | | | RESEARCH EXPERIENCE – Undergraduate | | Summer appointments to the Section on Biochemistry of Amino Acids, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland, in 1955, 1957 - 1961. (Dr. Simon Black, Chief) | | | | POSTGRADUATE MEDICAL TRAINING | Internship, Straight Medicine Ward Medical Service, Barnes Hospital Washington University School of Medicine, St. Louis, MO (Dr. Carl V. Moore, Chairman) | 1964-1965 | | Assistant Residency, Medicine Ward Medical Service, Barnes Hospital Washington University School of Medicine, St. Louis, MO (Dr. Carl V. Moore Chairman) | 1965-1966 | | Senior Residency in Medicine Bronx Municipal Hospital Center Albert Einstein College of Medicine, Bronx, NY (Dr. Irving M. London, Chief of Service) | 1966-1967 | | Research/Clinical Fellowship in Endocrinology Thorndike Memorial Laboratory, Harvard Medical Unit, Boston City Hospital (Dr. Sidney H. Ingbar, Chief of Service) | 1967-1969 | | | | | LICENSURE | | | Diplomat of National Board of Medical Examiners | 1965 | Licensed to practice medicine: New York Massachusetts Maryland California Washington, D.C. | | 1966 1968 1970-current 1970-2018 2004-2020 | Qualifying Examination, American Board of Internal Medicine Certifying (Oral) Examination, American Board Internal Medicine Board Certification in Endocrinology & Metabolism | 1968 1971 1972 | | | | | | | | HONORS | | Alpha Omega Alpha Honor Medical Society Smith‑Reed‑Russell Honor Medical Society Mosby Scholarship Prize Fellowship, American College of Physicians Elected to the American Society of Clinical Investigation Claire L. Chennault Award to an outstanding medical educator Peter Forsham Award: Outstanding Uniformed Endocrinologist Academy of Medicine of Washington Mastership, American College of Physicians Distinguished Lectureship Award, American Thyroid Association Laureate Award, American College of Physicians, Army Chapter President, The American Thyroid Association Elected to the Association of American Physicians Distinguished Service Award, American Thyroid Association Delta Omega Public Health Honor Society Distinguished Educator Award, The Endocrine Society President-Elect, The Endocrine Society Barbara and Wm. J. Howard Award for Academic Excellence Laureate Award, American College of Physicians, Wash., DC Chapter President, The Endocrine Society Distinguished Alumnus Achievement Award, The George Washington University School of Medicine Robert H. Williams Leadership Award of The Endocrine Society Delbert A. Fisher Research Scholars Award of The Endocrine Society Gold Cane Award, MedStar Washington Hospital Center Washington University, Barnes Hospital House Staff Outstanding Achievement Award, St. Louis, MO. Inaugural Luis Cesar Povoa Award of the Brazilian Endocrine Society Lewis E. Braverman Distinguished Lectureship Award, The American Thyroid Association, San Diego, CA W. Lester Henry Jr MD Award for Lifetime Teaching Excellence, American College of Physicians, Washington, DC Doctor Honoris Causa, University of Poznan, Poznan, Poland Doctor Honoris Causa, University of Athens, Athens, Greece | 1963 1964 1964 1975 1978 1986 1990 1991 1991 1992 1994 1995 1996 1996 1996 2001 2005 2006 2006 2006 2011 2012 2012 2012 2012 2014 2014 2015 2017 2017 | Sidney H. Ingbar Leadership Award of The Endocrine Society John B. Stanbury Thyroid Pathophysiology Medal of the American Thyroid Association | 2018 2021 | MILITARY HONORS AND AWARDS “A” Professional Designation, Army Medical Corps Meritorious Service Medal, Army Medical Corps Meritorious Service Medal, Oak Leaf Cluster Meritorious Service Medal, Second Oak Leaf Cluster Order of Military Medical Merit U.S. Army Commendation Medal Meritorious Service Medal, Third Oak Leaf Cluster Meritorious Service Medal, Fourth Oak Leaf Cluster Meritorious Service Medal, Fifth Oak Leaf Cluster Office of the Surgeon General: Lewis Aspey Mologne Award for Academic Excellence Legion of Merit | 1978 1979 1983 1986 1987 1991 1991 1992 1993 1993 1993 |
SOCIETY MEMBERSHIP American Medical Association American Federation for Clinical Research American Diabetes Association American Thyroid Association Society of Nuclear Medicine American College of Physicians (Membership) The Endocrine Society American Physiological Society American Society for Clinical Investigation Association of Military Surgeons of the U.S. Society of Medical Consultants to the Armed Forces New York Academy of Sciences European Thyroid Association American College of Physician Executives Association of Program Directors in Internal Medicine Society of General Internal Medicine Medical Society of the District of Columbia Association for Hospital Medical Education Sociedad Chilena de Endocrinologia y Metabolismo (Honorary) Association of American Physicians Association of Professors of Medicine Sociedad Medica de Santiago/Sociedad Chilena de Medicina Interna (Honorary) Sociedad Dominicana de Endocrinologia y Nutricion (Honorary) Council of Science Editors Endocrine Society of Poland (Honorary) | 1969-1980 1970 1971 1971 1972 1972 1973 1976 1978 1982 1982 1982 1989 1990 1991 1992 1993 1993 1995 1996 1997 2001 2003 2010 2012 | CURRENT POSITION | | MedStar Health Research Institute Director, Thyroid Cancer Research UnitWashington Hospital Center Chairman, Department of Medicine Medicine Residency Program Director, Internal Medicine Chairman Emeritus; Faculty in Endocrinology | 2017 - 1993-2014 1993-2000; 2002-3 2014 - | Uniformed Services University of the Health Sciences Professor of Medicine and Physiology Professor of Medicine, Anatomy, Physiology and Genetics | 1989-2001 2001-present | Georgetown University School of Medicine Clinical Professor of Medicine Professor of Medicine | 1985-2003 2003-present | Howard University School of Medicine Clinical Professor of Medicine | 1996-present | University of Maryland School of Medicine Clinical Professor of Medicine | 1999-present | George Washington University School of Medicine Clinical Professor of Medicine | 1995-present | HONORARY LECTURESHIPS: | | Boris Catz Thyroid Lectureship, Cedars‑Sinai Medical Center Technion Faculty of Medicine, 8th Hamburger Symposium, Haifa, Israel First Sidney H. Ingbar Memorial Lecture, The Endocrine Society, Seattle, Washington First Joseph Gaskins Memorial Lecture, Washington Hospital Center Distinguished Lectureship Award, 66th Annual Meetings, American Thyroid Association, Rochester, MN Third Sidney H. Ingbar Memorial Lecture, the Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts Samuel B. Haines Lecture and Visiting Professorship, The Mayo Clinic, Rochester, MN Edward Rose Memorial Lecture, The Philadelphia Endocrine Society Latin American Thyroid Association, Plenary Award Lectureship, Rio de Janeiro Great Teachers in Contemporary Clinical Medicine: Medical Grand Rounds, National Institutes of Health, Bethesda, Maryland First Dr. John Dunn Memorial Lectureship in Endocrinology and International Health, Univ. of Virginia School of Medicine, Charlottesville, Virginia Dr. Beverly Towery Memorial Lectureship in Medicine & Endocrinology, University of Louisville, Louisville, Kentucky Frank H. Tyler, M.D. Honorary Endowed Lectureship, University of Utah, Salt Lake City Opening Plenary Lecture, 35th Annual Meeting, Italian Endocrine Society, First Annual Meeting of Society of Endocrine Societies of Italy. Pescara, Italy Clark T. Sawin Memorial History of Endocrinology Lecture/Delbert A. Fisher Research Scholar Award Lectureship, 94th Annual Meeting, The Endocrine Society, Houston, TX Plenary Lecture, 20th Annual Meeting of the Endocrine Society of Poland, Poznan Seventh Annual Burritt L. Haag Endowed Honorary Lectureship and Visiting Professorship, Baystate Medical Center, Springfield, Massachusetts Third Annual Leon P. Georges Honorary Endowed Lectureship, Eastern Virginia School of Medicine Opening Plenary Lecture, Italian Society of Endocrinology Annual Meeting, Padova, Italy, Opening Plenary Lecture, Annual Meeting, Chinese Endocrine Society, Xi’an, China Opening Plenary Lecture, Endocrine Society of Turkey, Antalya, Turkey First Annual Luis Cesar Povoa Memorial Award Lectureship Lewis E. Braverman Distinguished Lectureship, American Thyroid Association, San Diego Honoris Doctor Causa, Award Lectureship, University of Poznan, Poznan, Poland Honoris Doctor Causa Award Lectureship, University of Athens, Athens, Greece | January 1987 March 1989 June 1989 March 1991 September 1992 October 1993 September 1994 November 1995 April 2001 November 10, 2004 April 8, 2008 April 9, 2009 February 17, 2011 May 18, 2011 June 26, 2012 September 2012 April 2-3, 2013 April 24, 2013 June 5-7, 2013 August 23, 2013 May 22, 2014 September 6, 2014 October 31, 2014 June 22, 2017 June 27, 2017 | TEACHING AND MENTORING: ENDOCRINOLOGY FELLOWSHIP TRAINING DIRECTOR Walter Reed Army Medical Center 1976-1993 Research Fellows Trained | James Low, MD Daniel Duick, MD Hunter Heath, MD Arthur Charles, MD Shelby Brammer, MD Kenneth Burman, MD Robert Adler, MD Prentice Thompson, MD Timothy Boehm, MD Robert Smallridge, MD Gerald Kidd, MD George Jones, MD Charles Smith, MD Louis Pangaro, MD Thomas Taylor, MD Thomas Jurney, MD Craig Holland, MD Wayman Cheatham, MD Nabil Gemayel, MD Hans DeRuyter, MD William Fears, MD Forrest Newman, MD Nelson Lum, MD Anthony Zavadil, MD Kristen Raines, MD Andrew Ahmann, MD Karen Murray, MD Sharon Jackson, MD James Hennessey, MD Jennifer Nuovo, MD Jonathan Kushner, MD Michael Brennan, MD Dennis Mong, MD Mark Peele, MD Richard Galloway, MD Michael Humphrey, MD Henry Burch, MD Michael Sokol, MD Thomas Francis, MD Victor Bernet, MD R. Michael Tuttle, MD Nikolaos Stathatos Joanna Klubo-Gwiezdzinska, MD Bikas, Thanos | To Univ. of So. California, later into practice To Mayo Clinic, Rochester, later into practice, President AACE To Mayo Clinic, then Chief, Endocrinol., Univ. Utah, then Lilly Pharma To, University of California, Davis To Diabetes Center, Univ. Tennessee, later to practice Chief, Endocrinology Walter Reed & Washington Hosp. Ctr., Prof. of Med, Georgetown Professor of Medicine, MCV, Richmond Chief, Endocrinology, Beaumont Medical Ctr., later into practice Univ. of Arkansas, Little Rock Chief, Physiology, Walter Reed Inst. Research; then to Mayo Clinic, Jacksonville Chief, Endocrinology, Fitzsimons Army Medical Ctr., later into practice Chief, Endocrinology, Ft. Jackson Hospital, later into practice Practice, Canton, Ohio Professor of Medicine and Chair, Uniformed Services University of Health Sciences Director, Endocrine Svc., Brook Army Med Ctr., later into practice Director, Endocrine Svc, El Paso Army Med Ctr., later into practice Faculty, University of Hawaii Chief of Endocrinology, Howard University; now MedStar Research Institute Assoc. Professor, Univ. Southern California, Los Angeles Chief, Endocrinology, Eisenhower Army Med. Ctr., then to RWJ Med. Ctr. Director, Texas Diabetes Institute, Dallas, TX Division Director, Endocrinology, Landstuhl Army Med. Ctr., later into practice Faculty. Letterman Army Med. Ctr., UCSF, then to practice Practice of Endocrinology Director of Medical Education, Office of Surgeon General, Washington, DC Professor Medicine, Oregon Health Sciences University, Portland, OR Endocrine Division, Food & Drug Administration, Rockville, MD Clinical practice Assoc. Professor of Medicine, Harvard University, Beth Israel Hospital Staff, Walter Reed Army Med. Ctr., then into practice, Sacramento, CA To Nutrition Fellowship, then Faculty Univ. of Kansas Career Army Administrator; retired Private practice of endocrinology Cardiology Fellowship; faculty positions transiently, then into practice Chief, Endocrinology, Frankfurt, Germany, Army Med. Ctr. Faculty, Madigan Army Medical Ctr., later into practice Chief, Endocrinology Division, Walter Reed Army Medical Center Private practice Endocrinology Chief, Endocrinology Tripler Med. Ctr., Assoc. Professor, Univ. of Hawaii Faculty, Mayo Clinic, Jacksonville, Florida Sloan Kettering Memorial Cancer Center, New York, NY Faculty, Massachusetts General Hospital, Harvard University, Boston, Mass. Director, Thyroid Research Unit, National Institutes of Health, Bethesda, MD Fellow, Brigham & Womens Hospital, Harvard University, Boston, Mass. | Recent Research Fellows: Dr. Dorina Ylli, MD, PhD, Dr. Wu Di, MD Dr. Cristiane Gomes Lima, MD, Dr. Leila Shobab, MD SERVICE | | Member, Program Committee, American Federation Clinical Research & American Society of Clinical Investigation Member, Program Committee, Endocrine Society Member, Program Committee, American Thyroid Association Chairman, Program Committee, American Thyroid Association First Vice President, American Thyroid Association Member, Committee on Education, The Endocrine Society Member, National Institutes of Health, Endocrinology Study Section Member, Search Committee, Chairman of Biochemistry, USUHS Member, Search Committee, Chairman, Gastroenterology Division, USUHS Member, Committee on Promotion to Professor, USUHS Coordinator and Program Chairman, Washington Endocrine Club Coordinator of Endocrinology Division, Department of Medicine, USUHS Member, National Institutes of Health Endocrinology Study Section Chairman, Awards Committee, Association of Military Surgeons of the United States Member, Committee on Appointments, Promotion and Tenure, USUHS Director and Member of Executive Council, American Thyroid Association Member, Search Committee, Chairman of Biochemistry, USUHS Quality Assurance Coordinator, Department of Medicine, Walter Reed Army Medical Ctr Governor, American College of Physicians Member, International Health Committee, American College of Physicians Member, Regional Meetings Committee, American College of Physicians Program Chair and Coordinator, American College of Physicians-Army Annual Meetings, Endocrinology Subsection, and Chairman, Awards Committee, San Francisco, CA Member, Thyroid Research Advisory Council, Boots (U.S.A.) National Secretary, American Thyroid Association1988‑1993 Member, Committee on Appointments, Promotion and Tenure, USUHS Chairman, Committee on Appointments, Promotion and Tenure, USUHS Member, Advisory Panel on Endocrinology, United States Pharmacopeial Convention Consultant, American Medical Association, Drug Evaluation Review Panel Education Committees, Departments of Medicine, Walter Reed Army Medical Center and Uniformed Services University Representative, American Thyroid Association, to Association of American Medical Colleges, Council of Academic Societies Representative, American Thyroid Association, to Council of Endocrine Associations President-Elect, American Thyroid Association Governor’s Advisory Council, American College of Physicians (D.C.) President, American Thyroid Association Member, Practice, Education, Credentials, and Clinical Competence Committees, Department of Medicine, Washington Hospital Center: Member, Bioethics, Critical Care, Cardiology Advisory, Credentials, Graduate Medical Education, and Executive Committees, and the Bioethics Consultation Team, Washington Hospital Center Member, Advisory Panel on Endocrinology, United States Pharmacopeial Convention ACP National Associates Abstract Review Board of Physicians MKSAP 11 Endocrinology and Metabolism Committee, American College of Physicians Program Chairman, Clinical Endocrinology Update, The Endocrine Society, Dallas, TX Member, American College of Physicians Review Committee, Self-Assessment Program (Multiple Choice Question Information Bank) Director, Clinical Endocrinology Update, The Endocrine Society, Founder & Director, Board Review Course at Clinical Endocrinology Update, The Endocrine Society ACP National Associates Abstract Review Board Program Committee, Association of Professors of Medicine Board of Directors, The Hormone Foundation Executive Council, The Endocrine Society MKSAP 12 Endocrinology and Metabolism Update Committee, ACP Co-Director, ACP Board Recertification Course, Washington, DC ACP National Associates Abstract Review Board MKSAP 13 Section Editor, Endocrinology and Metabolism, ACP Congressional Relations Committee, The Endocrine Society Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC Program Committee, Association of Professors of Medicine ACP National Associates Abstract Review Board Awards Committee, American College of Physicians, Washington, DC Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC2006 President-Elect, The Endocrine Society Program Committee, Association of Professors of Medicine ACP National Associates Abstract Review Board Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC Program Committee, Association of Professors of Medicine President, The Endocrine Society Chair, Committee on Governance Affairs, Endocrine Society Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC Alliance for Academic Internal Medicine (AAIM) Abstract Review Task Force Chair, Advocacy (Gov’t Relations) Public Outreach Committee, Endocrine Society Co-Director, Symposium: Controversies in Thyroidology, Buenos Aires Abstract Reviewer. 91st Annual Meeting, Endocrine Society, Nominating Committee, The Endocrine Society Chair, Annual Meeting Steering Committee, and overall Program Chair, 92nd Annual Meeting, Endocrine Society, San Diego, CA Medical Advisory Council, ThyCA (Thyroid Cancer Patient Support Group) Development Committee, American Thyroid Association ACP National Associates Abstract Review Board Pfizer Awards Jury Committee: The Endocrine Society / JCEM Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC Nominating Committee, American Thyroid Association Co-Director, ACP Board Recertification Course, Washington, DC Co-Director, ACP Board Certification Course, Washington, DC ACP National Associates Abstract Review Board The Endocrine Society Centennial Task Force American Thyroid Association Annual Meeting Program Committee Thyroid Cancer Guidelines Committee, American Thyroid Association Nominating Committee, American Thyroid Association MedStar Health Research Day Abstract Review Board ACP National Associates Abstract Review Board | 1979-1980 1980-1982 1981 1981 1979-1983 1977-1981 1981 1982-1983 1981-1993 1975-1991 1977-1991 1981-1985 1982-1983 1983-1985 1984-1987 1986-1987 1986-1989 1982-1987 1983-1985 1985-1987 1983-1991 1989-1993 1988-1993 1991-1992 1992-1993 1990-1995 1991-1993 1991-1993 1991-1993 1992-1994 1993-1994 1993-1996 1994-1995 1993-current 1993-current 1995-2000 1994-1997 1995-1997 1997 1997-2000 1998-2001 1998-2002 2000-2001 2001-2004 2001-2004 2001-2002 2003-2004 2002-2004 2002-2004 2004-2007 2005 2006 2004-2005 2004-2006 2005-2006 2006 2006 2005-2006 2005-2006 2006-2008 2007 2007 2006-2008 2006-2007 2007-2008 2008 2008-2010 2008-2010 2008-2010 2008 2009 2008-2011 2010 2010-2012 2009-2011 2007-2011 2010-2014 2008-2011 2008-2011 2011-2014 2011-2014 2010-2014 2010-2014 2014-2017 2013-2016 2014-2016 2011-2016 2016-2018 2018-2019 2018-2022 | EDITORIAL ACTIVITIES | | Editor (with U. Loos), Peripheral Metabolism of Thyroxine, Hormone and Metabolic Research, Supplement Series Volume 14, 1984, Georg Thieme Verlag, Stuttgart/New York. Editor (with U. Loos), Molecular Biological Approaches to Thyroid Research, Hormone and Metabolic Research, Supplement Series Volume 17, 1987, Georg Thieme Verlag, Stuttgart/New York. Associate Editor, Principles and Practice of Endocrinology and Metabolism, K.L. Becker (Ed.), Lippincott, Philadelphia, First Edition, 1990. Special Guest Editor, Inaugural Issue, Thyroid, Vol 1, No. 1, 1991. Mary Ann Liebert, Inc., New York, N.Y. Associate Editor, Principles and Practice of Endocrinology and Metabolism, K.L. Becker (Ed.), Lippincott, Philadelphia, Second Edition, 1995. Associate Editor, Endocrinology and Metabolism, Balliere Tindall LTD/W.H. Saunders, Inc., London and Philadelphia, 1994-1999. Editorial Board, The Endocrinologist, Williams & Wilkins, 1995-2001. Editor, Thyroid Cancer: A Comprehensive Guide to Clinical Management, Humana Press, 2000. Associate Editor, Principles and Practice of Endocrinology and Metabolism, K.L. Becker (Ed.), Lippincott Williams & Wilkins, Philadelphia, Third Edition, 2001. Section Editor, Endocrinology and Metabolism Section of MKSAP 13, ACP, 2003- 2004 Editor, Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, 2004. Editor, Wartofsky L. and Van Nostrand D. Thyroid Cancer: A Comprehensive Guide to Clinical Management, 2nd Edition, Humana Press, 2006. Editorial Board, Endokrynologia Polska, The Journal of the Polish Endocrine Society, 2008 – Editor, Cancer de Tiroides – Guia para Pacientes, [Spanish Language version] Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, 2008. Co-Editor, Translational Research in Endocrinology & Metabolism, An Online Anthology from the Endocrine Society Journals, Blaustein JD, DeFranco DB, Wartofsky L (Eds.), 2009 – 2014. Editor, Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, Second Edition, 2010. Update Translation to Chinese, 2014. Editorial Board, Journal of Dialog in Endocrinology, Turkish Endocrine Society, Istanbul, Turkey. 2010 – 2018 Editor-in-Chief, The Journal of Clinical Endocrinology and Metabolism, 2010-2015 Editorial Advisory Board, The Journal of Hospital Ethics, 2011-2016 Editor, Diagnostic Dilemmas: Case Studies and Images in Endocrinology, The Endocrine Society Press, 2011. Editorial Board/Scientific Committee: Pediatric Endocrinology, Diabetes and Metabolism, 2011-2013 Editorial Board, J Oncology/Hematology of Roumania (Oncolog Hematolog Ro), 2012-2014 Editor, Approaches to Endocrine and Metabolic Diseases. Volume II. The Endocrine Society Press, 2012. Editor, Diagnostic Dilemmas: Volume II. Case Studies and Images in Endocrinology, The Endocrine Society Press, June 2013. Editor, Approaches to Endocrine and Metabolic Diseases. Volume III. The Endocrine Society Press, 2015. Editor, Wartofsky L. and Van Nostrand D. Thyroid Cancer: A Comprehensive Guide to Clinical Management, 3rd Edition, Springer Publ. 2016. Editor, Luster M., Duntas L., Wartofsky L. The Thyroid and its Diseases, Springer Publ. 2019 Editor-in-Chief, Endocrine Reviews, the Endocrine Society, 2015 – 2018 | Editor, Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), Keystone Press, Third Edition, 2019. ABSTRACTS / PRESENTATIONS | 1. Wartofsky, L. and Ingbar, S.H.: Inhibitory Effect of Iodine on Thyroid Release of Thyroxine, and Iodide Leak in Thyrotoxicosis. Clinical Research 16:276, 1968. 2. Wartofsky, L. and Ingbar, S.H.: A Method of Assessing the Latency, Potency, and Duration of Action of Antithyroid Agents in Man. Clinical Research 17:295, 1969. 3. Wartofsky, L., Martin, D., Graham, B.S., and Earll, J.M.: Thyroid Function in Malaria. Clinical Research 19:384, 1971. 4. Burman, K.D., Fox, J.D., Earll, J.M., and Wartofsky, L.: Sources of Increasing Serum Triiodothyronine in Newborn Sheep. Program 50th Mtg. Amer. Thyroid Association. Endocrinology 93:T‑21, 1974. 5. Wartofsky, L., Dimond, R.C., Noel, G.L., Adler, R.A., and Earll, J.M.: Failure of T3 to Block TSH Responses to TRH in Normal Subjects and Patients with Primary Hypothyroidism. Program 50th Mtg. Amer. Thyroid Association. Endocrinology 93:T2, 1974. 6. Noel, G.L., Schaaf, M., Wartofsky, L., Earll, J.M., and Frantz, A.G.: Tests of Prolactin Secretion in the Differential Diagnosis of Galactorrhea. Presented at Regional Meeting American College of Physicians, October 1974. 7. Wartofsky, L.: Incidence of Remission After Antithyroid Therapy in Graves’ Disease. Presented at Regional Meeting, American College of Physicians, October 1974. 8. Dimond, R.C., Wartofsky, L., and Rosen, S.W.: Heterogeneity of Circulating Growth Hormone in Acromegaly: Demonstration of Three Immunoreactive Components Before and After TRH Administration. Program 56th Annual Meeting, Endocrine Society, Atlanta, GA, June 12‑14, 1974. Endocrinology 94:A‑133, 1974. 9. Burman, K.D., Yeager, H.C., Earll, J.M., Briggs, W.A., and Wartofsky, L.: Resin Hemoperfusion: A Potential New Treatment for Thyroid Storm. Program of the 7th International Thyroid Congress, June 9‑13, 1975, Boston, MA, p. 54, Abstract #93. 10. Wartofsky, L., Dimond, R.C., Noel, G.L., and Earll, J.M.: Estimates of Pituitary Stores of TSH in Normal Subjects and Patients With Primary Hypothyroidism by the Use of Continuous Infusion of TRH. Program of the 7th International Thyroid Congress, June 9‑13, 1975, Boston, MA, p. 13, Abstract #23. 11. McGuire, R.A., Burman, K.D., Wartofsky, L., and Berman, M.: Compartmental Models for Maternal, Fetal, and Amniotic Fluid Transfer of Iodide, Triiodothyronine, and Thyroxine in Pregnant Sheep. Program of the 57th Meeting of the Endocrine Society, June 18‑20, 1975. Endocrinology 96, Abstract #142. 12. Becker, R.A., Johnson, D.W., Wilmore, D.W., Burman, K.D., Wartofsky, L., and Woeber, K.A.: Alterations in Serum T3 and Reverse T3 in Thermal Injury. Clinical Research 24:269, 1976. 13. Burman, K.D., Dimond, R.C., McGuire, R.A., Earll, J.M., Strum, D., and Wartofsky, L.: The Effect of Varying Serum T4 Concentrations on Extrathyroidal Production of T3, Reverse T3 and 3‑3’Diiodothyronine. Clinical Research 24:270, 1976. 14. Burman, K.D., Dimond, R.C., Earll, J.M., Wright, F.D., and Wartofsky, L.: Sensitivity to Lithium in Treated Graves’ Disease: Effects on Serum T4, T3, and Reverse T3, Annual Meeting American College of Physicians, Philadelphia, PA, April 1976. 15. Read, J., Burman, K.D., Earll, J.M., Patow, W., and Wartofsky, L.: Thyroid Function Tests in Amniotic Fluid, Program 24th Annual Meeting, American College of Obstet. & Gynecol., Dallas, TX, May 1976. 16. Burman, K.D., Strum, D., Dimond, R.C., Djuh, Y.Y., Wright, F.D., Earll, J.M., and Wartofsky, L.: A Radioimmunoassay for 3,3’Diiodothyronine (3,3’‑T2), Program 52nd Annual Meeting, American Thyroid Association, Toronto. Endocrinology 98:T‑17, 1976. 17. Burman, K.D., Vigersky, R.A., Loriaux, D.L., Djuh, Y.Y., Wright, F.D., Strum, D., and Wartofsky, L.: Investigations Concerning Thyroxine Deiodinative Pathways in Patients With Anorexia Nervosa, Proceedings NIH Conference on Anorexia Nervosa, October 1976. 18. Kinsey, M.D., Donowitz, M., Wartofsky, L., Boehm, T.M., and Collin, D.P.: The Correlation Between Pruritus and Elevated Chenodeoxycholic Acid Levels in Hyperthyroidism. Gastroenterology 70:902, 1976. 19. Smallridge, R.C., Wartofsky, L., Desjardins, R.E., and Burman, K.D.: Reverse T3 Production Rates in Thyrotoxic, Euthyroid, and Hypothyroid Subjects. Clinical Research 25:302A, 1977. 20. Boehm, T.M., Burman, K.D., Barnes, S., and Wartofsky, L.: Synergism of Lithium and Iodine in the Treatment of Thyrotoxicosis, 59th Annual Meeting of the Endocrine Society, Chicago, IL, June 8‑10, 1977, Abstract #93. 21. Smallridge, R.C., Wartofsky, L., and Dimond, R.C.: Inappropriate Secretion of TSH: Discordance Between the Suppressive Effects of Corticosteroids and Thyroid Hormone, Program 53rd Annual Meeting American Thyroid Association, Cleveland, Ohio, September 7‑10, 1977. Endocrinology 100:T‑2. 22. Georges, L.P., Burman, K.D., Czerwinski, C.L., Herman, C.M., Sode, J., and Wartofsky, L.: The Effect of Sedation and Awakening on Peripheral Thyroid Hormone Levels in the Subhuman Primate. Clinical Research 25:13A, 1977. 23. Wray, H.L., Burman, K.D., Smallridge, R.C., Alford, J.P., and Wartofsky, L.: Effect of T3 and Reverse T3 Administration on Serum Tri‑, Di‑, and Mono‑iodothyronines in Sheep. Federation Proceedings 37:519, 1978. 24. Wannemacher, R.W., Dinterman, R.E., Burman, K.D., and Wartofsky, L.: The Possible Role of Thyroid Hormone in Regulating Rates of Protein Degradation in Skeletal Muscle. Federation Proceedings 37:1315, 1978. 25. Burman, K.D., Djuh, Y.Y., Kesler, P., and Wartofsky, L.: The Effect of T4 Administration on Hepatic Conversion of T4 to T3 in States of Altered Carbohydrate Economy, Endocrine Society, June 1978. Endocrinology 102:238, 1978. 26. Smallridge, R.C., Wartofsky, L., Dimond, R.C., and Burman, K.D.: 3’,5’‑Diiodothyronine and 3’‑Monoiodothyronine: Development of Radioimmunoassays and Demonstration of in vivo Peripheral Conversion, Endocrine Society, June 1978. Endocrinology 102:125, 1978. 27. Glass, A.R., Mellitt, R., Burman, K.D., Swerdloff, R.S., Wartofsky, L., and Fisher, D.A.: Effect of Dietary Composition on Serum Thyroxine and Triiodothyronine in Rats. Clinical Research 26:283A, April 1978. 28. O’Brian, J.T., Bybee, D.E., Wartofsky, L., Georges, L.P., and Burman, K.D.: Altered Peripheral Thyroid Hormone Metabolism and Diminished Hypothalamic Pituitary Responsiveness With Changes in Dietary Composition. Clinical Research 26:310A, April 1978. 29. Bybee, D., Taub, M., Burman, K.D., Wartofsky, L., Georges, L.P., and O’Brian, J.T.: The Effect of Hypocaloric Carbohydrate Feeding on Central and Peripheral Thyroid Hormone Regulation. Clinical Research 26:611, 1978. 30. Becker, R.A., Wilmore, D.W., Johnson, D.W., Burman, K.D., and Wartofsky, L.: Alterations in Peripheral Thyroid Economy and Pituitary Responsiveness in Thermally Injured Man. Clinical Research 26:14A, 1978. 31. Latham, K.R., Burman, K.D., and Wartofsky, L.: Separate T3 and T4 Receptors: Physiologic and Chromatographic Evidence, Amer. Thyroid Assn, 1978. Portland, Oregon, September 13‑16, 1978. Endocrinology 103:T‑17, 1978. 32. Wray, H.L., Burman, K.D., Alford, J.P., and Wartofsky, L.: Effect of T3 and Reverse T3 (rT3) Administration on Plasma Cyclic AMP (CAMP) and Cyclic GMP (CGMP) in Sheep. Clinical Research 26:16A, 1978. 33. Burman, K.D., Latham, K.R., Djuh, YY, Smallridge, R.C., Tseng, Y.C., Lukes, Y.G., Maunder, R., and Wartofsky, L.: Solubilized Nuclear T3 and T4 Receptors in Circulating Human Mononuclear Cells: Evidence for Increased Maximum Binding Capacities in Fasted Obese Subjects. Presented at Endocrine Society, June 1979, Los Angeles, CA. 34. Bybee, D.E., Taub, M., Burman, K.D., Wartofsky, L., Georges, L.P., and O’Brian, J.T.: The Effect of Hypocaloric Carbohydrate Feeding on the Integrated TSH Response to TRH. Clinical Research 27:249A, 1979. 35. Burman, K.D., Smallridge, R.C., Jones, L., Ramos, E.A., O’Brian, J.T., Wright, F.D., and Wartofsky, L.: Glucagon Kinetics in Fasting: A Metabolic Event Associated With Physiologic Alterations in Serum T3. Clinical Research 27:482A, 1979. 36. Burman, K.D., Smallridge, R.C., Osburne, R., Dimond, R.C., Whorton, N.E., Kesler, P., and Wartofsky, L.: Nature of Suppressed TSH Secretion During Under nutrition: Effect of Fasting and Refeeding on TSH Responses to TRH Infusions. Clinical Research 27:248A, 1979.
37. Smallridge, R.C., Latham, K.R., Ward, K.E., Wartofsky, L., and Burman, K.D.: Conditions Affecting 3’,5’diiodothyronine (3’,5’T2) to 3’‑Monoiodothyronine (3’T1) Conversion: Evidence for an Enzyme Separate from Thyroxine (T4) and Reverse T3 (rT3) 5’‑deiodinase. Clinical Research 27:260A, 1979. 38. Latham, K.R., Smallridge, R.C., Tseng, Y.L., Burman, K.D., and Wartofsky, L.: Nuclear Thyroid Hormone Receptors in Heart and Liver: Long‑term Effect of Hypo‑ and Hyperthyroidism. Clinical Research 27:255A, 1979. 39. Burman, K.D., Latham, K.R., Djuh, Y.Y., Tseng, Y.L., Lukes, Y.G., and Wartofsky, L.: Increased Nuclear T3 Maximum Binding Capacity (MBC) in Circulating Mononuclear Cells of Fasted Obese Subjects, 61st Annual Meeting of the Endocrine Society, Anaheim, CA, June 13‑15, 1979, Abstract #498. 40. Smallridge, R.C., Smith, C.E., Wright, F.D., and Wartofsky, L.: Metabolic Clearance Rates (MCRs) and Production Rates (PRs) of 3’,5’‑Diiodothyronine (3’,5’T2) in Hyper‑ and Hypothyroidism: Comparison of Infusions Using Labeled Versus Unlabelled Hormone, 61st Annual Meeting of the Endocrine Society, Anaheim, CA, June 13‑15, 1979, Abstract #74. 41. Latham, K.R., Smallridge, R.C., Tseng, Y.L., Burman, K.D., and Wartofsky, L.: Nuclear Thyroid Hormone Receptors in Heart and Liver: Long‑term Effect of Hypo‑ and Hyperthyroidism. Clinical Research 27:255A, 1979. 42. Pangaro L, Smallridge, R.C., Cahnmann, H.J., Wright, F.D., Burman, K.D., and Wartofsky, L.: Development of a Radioimmunoassay for 3,5T2 and Demonstration of Conversion from T3. Endocrine Society Poster Session, June, 1979, Los Angeles, CA. 43. Osburne, R.C., Bybee, D.E., O’Brian, J.T., Burman, K.D., Wartofsky, L., and Georges, L.P.: Sensitivity of the Hypothalamic Pituitary Axis to Triiodothyronine in the Underfed State. Clinical Research, January 1980. 44. Smallridge, R.C., Latham, K.R., Ward, K.E., Dimond, R.C., Wartofsky, L., and Burman, K.D.: 3’,5’‑Diiodothyronine to 3’‑Monodiothyronine (3’T1) Conversion in Rat Liver and Solubilization of Multiple Phenolic Ring Deiodinase Activities, Amer. Thyroid Assn, Portland, Oregon, Abstract #T7, 1978. 45. O’Brian, J.T., Bybee, D.E., Osburne, R.C., Burman, K.D., Czerwinski, C.L., Wartofsky, L., and Georges, L.P.: Responsiveness of the Hypothalamic‑Pituitary Axis to Triiodothyronine in the Underfed State. Program 6th International Congr. Endocrinol., Melbourne, Australia, Feb. 1980. 46. Chernow, B., Burman, K.D., Johnson, D.L., O’Brian, J.T., Wartofsky, L., Georges, L.P.: Iodothyronines: Bidirectional Transfer Across the Blood Brain Barrier. Clinical Research 28:624A, 1980, and Endocrinology (Suppl) Program, Amer. Thyroid Assn., T‑23, 1980. 47. Smallridge, R.C., Wartofsky, L., Ward, K.E., and Burman, K.D.: Dissociation of 5’ Deiodinase Activities for T4 and 3’,5’T2 in the Fasted Rat: Evidence for Multiple Enzymes and Their Subcellular Locations. Clinical Research 27:741A, 1979. 48. Burman, K.D., Lukes, Y.G., Latham, K.R., Smallridge, R.C., and Wartofsky, L.: Effects of Sulfhydryl Groups, 8‑anilino‑1‑naphthalene Sulfonic Acid and Ipodate on T3 Receptor Binding in Rat Liver. Clinical Research 28:256A, 1980. 49. Mehlman, I., Smallridge, R.C., Wartofsky, L., Perone, P., Dimond, R.C., Doyle, T., and Burman, K.D.: The Effect of Chronic Dexamethasone Treatment on the Pituitary Thyroid Axis and Metabolism of Thyroid Hormone in the Rhesus Monkey. Clinical Research 28:263A, 1980. 50. Smallridge, R.C., Mehlman, I., Pamplin, C., Whorton, N.E., Doyle, T., Dimond, R.C., and Wartofsky, L.: An Evaluation of Pituitary and Thyroid Function in the Cynmolgus Monkey. Clinical Research 28:267A, 1980. 51. Smallridge, R.C., Glass, A.R., Wartofsky, L., Ward, K.E., and Burman, K.D.: Investigations into the Etiology of Elevated Serum Tri‑iodothyronine (T3) Levels in Protein Malnourished Rats, 62nd Ann ual Meeting of the Endocrine Society, June 1980. Endocrinology 106:(Suppl) p. 223, 1980. 52. Thompson, P., Burman, K.D., Lukes, Y., McNeil, J.S., Jackson, B.D., Latham, K.R., and Wartofsky, L.: Uremia Decreases Nuclear T3 Receptors in Rats, 62nd Annual Meeting of the Endocrine Society, June 1980, Washington, DC. Endocrinology 106 (Suppl) p. 200, Abstract #503. 53. Fears, W.B., Burman, K.D., Djuh, Y.Y., Wartofsky, L., and Latham, K.R.: Nuclear Thyroid Hormone Receptors and Acetylase Activity in Normal, Hyper‑, and Hypothyroid Rats, Presented at the 57th Annual Meeting, Amer. Thyroid Assn, Minneapolis, 1981. Endocrinology (Suppl) 109:T‑15. 54. Burman, K.D., Wartofsky, L., and Smallridge, R.C.: Ipodate Restores the Fasting Induced Decrement in TSH Secretion, 12th Annual Meeting European Thyroid Association, Brussels, Belgium, September 1982. 55. Wartofsky, L., DeRuyter, H., Smallridge, R.C., and Burman, K.D.: Thyrotropin Secretion in Starved Rats is Enhanced by Somatostatin Antiserum, 12th Annual Meeting of the European Thyroid Association, Brussels, Belgium, September 1982. 56. Burman, K.D., Smallridge, R.C., and Wartofsky, L.: Iodide Administration Enhances Thyrotropin Responsiveness to TRH During Fasting: Evidence for Normal Pituitary Feedback Regulation. Presented at the 7th International Congress of Endocrinology, Quebec, Canada, July 1984, A538. 57. Burman, K.D., Baker, J.R., Lukes, Y.G., Djuh, Y‑Y., Peter, J.B., Granlund, D., Dembrow, D., and Wartofsky, L: Characterization of a Monoclonal Antibody Developed Against the TSH Receptor. Presented at the Annual Meeting, American Thyroid Association, New York, September 1984, T‑25. 58. Burman, K.D., Lukes, Y., Wartofsky, L., Djuh, Y‑Y., and Baker, J.R.: Preparation of Biotinylated Receptor‑purified Graves’ IgG: A Simple Technique Allowing Direct Functional Assessment of TSH Receptor Antibody Interaction with Membrane. Journal of Steroid Biochemistry. 20(6B):1650, June 1984 (Abstr. L‑30); and Proceedings of Symposium “Autoimmunity and the Thyroid”, p. 387‑389, Toronto, June 29‑30, 1984. 59. Baker, J.R., Wartofsky, L., Wortsman, J., and Burman, K.D.: TSH Receptor Antibody and Anti‑Idiotypic Antibody Containing Immune Complexes in Graves’ Disease. Clinical Research 33:304A, 1985. 60. Sack, J., Baker, J.R. Jr., Wartofsky, L., Weetman, A.P., Volkman, D., Margolick, J., and Burman, K.D.: Natural Killer Cells in Hashimoto’s Thyroiditis. Endocrine Society. Abstract #724, 1985. 61. Hennessey, J.V., Burman, K.D., and Wartofsky, L.: Equivalency of Two Brand Name L‑thyroxine Preparations. Society A.F. Physicians/ACP Meeting, Dayton, Ohio, March 1985. 62. Smallridge, R.C., Dekeyser, F.M., Van Herele, A.J., Butkus, N.E., and Wartofsky, L.: Thyroid Iodine Content, Serum Thyroglobulin, and Perchlorate Discharge Tests in Destruction Induced Thyroiditis. 9th International Thyroid Congress, Sao Paolo, Brazil, September 1985. 63. Ahmann, A.J., Wartofsky, L., Baker, J.R., and Burman, K.D.: Evidence for Antibodies to Porcine Eye Muscle in Endocrine Ophthalmopathy, Presented at American College of Physicians‑Army Regional Meeting, San Francisco, 7‑11 October, 1985, p. 50‑1.
64. Hennessey, J.V., Evaul, J., Tseng, Y‑C., and Wartofsky, L.: Levothyroxine Therapy: A Re‑evaluation of Dosage Requirement. Presented at 2nd Annual American College of Physicians‑Army Regional Meeting, 7‑11 October 1985, p. 51‑1. 65. Sack, J., Baker, J.R. Jr., Weetman, A.P., Wartofsky, L., Burman, K.D.: The Role of Antibody Dependent Cytotoxicity and Natural Killer Cells in Hashimoto’s Disease. Presented at the 9th International Thyroid Congress, Sao Paulo, Brazil, September 1985. 66. Baker, J.R. Jr., Wartofsky, L, Burman, K.D.: Mouse Monoclonal Antibodies to Human Thyrocyte Membrane Proteins Which Augment Both TSH and Graves’ IgG Mediated Production of Cyclic Adenosine Monophosphate. Presented at the AFCR, Washington, DC, May 1986. Clinical Research 34:421a, 1986. 67. Ahmann, A., Baker, J.R. Jr., Weetman, A.P., Wartofsky, L., Nutman, T., Burman, K.D.: Serum Immunoglobulins in Patients with Graves’ Ophthalmopathy Directed Against Unique Determinants of Porcine Eye Muscle. Presented at the AFCR, Washington, DC, May 1986. Clinical Research 34:420A, 1986. 68. Tseng, Y‑C., Burman, K.D., Baker, J.R. Jr., d’Avis, J., Wartofsky, L.: Intrinsic Abnormality of Thyroid Cells From a Brobdingnagian Goiter. Presented at the 68th Annual Meeting of the Endocrine Society, Anahein, CA, June 1986. 69. Tseng, Y‑C., Burman, K.D., Baker, J.R. Jr., Ahmann, A.J., Wartofsky, L.: Autoantibody to Calcitonin in Hashimoto’s Thyroiditis: An Immunologic Basis for Calcitonin Deficiency? American Thyroid Assoc. 1986. 70. Sack, J., Zilberstein, D., Barile, M.F., Wartofsky, L., Dwyer, D., Burman, K.D.: Characterization of Thyrotropin Binding Proteins in Mycoplasma: Serum Antibodies Directed Against a Specific Mycoplasma Membrane Determinant in Patients with Auto‑immune Thyroid Disease. Presented at Endocrine Society Meeting, Abstract 834, 1986. 71. Fein, H.G., Smallridge, R.C., Hart, C.E., Burman, K.D., Wartofsky, L.: Novel therapies for defects in intestinal absorption of calcium and thyroid hormones. Clinical Research 35:589A, April 1987. 72. Ahmann, A., Solomon, B., Duncan, W., and Wartofsky, L.: Normal Bone Mineral Density (BMD) in Premenopausal Women on Suppressive Doses of L‑thyroxine. Presented at American Thyroid Association National Meeting and Abstract. Washington, DC, September 1987. 73. Sellitti, D.F., Tseng, Y‑C., and Wartofsky, L.: Receptors for Atrial Natriuretic Factor (ANF) in Human Thyroid Cells. Clinical Research 36: April 1988 (Presentation AFCR/ASCI, May 1988). 74. Tseng, Y‑C., Burman, K.D., d’Avis, J.C., Lahiri, S., and Wartofsky, L.: Thyrotropin Enhances Epidermal Growth Factor Receptors in Intact Human Thyroid Cells. Endocrine Society 70th Annual Meeting, New Orleans, LA, June 1988. 75. Tseng, Y‑C., Sellitti, D.F., and Wartofsky, L.: TSH Modulates Atriopeptin Receptors on Intact Human Thyroid Cells. Clinical Research 36: April 1988 (Presentation at AFCR/ASCI, Washington, DC, May 1988). 76. Ahmann, A.J., Tseng, Y‑C., Burman, K.D., Sellitti, D.F., and Wartofsky, L.: [125I]‑Atriopeptin Binding to Cultured Porcine Thyrocytes: Influence of Iodine and Thyrotropin. 70th Annual Meeting Endocrine Society, New Orleans, LA, June 1988. 77. Brennan, M.J., Duncan, W.E., Wartofsky, L., Butler, V.M., and Wray, H.L. In Vitro Dissolution of Calcium Carbonate Preparations. Presented at the Society of Bone and Mineral Research, New Orleans, LA, June 1988. 78. Tseng, Y.C., Schaudies, R.P., Ahmann, A., d’Avis, J., Geelhoed, G.W., Burman, K.D., Wartofsky, L.: Effects of Epidermal Growth Factor (EGF) on Thyroglobulin (Tg) and Cyclic AMP Production by Human Thyrocytes in Long‑Term Culture. Presented at the 63rd Annual Meeting, American Thyroid Association, Montreal, October 1988, Endocrinology 121:T‑59, 1988. 79. Solomon, B., Glinoer, D., LaGasse, R., Wartofsky, L.: Management of Hyperthyroidism Due to Graves’ Disease: Results of a Survey of Members of the A.T.A. Presented at the 63rd Annual Meeting, American Thyroid Association, Montreal, October 1988, Endocrinology 121:T‑34, 1988. 80. Poth, M., Tseng, Y.L. Wartofsky, L.: Does Cachectin Mediate Altered Thyroid Function in Systemic Illness? A Cell Culture Model. Presented at 71st Annual Meeting of the Endocrine Society, Seattle, WA, June 1989. 81. Tseng, Y.L., Lahiri, S., Sellitti, D.F., Burman, K.D., Wartofsky, L.: Atrial Natriuretic Peptide Inhibits Thyroglobulin Secretion from Human Thyroid Cells by Decreasing Cyclic AMP Production. Presented at 71st Annual Meeting of the Endocrine Society, Seattle, WA, June 1989. 82. Sellitti, D.F., Tseng, Y.C., Wartofsky, L.: Amiloride Modulates Atrial Natriuretic Peptide (ANP) Binding to Human Thyroid Cells. Clinical Research 37:363a, April 1989. 83. Wartofsky, L.: Management of Graves’ Disease 1989: Lessons from American Thyroid Association Member Survey. First Sidney H. Ingbar Memorial Lecture. Presented at the Clinical Day, 71st Annual Meeting of the Endocrine Society, Seattle, WA, June 1989. 84. Tseng, Y.L., Sellitti, D., Burman, K.D., Wartofsky, L.: Characterization of a Receptor for Atrial Natriuretic Peptide in Human Thyroid Cells by Affinity Cross‑Linking. Presented at the 64th Annual Meeting, American Thyroid Association, San Francisco, CA, September 1989. 85. Burch, H.B., Lukes, Y.G., Cai, W.Y., Carr, F.E., Wartofsky, L., Burman, K.D.: A Novel Approach to the Identification of Uniquely Expressed Genes in Graves’ Disease Thyroid Tissue. Clinical Research 38:264A, 1990. 86. Solomon, B., Wartofsky, L., Burman, K.D.: Cholestyramine Treatment of Thyrotoxicosis. Presented at the Endocrine Society 1990, Abstract 329. 87. Humphrey, M., Mosca, J., Baker, J.R., Drabick, J., Carr, F.W., Burke, D., Wartofsky, L., Burman, K.D.: Search for Retroviral DNA Sequences in Genomic DNA Isolated from Patients with Graves’ Disease. Clinical Research 38:383A, 1990. 88. Peele, M., Carr, F.E., Baker, J.R., Wartofsky, L., Burman, K.D.: Thyrotropin Gene Expression in Human Lymphocytes. Clinical Research 38:296A, 1990. 89. Hicks, K.A., Tseng, Y.L., Lahiri, S., Burman, K.D., d’Avis, J.C., Wartofsky, L.: Identification of Epidermal Growth Factor Receptor in a Cultured Medullary Carcinoma Cell Line. Clinical Research 38:385A, 1990. 90. Tseng, Y.L., Lahiri, S., Burman, K.D., d’Avis, J.C., Sellitti, D., Wartofsky, L.: Thyrotropin Augments Internalization of the Atrial Natriuretic Peptide Receptor Complex in Thyrocytes. Presented at the 72nd Annual Meeting, Endocrine Society, Atlanta, GA, June 1990, Abstract #729. 91. Wartofsky, L., Burman, K.D., d’Avis, J.C., Tseng, Y.L.: Thyrotropin Modulates Internalization of Epidermal Growth Factor in Cultured Thyroid Cells. Presented at 10th International Thyroid Congress, The Hague, Holland, February 1991. 92. Wartofsky, L., Wardzala, L., Schaudies, P., Burman, K.D., d’Avis, J.C., Tseng, Y.L.: Iodide Modulates Epidermal Growth Factor (EGF) Binding on Human Thyroid Cells. Symposium on Iodine and the Thyroid, Athens, Greece, September 1990. 93. Gililland, J., Tseng, Y., Troche, V., Lahiri, S., Wartofsky, L.: Atrial Natriuretic Peptide Receptors in Human Endometrial Stromal Cells. 73rd Annual Meeting, The Endocrine Society, Washington, DC, June 1991. 94. Burman, K.D., Djuh, Y.Y., Nicholson, D., Fein, H., Usala, S., Bradley, W.E.C., Berard, J., Wartofsky, L.: Identification of a Unique Mutation in Affected Members of a Family with the Syndrome of Generalized Thyroid Hormone Resistance. 73rd Annual Meeting, The Endocrine Society, Washington, D.C., June 1991. 95. Tseng, Y.L., Lahiri, S., d’Avis, J.C., Wartofsky, L: Effects of Transforming Growth Factor‑b on Growth and Thyroglobulin Synthesis in Cultured Human Thyroid Cells. Presented at 73rd Annual Meeting, The Endocrine Society, Washington, DC, June 1991. 96. Burch, H.B., Nagy, E., Cai, W‑Y., Wartofsky, L., Carr, F.E.: Investigation of Functional Homology Between the HIV‑1 Nef Protein and the Human Thyrotropin Receptor (h‑TSH‑R). Program, 65th Annual Meeting, American Thyroid Association, Boston, MA, September 1991, Thyroid 1: S- 65, (Suppl 1), 1991. 97. Tseng, Y.L., Lahiri, S., d’Avis, J.C., Wartofsky, L.: Transforming Growth Factor ‑ Alpha Modulates Cell Growth and Thyroglobulin Production by Cultured Thyroid Cells. Program, 65th Annual Meeting, American Thyroid Association, Boston, MA, September 1991, Thyroid 1: S-35 (Suppl. 1), 1991. 98. Tseng, Y.L., Lahiri, S, Jackson, S, Wartofsky, L: Endothelin Production by Human Thyroid Follicular Cells and its Modulation by Thyrotropin and Transforming Growth Factor-Beta. Program, 74th Annual Meeting, Endocrine Society, 1992, San Antonio, TX, June 1992, Abstract 432, p. 159. 99. Peters, M.H., Tseng, Y.L., Lahiri, S., Wartofsky, L.: Hydrocortisone Enhances Binding of Atrial Natriuretic Peptide and Thyroglobulin Secretion in Human Thyroid Cells. Program, 74th Annual Meeting, Endocrine Society, 1992, San Antonio, TX, June 1992, Abstr. 145, p. 88. 100. Wartofsky, L., Burman, K., Lahiri, S., Jackson, S., Tseng, Y.: Modulation by TSH and TGF-ß of Endothelin in Thyroid Cells. Program, 20th Annual Meeting, European Thyroid Association, Dublin, Ireland, June 1992. 101. Duncan, W.E., Solomon, B.L., Chang, A.S., Wartofsky, L.: Treatment with Thyroid Hormone: Effect on Spine Bone Mineral Density (BMD). American Society for Bone and Mineral Research, 1992. 102. Tseng, Y.L. and Wartofsky, L.: Identification of Endothelin Receptors on FRTL5 Cells and Modulation of Receptor Binding Activity by Thyrotropin. American Thyroid Association 66th Annual Meeting, Rochester, MN, September 1992, Thyroid 2 (Suppl 1), page S-53, 1992. 103. Jackson, S., Tseng, Y.L., and Wartofsky, L.: Insulin Increases Endothelin Binding in Cultured Human Thyroid Cells. 66th Annual Meeting of the American Thyroid Association, Rochester, MN, September 1992, Thyroid 2 (Suppl 1), page S-52 1992. 104. Wartofsky, L.: Management of Graves’ Ophthalmopathy. Program, 74th Annual Meeting, Endocrine Society, San Antonio, TX, June 1992, 14A, Page 26. 105. Wartofsky, L: Treatment of Graves’ Disease: Is the Use of Antithyroid Drugs Obsolete? Presented at the 66th Annual Meeting, American Thyroid Association, Rochester, MN, September 1992. 106. Wartofsky, L: Radioiodine Therapy of Graves’ Disease and Exacerbation of Ophthalmopathy. Program, 75th Annual Meeting, Endocrine Society, Las Vegas, NV, June 1993, Session 2B, p. 5. 107. Wartofsky L: Is There a Role for Thyroid Hormone Treatment in Patients with the Sick Euthyroid Syndrome? Program, 67th Annual Meeting, American Thyroid Association, Tampa, FL, November 1993. 108. Wartofsky L: Thyroid Hormone Therapy: Pearls and Baroques for the Thyroidologist. Program, 68th Annual Meeting, The American Thyroid Association, Chicago, Ill., September 1994. 109. Burch HB, Solomon BS, Wartofsky L, Burman KD. A Comparison of radioiodine therapy for Graves’ disease (GD) with and without antithyroid drug pretreatment. Program, 76th Annual Meeting, the Endocrine Society, Anaheim, CA, June 1994, Abstract 254, p. 264. 110. Wartofsky L: Endothelin and the Thyroid Gland. Program, “Endothelins in Endocrinology: New Advances”, Serono Symposium, Florence, Italy, October 6-8, 1994. 111. Wartofsky L: Treatment of Hyperthyroid Disease: Commentary. Abstracts of Clinical Care Guidelines. Joint Commission on Accreditation of Healthcare Organizations, Mosby-Yearbook, Volume 7, Number 4, pp. 11, 14, April 1995. 112. Wartofsky L: The scope and impact of thyroid disease. Presented at the National Academy of Biochemistry Symposium on Standards of Practice in Thyroid Testing, Anaheim, California, July 14-15, 1995. 113. Torrens J, Bernet V, Mahoney K, Solomon B, Burman K, Wartofsky L, Duncan W. The effect of cyclic etidronate on the bone mineral density (BMD) of women taking levothyroxine. 10th International Congress of Endocrinology, San Francisco, CA, June 12-15, 1996. 114. Calamities S, Burman KD, Perry D, Wartofsky, L. RET oncogene testing for medullary cancer: a clinically relevant advance. Oral presentation, 77th National Meeting American College of Physicians, April 25-28, 1996. 115. Lu R, Wartofsky L, Bahn R, Garrity J, Sutton BD, Burman KD. Role of oxygen free radicals in IL-1B-induced glycosaminoglycan production by retroocular fibroblasts from patients with Graves’ ophthalmopathy. 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997, P3-32. 116. Karl M, Ellahham S, Oskoui R, Wartofsky L, Burman KD. Thyrotoxicosis associated with rapidly reversible low-output heart failure and dilated cardiomyopathy. 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997, P3-40. 117. Wartofsky, L., Meet the Professor: “Hyperthyroidism”, 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997. 118. Wartofsky, L. Antithyroid drugs and outcome of radioiodine therapy for Graves’ disease. 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997, S15-2, p 34. 119. Wartofsky, L., Practical aspects of thyroid hormone therapy. 70th Annual Meeting, The American Thyroid Association, October 1997, Colorado Springs, CO. 120. Ringel M, Balducci-Silano P, Tuttle R, Djuh Y, Anderson J, Burman K, Wartofsky L, Silverman J, Kazarosyan M., Spencer C, Ladenson P, Levine M. Quantitative thyroglobulin RT-PCR detection of recurrent or residual thyroid carcinoma in patients with anti-thyroglobulin antibodies. Presented at the 71st Annual Meeting, American Thyroid Association, Portland, Oregon, September 16-20, 1998, Abstract # 169. 121. Gardner R, Tuttle M, Burman KD, Haddady S, Truman C, Sparling Y, Wartofsky L, Sessions R, Ringel MD. Intrathyroidal and extrathyroidal vascular invasion are associated with distant metastases at diagnosis and tumor recurrence in papillary thyroid carcinoma. Presented at the 71st Annual Meeting, American Thyroid Association, Portland, Oregon, September 16-20, 1998, Abstract # 171. 122. Gardner R, Tuttle M, Burman KD, Haddady S, Truman C, Sparling Y, Wartofsky L, Sessions R, Ringel MD. Prognostic importance of intrathyroidal and extrathyroidal vascular invasion in papillary thyroid carcinoma. Presented at 1999 Annual Meeting, American Head & Neck Society, New Orleans, LA. 123. Wartofsky, L., Meet the Professor: “Subclinical Thyroid Disease”, Annual Meeting of the American College of Physicians-American Society of Internal Medicine, Philadelphia, PA., April 13-16, 2000. 124. Wartofsky, L., Plenary lecture: “Uses and Abuses of Thyroid Hormone”, Annual Meeting of the American College of Physicians-American Society of Internal Medicine, Philadelphia, PA., April 13-16, 2000. 125. Wartofsky, L., Meet the Professor: “Thyroid Cancer”, 82nd Annual Meeting of the Endocrine Society Toronto, Canada, June 23 and June 24, 2000. 126. Wartofsky, L., Ringel MD, Burman KD. T3 Treatment of Critically Ill Patients. Presented at 82nd Annual Meeting of the Endocrine Society, Toronto, Canada, June 24, 2000. 127. Wartofsky, L. Clinical utility of rh-TSH-stimulated thyroglobulin testing without scan in the follow-up of patients with well differentiated thyroid cancer. Short call Abstract SC-3, Presented at the 12th International Thyroid Congress, October 22-27, 2000, Kyoto, Japan. 128. Wartofsky, L. Thyroxine/Triiodothyronine combination therapy for hypothyroidism. Presented at the 12th International Thyroid Congress, October 22-27, 2000, Kyoto, Japan, Abstract WS-88. 129. Rosenson R, Miller TF, Otvos J, Ladenson P, Wartofsky L, Ridgway EC. Atherogenicity of serum lipoproteins in mild thyroid failure. Presented at the 12th International Thyroid Congress, October 22-27, 2000, Kyoto, Japan, Abstract P-477/D. 130. Wartofsky, L. Update in Endocrinology - 2000. American College of Physicians Annual Meeting, Atlanta, GA., March 2001. 131. Wartofsky, L. Meet the Professor: “Issues in Thyroid Disease”. American College of Physicians Annual Meeting, Atlanta, GA., March 2001. 132. Wartofsky, L. Thyroid Hormone Therapy: Caveats & Controversies. Annual Meeting South African Endocrine Society, Johannesburg, April 2001. 133. Wartofsky, L. Controversies in the Management of Thyroid Cancer. Annual Meeting South African Endocrine Society, Johannesburg, April 2001. 134. Wartofsky, L. Therapy of Graves’ Disease: Is it time to Abandon Use of Antithyroid Drugs? Annual Meeting South African Endocrine Society, Johannesburg, April 2001. 135. Wartofsky, L. Management of Papillary and Follicular Thyroid Carcinoma. Award Plenary Lectureship, Annual Meeting Latin American Thyroid Association, Rio de Janeiro, April 2001. 136. Wartofsky, L. Diagnosis and Management of Subclinical Hyperthyroidism. Annual Meeting Latin American Thyroid Association, Rio de Janeiro, April 2001. 137. Wartofsky, L. Therapeutic Approaches to Dysthyroid Orbitopathy. Annual Meeting Endocrine Society of Argentina, University of Buenos Aires, May 2001. 138. Wartofsky, L. Dosimetric Approaches to Radioiodine Therapy of Thyroid Cancer. Annual Meeting Endocrine Society of Argentina, University of Buenos Aires, May 2001. 139. Wartofsky, L. Adjuncts to Treatment of Thyroid Malignancies: Redifferentiation Therapy. Annual Meeting Endocrine Society of Argentina, University of Buenos Aires, May 2001. 140. Wartofsky, L. New Approaches to Management of Thyroid Cancer. Sixth Congress of Endocrinology of Ukraine, Kiev, May 24, 2001. 141. Rosenson R, Ridgway EC, Ladenson P, Foust R, Miller TF, Wartofsky, L. Plasma homocysteine correlation in mild thyroid failure patients with elevated LDL. 83rd Annual Meeting of the Endocrine Society, Denver, Colorado, June 18-22, 2001. 142. Wartofsky, L. Clinical utility of rh-TSH-stimulated thyroglobulin testing without scan in the follow-up of differentiated thyroid cancer. 83rd Annual Meeting of the Endocrine Society, Denver, Colorado, June 18-22, 2001. 143. Wartofsky, L., Meet the Professor: “Graves’ Ophthalmopathy”, 83rd Annual Meeting of the Endocrine Society, Denver, Colorado, June 18-22, 2001. 144. Wartofsky, L. 1) Thyrogen-stimulated thyroglobulin without scan in the management of Thyroid Cancer; 2) Benefits of thyroxine treatment on cardiac manifestations of subclinical hypothyroidism.; presented at the 73rd Annual meeting, American Thyroid Association, Washington, DC, November 6-10, 2001. 145. Wartofsky, L., Meet the Professor: “Thyroid Nodules & Thyroid Cancer”, 84th Annual Meeting of the Endocrine Society, San Francisco, California, June 19-22, 2002. 146. Wartofsky, L. Plenary Lectures: “Redefining the normal TSH Range and Early Thyroid Failure”; Adjuvant approaches to the Treatment of Thyroid Cancer”, and “Innovations in the Management of Low Risk differentiated Thyroid Cancer employing Thyrogen”, 12th Endocrine Congress, Sociedad Dominicana Endocrinologia, Santo Domingo, March 2003. 147. Wartofsky, L., Meet the Professor: “Update in Thyroid Disorders”, Annual Meeting of the American College of Physicians, New Orleans, LA, April 26, 2004. 148. Wartofsky, L., Meet the Professor: “Thyroid Nodules and Risk of Thyroid Cancer”, 86th Annual Meeting of the Endocrine Society, New Orleans, LA, June 18, 2004. 149. Licht S, Wartofsky, L. Graves’ Alternans, Hashitoxicosis or the Thyroid Yo-Yo Syndrome. Presented at 76th Annual Meeting, The American Thyroid Association, Vancouver, Canada, October 1, 2004. 150. Wartofsky, L. Treatment of Hypothyroidism with Combinations of T4 plus T3. The Endocrine Society Clinical Endocrinology Update, Baltimore, MD. October 4, 2004. 151. Wartofsky, L., Meet the Professor: “Thyrotoxic Crisis and Myxedema Storm”, 87th Annual Meeting of the Endocrine Society, San Diego, CA, June 18, 2004. 152. Wartofsky, L., “Update in Endocrinology”, Annual Meeting of the American College of Physicians, San Francisco, CA, April 16, 2005. 153. Atkins F, Van Nostrand D, Kulkarni K, Burman KD, Wartofsky, L. The frequency with which empiric amounts of radioiodine “over” or “under” treat patients with metastatic well-differentiated thyroid cancer. J Nucl Med 2005; 46:129 P. 154. Wartofsky, L. Evaluation and Management of the Thyroid Nodule, Endocrine Society of Puerto Rico, Ponce, Puerto Rico, April 1, 2006. 155. Wartofsky, L. Current Concepts in Thyroid Cancer – 2006. Fifth Annual Romulo Ayoso Memorial Lecture, Endocrine Society of Puerto Rico, San Juan, Puerto Rico, April 2, 2006.
156. Van Nostrand D, Atkins F, Kulkarni K, Burman K, and Wartofsky, L. The Utility of Percent 48-Hour Whole Body Retention for Modifying Empiric Amounts of I-131 for the Treatment of Thyroid Carcinoma. Society of Nuclear Medicine meetings. J Nucl Med, (abstract). 2006:7(1):324P. 157. Esposito G, Van Nostrand D, Atkins F, Burman K, Wartofsky L, Kulkarni, K. Frequency of “Over” and “Under” Treatment with Empiric Dosage of I-131 in patients with and without Lung Metastasis Secondary to Well-Differentiated Thyroid Cancer. Society of Nuclear Medicine meetings, J Nucl Med, (abstract) 2006;47(1):238P. 158. Seiboth L, Van Nostrand D, Wartofsky L, Ousman Y, Jonklaas J, Butler C, Burman K. Analysis of the role of PET/MRI digital fusion images in detection and management of recurrent or persistent thyroid cancer. Society of Nuclear Medicine, 2006. 159. Wartofsky, L. Epidemiology of Thyroid Cancer. Presented at the First International Congress on Thyroid Cancer, Siena, Italy, May 30- June 2, 2006.
160. Wartofsky, L. Use and Abuse of Triiodothyronine. Presented at the Oregon Health Sciences University Ashland Endocrine Symposium, August 3, 2006.
161. Wartofsky, L. Thyrotropin Levels and Health Outcomes. Presented at 31st Annual Meeting, the European Thyroid Association, Naples, Italy, 3-6 September 2006. 162. Atkins F, Van Nostrand D, Moreau S, Burman K, and Wartofsky, L. Percent 48-hr Whole Body Retention for Estimating Maximum Tolerated Activity of 131-I for the Treatment of Well-Differentiated Thyroid Cancer: The effect of rhTSH Stimulation vs. Thyroid Hormone Withdrawal on a Bi-Exponential Dosimetry Model . Society Nuclear Medicine, Washington, DC, June 2007.
163. Wartofsky, L. Thyroid Cancer in the Elderly. Presented at the American Thyroid Association Spring Symposium, Washington, DC, May 18, 2007. 164. Wartofsky, L. Global rising incidence of thyroid cancer: increased detection or higher radiation exposure? Presented at “Thyroid Cancer and the Environment”, sponsored by the European Thyroid Association and Hellenic Ministry of Health, Santorini, Greece, 8-10 June 2007.
165. Wartofsky, L. The Basis for Changing the Reference Range for TSH. Presented at Symposium: Thyrotropin: Clinical Issues for 2007 at the joint U.S. Endocrine Society – Società Italiana di Endocrinologia Annual Meeting,, Verona, Italy, 13-16 June 2007.
166. Van Nostrand D, Moreau S, Atkins F, Shin YR, Burman K, Wartofsky, L. I-124 versus I-131 in the identification of suspected metastasis in patients with well-differentiated thyroid cancer. Society Nuclear Medicine Mid-Atlantic Regional Meeting, December 2007.
167. Aiken M, Shin Y-R, Kulkarni K, Van Nostrand D, Burman KD, Wartofsky, L. Quantitating the superiority of pinhole relative to parallel hole collimator images in detecting foci of radioiodine uptake in the thyroid bed/neck of patients with well-differentiated thyroid cancer. Society Nuclear Medicine, December 2007.
168. Shin Y-R, Bandaru V, Van Nostrand D, Moreau S, Burman KD, Wartofsky, L. The frequency of heterogeneous uptake and/or hypofunctioning areas on thyroid scintigraphy in patients with Graves’ disease. Society Nuclear Medicine, December 2007.
169. Wells KJ, Moreau S, Shin Y-R, van Nostrand D, Burman KD, Wartofsky, L. Predictive factors for, and the frequency of, positive post-treatment scans after radioiodine therapy of patients with well-differentiated thyroid cancer, positive serum thyroglobulin levels, and negative diagnostic radioiodine whole body scans. Society Nuclear Medicine, December 2007.
170. Wartofsky, L., Meet the Professor: “Thyroid Cancer - 2008”, 90th Annual Meeting of the Endocrine Society, San Francisco, CA, June 16, 2008.
171. Bandaru V, Shin Y-R, Van Nostrand D, Kulkarni K, Moreau S, Burman K, Wartofsky, L. The prognostic significance of pulmonary findings on diagnostic imaging modalities in patients with pulmonary metastases secondary to well-differentiated thyroid cancer. Presented at Society of Nuclear Medicine, New Orleans, LA, June 2008 (SNM Supplement May 2008).
172. Van Nostrand D, Moreau S, Atkins F, Shin Y-R, Burman KD, and Wartofsky, L. I-124 versus I-131 in the identification of suspected residual thyroid tissue or metastasis in patients with well-differentiated thyroid cancer. Presented at Society of Nuclear Medicine, New Orleans, LA, June 2008 (SNM Supplement May 2008). 173. Wartofsky L, Gharib H, Ross D. “Subclinical Hypothyroidism: To Treat or Not to Treat”, 90th Annual Meeting of the Endocrine Society, San Francisco, CA, June 16, 2008.
174. Loh J, Wartofsky L, Jonklaas J, Burman KD. An optimal management strategy for levothyroxine dosing in hypothyroid women during pregnancy. Presented at 90th Annual Meeting, The Endocrine Society, June 15-18, 2008.(Submitted for publication 2008)
175. Wartofsky L, “Thyroid Cancer – A 2008 Update” presented at the Yale University Thyroid Ultrasound Course, May 28, 2008, Trumbull, Connecticut. 176. Wartofsky L, “Management of thyroid cancer with recombinant human TSH in 2008”, Presented at the 19th Congress of the Polish Endocrine Society, September 25-28, 2008, Wroclaw, Poland. 177. Wartofsky L, “What’s new in Thyroid Cancer for 2009?”, Presented at the 8th annual Congresso Paulista de Endocrinologia et metabolismo, Sao Paulo, Brazil, May 9, 2009. 178. Wartofsky L, “Subclinical Hypothyroidism”, Presented at the 8th annual Congresso Paulista de Endocrinologia et metabolismo, Sao Paulo, Brazil, May 9, 2009. 179. Wartofsky L. The 2009 American Thyroid Association Guidelines for Management of Thyroid Cancer. Presented at the Philadelphia Endocrine Society, Jefferson Medical Center, Philadelphia, October 14, 2009. 180. Samuels M, Ridgway EC, Franklyn J, Wartofsky L. Thyroid Grand Rounds, 80th Annual Meeting, The American Thyroid Association, Palm Beach, Florida, September 25, 2009. 181. Wartofsky L. Thyroid Nodules – 2009. Presented at the Endocrine Society’s Clinical Endocrinology Update, Atlanta, GA., October 10, 2009. 182. Wartofsky L. Thyroid Cancer – 2009. Presented at the Endocrine Society’s Clinical Endocrinology Update, Atlanta, GA., October 11, 2009. 183. Klubo-Gwiezdzinska J, Jensen K, Hardwick M, Burman KD, Wartofsky L, Van Nostrand D, Vasko VV. Translocator protein (TSPO) in human thyroid tumors: correlation with thyroid cancer phenotype, Akt activation and resistance to apoptosis. Program of The Endocrine Society, 92nd annual Meeting, San Diego, CA, June 18-23, 2010. 184. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. An undetectable initial rhTSH-stimulated Tg levels 12 months after the initial treatment of thyroid cancer serves as an excellent, but not infallible, indicator for cure. Program of The Endocrine Society, 92nd annual Meeting, San Diego, CA, June 18-23, 2010. 185. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Dosimetric vs. Empiric dosage radioiodine therapy for thyroid cancer. Presented at the 14th International Thyroid Congress, 11-16 September 2010, Paris, France. 186. Khorjekar G, Van Nostrand D, Kharazi P, Moreau S, Atkins F, Chennupati S, Mete M, Burman K, Wartofsky L. 124I PET versus 131I Planar Imaging in the Identification of Functioning Residual Thyroid Tissue and/or Metastases in Patients with Differentiated Thyroid Cancer. Society of Nuclear Medicine, San Antonio, TX, 2011. 187. Kulkarni K, Van Nostrand D, Atkins F, Kharazi P, Wexler J, Burman K, Wartofsky L. Does Lemon Juice Increase Radioiodine Re-Accumulation within the Parotid Glands Greater Than If Lemon Juice Had Not Been dministered? Society of Nuclear Medicine, San Antonio, TX, 2011. 188. Khorjekar G, Van Nostrand D, Moreau S, Atkins F, Mete M, Burman K, Wartofsky L. Survival rate in patients diagnosed with well differentiated thyroid cancer with bone metastases. Society of Nuclear Medicine, 2011, J Nuclear Med 2011; 51s: 1080. 189. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Mete M, Wartofsky L. Preparation with rhTSH stimulation or levothyroxine withdrawal for RAI treatment gives comparable results in patients with metastatic differentiated thyroid cancer. Endocrine Society Annual Meeting, Boston, Mass., June 2011. 190. Klubo-Gwiezdzinska J, Costello J, Jensen K, Patel A, Burman KD, Wartofsky L, Vasko VV. Metformin activates AMPK and inhibits Thyroid cancer cell growth in an oncogene-specific manner. Endocrine Society Annual Meeting, Boston, Mass., June 2011. 191. Wartofsky L. The Future of Endocrinology. Plenary Opening Lecture, First Meeting of the Federation of Italian Societies of Endocrinology, Pescara, Italy, May 2011. 192. Klubo-Gwiezdzinska J, Costello J, Jensen K, Patel A, Burman KD, Wartofsky L, Vasko V. Metformin Inhibits Anaplastic Thyroid Cancer Cells Growth through AMPK-dependent Down-regulation of mTOR/6SK Signaling. 81st Annual Meeting American Thyroid Association, Indian Wells, CA, October 26-30, 2011. 193. Khorjekar, G. R., Van Nostrand, D., O’Neil, J., Moreau, S., Atkins, F., Kharazi, P., Chennupati, C., Burman, K., Wartofsky, L. Thyroid Hormone Withdrawal (THW) versus Recombinant Human Thyroid Stimulating Hormone (rhTSH) in the Identification of Metastasis (Mets) in Differentiated Thyroid Cancer (DTC) With 131I Planar Whole Body (WB) and 124I Positron Emission Tomography (PET-CT) Imaging. Presented at Society Nuclear Medicine, mid-Winter meeting, 2011. Clin Nucl Med 2011;36 (7): 623
194. Chennupati, SP; Kharazi P, Khorjekar G, O’Neil J, Moreau S, Wartofsky L, Van Nostrand D. Thyroid hormone withdrawal increased radioiodine uptake relative to recombinant human thyroid stimulating hormone injections in distant metastases of differentiated thyroid cancer: a case report. Presented at Society Nuclear Medicine, mid Winter meeting, 2011. Clin Nucl Med 2011;36(7):628 195. Klubo-Gwiezdzinksa J, Jensen K, Costello J, Patel A, Bauer A, Burman KD, Wartofsky L, Vasko V. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Program, The Endocrine Society, Houston, Tx, June 2012.
196. Hall JP, Van Nostrand D, Kharazi P, Mete M, Moreau S, Acio E, Wartofsky L. Predicting positive post 131-I therapy scans in patients who have thyroid cancer and negative pre-radioiodine therapy scans. Annual Meeting of the Society of Nuclear Medicine, 2012, J Nucl Med (abstract).
197. Schneider M, Van Nostrand D, Khorjekar G, Burman KD, Wartofsky L. Retrospective sudy of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer. Presentation at the 55th Annual Meeting of the Society of Nuclear Medicine, 2012, J Nucl Med (abstract).
198. Khorjekar G, Van Nostrand d, Moreau S, Burman KD, Chennupati SP, Bandaru VV, Wartofsky L. Does a negative diagnostic 131-I planar scan and 124-I PET scan in patients with elevated thyroglobulin exclude 131-I uptake on the 131-I post therapy scan? Annual meeting of the Society of Nuclear Medicine, 2012, J Nucl Med (abstract). 199. Garcia C, Schneider M, Van Nostrand D, Burman KD, Wartofsky L. 18F-fluorodeoxyglucose PET and thyroid nodules: An educational exhibit. 55th Annual Meeting of the Society of Nuclear Medicine, 2012, J Nucl Med (abstract). 200. Hall JP, Van Nostrand D, Kharazi P, Mete M, Moreau s, Acio E, Wartofsky L. Predicting positive post-131I therapy scans in patients who have thyroid cancer and negative pre-radioiodine therapy scans. Presentation at the 55th Annual Meeting of the Society of Nuclear Medicine, 2012, J Nucl Med (abstract). 201. Wartofsky L. Dosimetric Approaches to the Treatment of Thyroid Cancer. Plenary lecture at the 39th Congress of the Hellenic Endocrine Society, 4 - 7 April 2012, Athens, Greece. 202. Wartofsky L. Application of the American Thyroid Association Guidelines on Thyroid Cancer to the Management of Papillary Microcarcinoma. International Congress of Endocrinology/European Congress of Endocrinology (ICE/ECE), 4-9 May 2012, Florence, Italy. 203. Wartofsky L. Clark T. Sawin Memorial History of Endocrinology Lecture/Delbert A. Fisher Research Scholar Award Lectureship, 94th Annual Meeting of The Endocrine Society, Houston, TX, June 26, 2012. 204. Wartofsky L. How to write a scientific paper and get it published in the literature. Annual Trainee Day, 94th Annual Meeting of The Endocrine Society, Houston, TX, June 23, 2012. 205. Wartofsky L. “Nobel Prize Laureates in Endocrinology”, 2012 Clinical Endocrinology Update of The Endocrine Society, Miami, Florida, September 13-15, 2012/ 206. Orquiza M, Schneider M, Garcia C, O’Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L. Retrospective study of the utilkity of 18F-sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases. ACNM meeting, New Orleans, LA, 2013. 207. Khorjekar G, Orquiza M, Kharazi P, Moreau S, Kulkarni K, Van Nostrand D, Burman K, Wartofsky L. Salivary gland and gastrointestinal side effect survey study in patients treated with 131-I for Differentiated thyroid cancer: The Washington Hospital Center Experience. Society of Nuclear Medicine meeting, Vancouver, Canada, 2013. 208. Atkins F, Van Nostrand D, Orquiza M, Wartofsky L. Whole body retention of I-131 at 24 hr vs 48 hr as a predictor of maximum tolerated activity. Presented at Annual Meeting, Society of Nuclear Medicine, Vancouver, Canada, June 10-13, 2013. 209. Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D. Characterization of sialoadenitis after administration of continuous sialogogues during the day and nigtht after 131-I therapy. Presented at Annual Meeting, Society of Nuclear Medicine, Vancouver, Canada, June 10-13, 2013. 210. Wartofsky L. Combination therapy with triiodothyronine and levothyroxine for hypothyroidism. Opening plenary lecture, the Italian Society of Endocrinology Annual Meeting, Padova, Italy, June 5-7, 2013.
211. Wartofsky L. Ethical Issues in Scientific Publishing. Lecture at Trainee Development Workshop, ENDO 2013, 96th Annual Meeting of the Endocrine Society, San Francisco, CA, June 14-18, 2013. 212. Orquiza M, Khorjekar GR, Schneider M, Mark T, Kulkarni K, Garcia C, Acio E, Mete M, Burman K, Wartofsky L, Van Nostrand D. Altered taste after 131-I therapy: frequency, time of onset, and duration. Presented at Winter Meeting, Society of Nuclear Medicine, Palm Spring, CA, February 5-8, 2014. 213. Orquiza M, Van Nostrand D, Moreau S, Atkins F, Khorjekar G, Kulkarni K, Burman K, Wartofsky L. Survival rate in differentiated thyroid cancer patients with bone metastases. Presented at Winter Meeting, Society of Nuclear Medicine, Palm Spring, CA, February 5-8, 2014. 214. Orquiza M, Khorjekar GR, Schneider M, Mark T, Kulkarni K, Garcia C, Acio E, Mete M, Burman K, Wartofsky L, Van Nostrand D. Epiphora and xerophthalmia after 131-I therapy: frequency, time of onset, and duration. Presented at Winter Meeting, Society of Nuclear Medicine, Palm Spring, CA, February 5-8, 2014. 215. Guan H, Van Nostrand D, Li Y, Orquiza M, Ten W, Wartofsky L. Comparison of bone metastases guidelines from seven organizations. Presented at Winter Meeting, Society of Nuclear Medicine, Palm Spring, CA, February 5-8, 2014. 216. Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D. Assessment of Serial Complete Blood Counts following Dosimetry-Guided 131I Treatment for Metastatic Differentiated Thyroid Cancer. Presented at 98th Annual Meeting of the Endocrine Society, San Diego, CA, March 2015. 217. Bikas A., Kundra P., Wexler J., Mete M., Desale S., Wray L., Barett C., Clark B., Wartofsky L., Burman K. Phase II Clinical Trial of Sunitinib As Adjunctive Treatment in Patients with Advanced Differentiated Thyroid Cancer. Presented at 98th Annual Meeting of the Endocrine Society, San Diego, CA, March 2015. 218. Garcia CA, Van Nostrand D, Wexler J, Burman KD, Wartofsky L. The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer. Society of Nuclear Medicine, Baltimore, MD., June 6-10, 2015. 219. Bikas A, Van Nostrand D, Jensen S, Desale S, Mete M, Wartofsky L, Vasko V, Burman K. Metformin Attenuates 131I – Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. Society of Nuclear Medicine, Baltimore, MD., June 6-10, 2015. 220. Bikas A, Jensen KE, Costello J, Patel A, Wartofsky L, Burman K, Vasko V. Induction of the Oncotic Death Pathway in Thyroid Cancer Cells, Presented at the 15th International Thyroid Congress, Orlando, Florida, Program page A-19, October 18-23, 2015. 221. Singh I, Bikas A, Garcia CA, Wartofsky L, Desale S, Burman K. Relation Between Increases in 18FDG-PET SUV and Size of Lesions in Thyroid Carcinoma. Presented at the 15th International Thyroid Congress, Orlando, Florida, Program page A-250, October 18-23, 2015. 222. Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K. The Metabolic Profile Post a Dosimetry-Guided I-131 Therapy in Patients with Metastatic Differentiated Thyroid Cancer. Presented at ENDO 16, Annual meeting of the Endocrine Society, Boston, Mass, April 1- 4, 2016. 223. Bikas A, Jensen A, Patel J, Costello L, Wartofsky L, Burman K, Vasko V. High Glucose Decreases the Anti-Neoplastic Efficacy of Metformin in Medullary Thyroid Cancer Cells. Presented at ENDO 16, Annual meeting of the Endocrine Society, Boston, Mass, April 1- 4, 2016. 224. Bikas A, Jensen A, Patel J, Costello L, Wartofsky L, Burman K, Vasko V. The role of autophagy regulator LC3B in thyroid cancer cells response to metabolic stress and radiation. Presentation at the 86th Annual Meeting of the American Thyroid Association, Denver, CO, September 21-25 2016. 225. Klubo-Gwiezdzinska J, Auh S, Cochran C, Lima CJ, Van Nostrand D, Burman KD, Wartofsky L, Kebebew E, Skarulis M. Does pre-treatment with Lithium prior to radioiodine therapy improve outcome in patients with metastatic differentiated thyroid cancer? Presented at ENDO 17, Annual Endocrine Society Meetings, Orlando, FL., March 31, 2017. 226. Luo H, Tobey A, Auh S, Cochran C, Lima C, Van Nostrand D, Burman K, Wartofsky L, Skarulis M, Klubo Gwiezdzinska J. Pretreatment with lithium might be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment (RAI) for metastatic differentiated thyroid cancer (DTC). American Thyroid Association Annual Meeting, Victoria, Canada, October 2017. 227. Turner D, Wu D, Burman KD, Wartofsky L, Van Nostrand D. Low-iodine diet and urine iodine measurements for 131I treatments in patients in differentiated thyroid cancer: a comparison of 18 clinical practice guidelines. American Thyroid Association Annual Meeting, Victoria, Canada, October 2017. 228. Bikas A, Jensen K, Costello J, Patel A, Wartofsky L, Burman KD, Vasko V. Mitotane as a novel therapeutic strategy against thyroid cancer cells. Annual Meeting, American College of Physicians, 2018. 229. Wu D, Gomes-Lima C, Moreau S, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. Prognostic factors in the overall survival rate of patients with differentiated thyroid cancer bone metastases. American Thyroid Association Annual Meeting, Victoria, Canada, October 2017. 230. Wu D, Khorjekar G, Kharazi P, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. Xerophthalmia and epiphora secondary to 131-I therapy in patients with differentiated thyroid cancer: A prospective study. American Thyroid Association Annual Meeting, Victoria, Canada, October 2017. 231. Gomes-Lima CJ, Chittimoju S, Wehbeh L, Jat SK, Pagadala P, Jhawar S, Al-Jundi MN, Zeymo A, Mete M, Klubo-Gwiezdzinska J, Jonklaas J, Van Nostrand D, Wartofsky L, Burman KD. Radioiodine treatment of metastatic thyroid cancer: progression free survival is similar for patients with distant metastases prepared with recombinant human TSH or with thyroid hormone withdrawal. Presented at 100th Annual Meeting, the Endocrine Society, Chicago, IL, 2018. 232. Ylli D, Patel A, Jensen K, Mendoca-Torres MC, Costello J, Lima C, Wartofsky L, Burman KD, Vasko VV. Microfluidic droplet digital PCR is a powerful tool for detection of BRAF and TERT mutations in papillary thyroid carcinomas. Presented at 2020 Annual Meeting of the Endocrine Society, March 28-31, 2020, San Francisco, CA. 233. Shobab L, Gomes-Lima CJ, Jonklaas J, Wartofsky L, Zeymo A, Burman KD. Clinical, pathological and molecular profiling of radioactive iodine refractory differentiated thyroid cancer. Presented at 88th Annual Meeting, the American Thyroid Association, Washington, DC 2018. 234. Wu D, Bloom G, Burman KD, Wartofsky L, Van Nostrand D. Nationwide survey on the changes in release of 131-I therapy patients after the implementation of the 2011 NRC regulatory policy. Preented at the 88th Annual Meeting, the American Thyroid Association, October 3-7, 2018, Washington, DC, p. 311. 235. Wu D, Heimlich SL, Burman KD, Wartofsky L, Van Nostrand D. The diagnostic value of 124-I PET compared to 131-I imaging in differentiated thyroid cancer: systematic review and metaanalysis. Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, Philadelphia, PA, 2018. 236. Wu D, Khorjekar G, Kharazi P, Moreau S, Kulkarni K, Burman K, Wartofsky L, Van Nostrand D. Poor compliance for continuous sialogogues in patient reported surveys. Presented at Annual Meeting, Society of Nuclear Medicine and Molecular Imaging, Philadelphia, PA, 2018. 237. Wu D, Kulkarni K, Garcia C, Burman KD, Wartofsky L, Van Nostrand D. Optimal time for 124-I PET/CT imaging in metastatic differentiated thyroid cancer. Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, Philadelphia, PA, 2018. 238. Wu D, Ylli D, Gomes-Lima CJ, Lee W, Burman KD, Wartofsky L, Van Nostrand D. New use for an old isotope. Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, Philadelphia, PA, 2018. 239. Bikas A, Jensen K, Patel A, Costello J, Larin O, Wartofsky L, Burman KD, Vasko V. Identification of molecular targets in distant metastases of patients with thyroid cancer. Presented at 88th Annual Meeting, American Thyroid Association, Washington, DC, 2018. 240. Papoian V, Ylli D, Wartofsky L, Rosen JE. Evaluation of thyroid hormone replacement dosing in overweight and obese patients after thyroidectomy. Presented at 88th Annual Meeting, American Thyroid Association, Washington, DC, October 3-7, 2018, p. 232. 241. Shobab L, Patel A, Costello J, Mendonca-Torres MF, Jensen K, Burman KD, Wartofsky L, Vasko V. Sex-specific expression of the histone lysine-specific demethylases in normal thyroid and thyroid cancer. Presented at 88th Annual Meeting, American Thyroid Association, Washington, DC, October 3-7, 2018, P.291. 242. Ylli D, Jensen K, Costello J, Patel A, Hoperia V, Wartofsky L, Burman KD, Vasko V. Viral-inducible cell fusion affects differentiation and chemokine expression in thyroid cancer cells. Presented at 88th Annual Meeting, American Thyroid Association, Washington, DC, October 3-7, 2018, p. 249. 243. Patel A, Costello J, Yllli D, Wartofsky L, Burman KD, Vasko V, Jensen K. Targeting next-generation-sequencing for analysis of oncogenic mutations in medullary thyroid cancers. Presented at 88th Annual Meeting, American Thyroid Association, Washington, DC, October 3-7, 2018, p. 296. 244. Shobab L, Lee W, Carroll N, Felger E, Rosen J, Jonklaas J, Lima C, Zeymo A, Belkaid Y, Branchley J, Wartofsky L, Burman KD. Sex-Specific Landscape of Normal and Malignant Thyroid. Presented at 89th Annual Meeting, American Thyroid Association, Chicago, IL, October 30-November 2, 2019. 245. Ylli D, Lima C, Wu D, Gitterman AL, Fernandez SJ, Mete M, Burman KD, Wartofsky L. Immediate Cause of Death in Patients with Thyroid Cancer Progression. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019. 246. Ylli D, Patel A, Jensen KE, Mendonca-Torres MC, Wartofsky L, Burman KD, Vasko V. Quantitative Assessment of BRAF Mutations in Thyroid Cancer Using Droplet Digital PCR. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019. 247. Shobab L, Wartofsky L, Jonklaas J, Vasko V, Jensen KE, Zeymo A, Burman KD. Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019. 248. Wu D, Mittra E, Tulchinsky M, Avram A, Ahuja S, Greenspan B, Lima CJ, Ylli D, Burman K, Wartofsky L, Van Nostrand D. Radioiodine dosimetry practices in the United States for differentiated thyroid cancer: preliminary report. Journal of Nuclear Medicine. 2019 May 1;60(supplement 1):1526- SNMMI 2019 Annual Meeting, Anaheim, CA. 249. Baral N, Wartofsky L, Sharma M. Thyrotoxic Hashimoto’s Disease: Is it Graves’ thyrotoxicosis or “Hashitoxicosis”? Presented at 89th Annual Meeting, American Thyroid Association, Chicago, IL, October 30-November 2, 2019. 250. Phillips A, Diamond S, Kleess L, Yoo EJ, Veluru M, Tefera E, Gomes-Lima CG, Jonklaas J, Wartofsky L, Burman KD. Effect of radioactive iodine on Hurthle cell thyroid carcinoma. Presented at Annual Meeting, American Association of Clinical Endocrinology, Washington, DC, May 7-10, 2020. 251. Bikas A, Reinolds S, Mendonca-Torres M, Patel A, Jensen K, Wartofsky L, Burman KD, Vasko V. Chlorpromazine Inhibits Mitochondrial Functions, Induces DNA Damage and Inhibits Medullary Thyroid Cancer Cell Growth in vitro and in vivo. 91st Annual Meeting, American Thyroid Association, 2021. 252. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen JE. Black Race and Female Gender were Independent Protective Factors for Thyroid Cancer. Presented at 90th Annual Meeting, American Thyroid Association, 2021.Annual Meeting of the American Association of Endocrine Surgeons, April 2021. 253. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Desale S, Burman KD, Wartofsky L, Rosen JE..Multivariate Analysis of Clinical Factors Predictive of Thyroid Cancer Risk. Poster #103 Presented at 90th Annual Meeting, American Thyroid Association, October 2021. 254. Zheng H, Lai V, Lu J, Kang JK, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen JE. Predictive Value of Bethesda Classification and Race on the Aggressive Behaviors of Thyroid Cancer, Poster #158 Presented at 90th Annual Meeting, American Thyroid Association, October 2021. 255. Shobab L, Kumari S, Zheng H, Patel A, Mendonca-Torres M, Jensen K, Klubo-Gwiezdzinska J, Burman KD, Wartofsky L, Vasko V. Development of benign and malignant thyroid tumors is associated with aberrant expression of the histone lysine-specific demethylases. Poster #263 Presented at 90th Annual Meeting, American Thyroid Association, October 2021. 256. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen J. Multivariate Analyses of Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer patients. Presented at Annual Meeting of the Southern Surgical Association, September 2021. 257. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen J. Black race and female gender were Independent Protective Factors for Thyroid Cancer. Poster #263 Presented at 90th Annual Meeting, American Thyroid Association, October 2021. 258. Bikas A, Reynolds S, Mendonca-Torres M, Patel A, Costello J, Jensen K, Thakur S, Klubo-Gwiezdzinska J, Wartofsky L, Burman KD, Vasko V. Chlorpromazine inhibits mitochondrial function, induces DNA damage and inhibits medullary thyroid cancer cell growth in vitro and in vivo. Oral Presentation at 90th Annual Meeting, American Thyroid Association, October 2021. 259. Scarsi C, Mautone G, Landi G, Moriarty PL, Sachmechi I, Wartofsky L, Burman KD. An Open-Label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors. Presented at the Endocrine Society Annual Meeting, ENDO 2022, Atlanta, GA, June 11-14, 2022. 260. Bikas A, Mendonca-Torres M, Patel A, Jensen K, Wartofsky L, Burman KD, Vasko V. Expression of Forkhead Box Transcription Factor (FOXM1) in Medullary Thyroid Cancer. Oral Presentation at 91st Annual Meeting, American Thyroid Association, Montreal, Canada, October 2022. 261. Shobab L, Zheng H, Mendonca-Torres M, Patel A, Jensen K, Kumari S, Rosen J, McCoy M, Klubo-Gwiezdzinska J, Burman KD, Wartofsky L, Vasko V. Expression of the Histone Lysine-specific Demethylase KDM5C is Distinct in Thyroid Cancers from Pre- and Post-menopausal Women. Oral Presentation at 91st Annual Meeting, American Thyroid Association, Montreal, Canada, October 2022. 262. Shobab L, Zheng H, McCoy M, Rosen J, Kumari S, Wartofsky L, Burman KD, Klubo-Gwiezdzinska J. Thyroid Cancer is Associated with Sex-specific Local and Systemic Immune Response. Oral Presentation at 91st Annual Meeting, American Thyroid Association, Montreal, Canada, October 2022. 263. Zheng H, Lai V, Lu J, Burman KD, Wartofsky L, Rosen JE. Improved Sexual Function after Parathyroidectomy in Women with Primary Hyperparathyroidism. Presented at Annual Meeting of Association of Endocrine Surgeons, 2023. 264. Al-Souri D, Alper L, Barrison L, Haque Mir A, Kunestner W, Budd S, Agrawal R, Baral N, Amin R, Maher J, Jonklaas J, Gomez-Lobo V, Wartofsky L, Burman K, and Shobab L. Impact of Radioactive Iodine Therapy on Menstrual Cycle and Pregnancy (IRON-MAP) in Women with Differentiated Thyroid Cancer. Presentation at 92nd Annual Meeting, American Thyroid Association, Washington, DC, October 2023. 265. Al-Souri D, Wartofsky L, Jensen K, Baral N, Hubbard G, Veytsman I, Vasko V, Burman KD, Shobab L. Advanced Thyroid Cancer is Associated with Multiple Driver Mutations involving Different Signaling Pathways. Presentation at 92nd Annual Meeting, American Thyroid Association, Washington, DC, October 2023. 266. Shobab L, Al‐Souri D, McCoy M, Harris B, Lee B, Rosen J, Klubo‐Gwiezdzinska J, Wartofsky L, Burman KD. Local immune response in thyroid cancer is specific to mutational background and histological type. Presentation at 92nd Annual Meeting, American Thyroid Association, Washington, DC, October 2023. 267. Zheng H, Lai V, Lu J, Hu D, Kang JK, Burman KD, Wartofsky L, Rosen JE. Machine Learning Identified Clinical Factors Influencing the Dose of Levothyroxine After Total Thyroidectomy – presented at American Association of Endocrine Surgeons, Feb 3, 2022, Virtual/ Orlando, FL (Abstract#ASC20220439) | ARTICLES (PEER REVIEWED) | 1. Black, S., Harte, M., Hudson, B., and Wartofsky, L.: A Specific Enzymatic Reduction of L (‑) Methionine Sulfoxide, and a Related Non‑specific Reduction of Disulfides. J Biol Chem 235:2910‑2917, 1960. 2. Wartofsky, L., Ransil, B.J., and Ingbar, S.H.: Inhibition by Iodine of the Release of Thyroxine From the Thyroid Glands of Patients With Thyrotoxicosis. J Clin Invest 49:78‑86, 1970. 3. Wartofsky, L. and Ingbar, S.H.: Estimation of the Rate of Release of Non‑thyroxine Iodine from the Thyroid Glands of Normal Subjects and Patients With Thyrotoxicosis. J Clin Endocrinol & Metab 33:488‑500, 1971. 4. Wartofsky, L., Martin, D., and Earll, J.M.: Alterations in Thyroid Iodine Release and the Peripheral Metabolism of Thyroxine During Acute Falciparum Malaria in Man. J Clin Invest 51:2215‑2232, 1972. 5. Wartofsky, L and Earll, J.M.: Non‑thyroxine Iodine Release from the Thyroid During Acute Malaria. J Clin Endocrinol & Metab 35:624‑626, 1972. 6. Burman, K.D., Broughton, W., Pflaum, W.K., and Wartofsky, L.: Deiodination of Thyroxine in the Fetal Rat. Proc Soc Exper Biol Med 143:1003‑1007, 1973. 7. Burman, K.D., Warkel, R.L., and Wartofsky, L.: Hyperfunctioning Thyroid Nodules that Become “Cold.” Med Annals of D.C. 42:541‑544, 1973. 8. Wartofsky, L.: Low Incidence of Remission After Antithyroid Drug Therapy for Graves’ Disease ‑ Relation to Dietary Iodine. J Amer Med Assn 226:1083‑1088, 1973. 9. Wartofsky, L.: Response of the Thyroid Gland and Thyroid Hormone Metabolism to Infectious Disease. Hormone Research 5:112‑128, 1974. 10. Noel, G.L., Dimond, R.C., Wartofsky, L., Earll, J.M., and Frantz, A.G.: Studies of Prolactin and TSH Secretion by Continuous Infusion of Small Amounts of Thyrotropin‑Releasing Hormone (TRH). J Clin Endocrinol & Metab 39:6‑17, 1974. 11. Burman, K.D., Earll, J.M., Johnson, M.J., and Wartofsky, L.: Clinical Observations on the Solitary Autonomous Thyroid Nodule. Arch Intern Med 134:915‑919, 1974. 12. Heath, H., Lee, R.B., Dimond, R.C., and Wartofsky, L.: Conjugated Estrogen Therapy and Tests of Thyroid Function. Annals of Internal Medicine 81:351‑354, 1974. 13. Dimond, R.C., Wartofsky, L., and Rosen, S.W.: Heterogeneity of Circulating Growth Hormone in Acromegaly. J Clin Endocrinol & Metab 39:1133‑1137, 1974. 14. Burman, K.D., Adler, R.A., and Wartofsky, L.: Hemiagenesis of the Thyroid Gland. Amer J Med 58:143‑146, 1975. 15. Atkinson, R.L., Dimond, R.C., Becker, D.C., Martins, A.N., Schaaf, M., Wartofsky, L., and Earll, J.M.: Treatment of Acromegaly by Transsphenoidal Microsurgery. J Amer Med Assn 233:1279‑1283, 1975. 16. Burman, K.D., Wright, F.D., Earll, J.M., and Wartofsky, L.: Evaluation of a Rapid and Simple Technique for the Radioimmunoassay of Triiodothyronine (T3). J Nucl Med 16:662‑665, 1975. 17. Burman, K.D., Yeager, H.C., Briggs, W.A., Earll, J.M., and Wartofsky, L.: Resin Hemoperfusion: A Potential New Treatment for Thyroid Storm. Thyroid Research, Proceedings of the 7th International Thyroid Conference, Boston, MA, 1975, p 437‑440. 18. Adler, R.A., Noel, G.L., Wartofsky, L., and Frantz, A.G.: The Effects of Oral Water Loading and Intravenous Hypotonic and Hypertonic Saline on Plasma Prolactin in Man. J Clin Endocrinol Metab 41:383‑389, 1975. 19. Wartofsky, L., Dimond, R.C., Noel, G.L., Adler, R.A., Frantz, A.G., and Earll, J.M.: The Effect of an Oral Water Load on Serum TSH in Normal Subjects, and on TSH and PRL Responses to TRH in Patients With Primary Hypothyroidism. J Clin Endocrinol Metab 41:725‑728, 1975. 20. Wartofsky, L., Dimond, R.C., Noel, G.L., Frantz, A.G., and Earll, J.M.: Failure of Propranolol to Alter Thyroid Iodine Release, Thyroxine Turnover, or the TSH and PRL Responses to TRH in Patients With Thyrotoxicosis. J Clin Endocrinol Metab 41:427‑432, 1975. 21. Burman, K.D., Dimond, R.C., Noel, G.L., Earll, J.M., Frantz, A.G., and Wartofsky, L.: Klinefelter’s Syndrome: Examination of Thyroid Function, and the TSH and PRL Responses to TRH Prior to and After Testosterone Administration. J Clin Endocrinol Metab 41:1161‑1166, 11976. 22. Burman, K.D., Yeager, H.C., Briggs, W.A., Earll, J.M., and Wartofsky, L.: Resin Hemoperfusion: A Method of Removing Circulating Thyroid Hormones. J Clin Endocrinol Metab 42:70‑78,1976. 23. Wartofsky, L., Dimond, R.C., Noel, G.L., Frantz, A.G., and Earll, J.M.: Effect of Acute Increases in Serum Triiodothyronine on TSH and Prolactin Responses to TRH, and Estimates of Pituitary Stores of TSH and PRL in Normal Subjects and Patients With Primary Hypothyroidism. J Clin Endocrinol Metab 42:443‑458, 1976. 24. Adler, R.A., Corrigan, D.F., and Wartofsky, L.: Hypothyroidism After X‑irradiation to the Neck. Johns Hopkins Medical Journal 138:180‑184, 1976. 25. Burman, K.D., Read, J., Dimond, R.C., Strum, D., Wright, F.D., Patow, W., Earll, J.M., and Wartofsky, L.: Measurements of 3,3’,5‑Triiodothyronine (Reverse T3), 3,3’‑Diiodothyronine, T3, and T4 in Human Amniotic Fluid and in Cord and Maternal Serum. J Clin Endocrinol Metab 43:1351‑1359, 1976. 26. Burman, K.D., Monchik, J.M., Earll, J.M., and Wartofsky, L.: Ionized and Total Serum Calcium and Parathyroid Hormone in Hyperthyroidism. Annals Int Med 84:668‑671, 1976. 27. Boehm, T.M., Dimond, R.C., and Wartofsky, L.: Isolated Thyrotropin Deficiency With Thyrotropin‑Releasing‑Hormone Induced TSH Secretion and Thyroidal Release. J Clin Endocrinol Metab 43:1041‑1046, 1976. 28. Burman, K.D., Dimond, R.C., Earll, J.M., Wright, F.D., and Wartofsky, L.: Sensitivity to Lithium in Treated Graves’ Disease: Effects on Serum T4, T3, and Reverse T3. J Clin Endocrinol Metab 43:606‑613, 1976. 29. Boehm, T.M., Rothouse, L., and Wartofsky, L.: Occult Follicular Carcinoma of the Thyroid with a Solitary Slowly Growing Metastasis. JAMA 235:2420‑2421, 1976. 30. Burman, K.D., Dimond, R.C., Wright, F.D., Earll, J.M., Bruton, J., and Wartofsky, L.: A Radioimmunoassay for 3,3’,5’‑L’Triiodothyronine (Reverse T3): Assessment of Thyroid Gland Content and Serum Measurements in Conditions of Normal and Altered Thyroidal Economy and Following Administration of TRH and TSH. J Clin Endocrinol Metab 44:660‑672, 1977. 31. Wartofsky, L., Burman, K.D., Dimond, R.C., Noel, G.L., Frantz, A.G., and Earll, J.M.: Studies on the Nature of Thyroidal Suppression During Acute Falciparum Malaria: Integrity of Pituitary Response to TRH and Alterations in Serum T3 and Reverse T3. J Clin Endocrinol Metab 44:85‑90, 1977. 32. Burman, K.D., Strum, D., Dimond, R.C., Djuh, Y.Y., Wright, F.D., Earll, J.M., and Wartofsky, L.: A Radioimmunoassay for 3,3’L‑Diiodothyronine (3,3’T2). J Clin Endocrinol Metab 45:339‑352, 1977. 33. Burman, K.D., Lukes, Y., Wright, F.D., and Wartofsky, L.: Reduction in Hepatic Triiodothyronine Binding Capacity Induced by Fasting. Endocrinology 101:1331‑1334, 1977. 34. Corrigan, D.F., Burman, K.D., Dimond, R.C., Schaaf, M., Earll, J.M., Rogers, J.E., Wright, F.D., and Wartofsky, L.: Parameters of Thyroid Function in Patients with Active Acromegaly. Metabolism 27:209‑216, 1978. 35. Thrall, J.H., Burman, K.D., Gillin, M.T., Corcoran, R.J., Johnson, M.J., and Wartofsky, L.: Solitary Autonomous Thyroid Nodules: Comparison of Fluorescent and Pertechnetate Imaging. J Nucl Med 18:1064‑1068, 1977. 36. Smallridge, R.C., Wartofsky, L., Desjardins, R.E., and Burman, K.D.: Metabolic Clearance and Production Rates of 3,3’5’‑triiodothyronine (Reverse T3) in Hyperthyroid, Euthyroid, and Hypothyroid Subjects. J Clin Endocrinol Metab 47:345‑349, 1978. 37. Burman, K.D., Dimond, R.C., Djuh, Y.Y., Bruton, J., Washburn, T.B., Wright, F.D., and Wartofsky, L.: Failure of 3,3’‑T2 Administration to Alter TSH and Prolactin Responses to TRH Stimulation. Metabolism 27:677‑683, 1978. 38. Thrall, J., Corcoran, R., Wartofsky, L., Gillin, M., and Johnson, M.C.: Quantitative Thyroid Fluorescent Scanning: Technique and Clinical Experience. Amer J Roentgenol 130:517‑522, 1978. 39. Thompson, P., Boehm, T.M., Strum, D., and Wartofsky, L.: Abnormalities of Liver Function Tests in Thyrotoxicosis. Military Medicine 143:548‑551, 1978. 40. Smallridge, R.C., Wartofsky, L., Chopra, I.J., Dimond, R.C., Marinelli, P.C., Broughton, R.E., and Burman, K.D.: Neonatal Thyrotoxicosis: Relationship of LATS‑Protector to Alterations in Serum T4, T3, Reverse T3, and 3,3’‑T2 Concentrations. J Pediatrics 93:118‑120, 1978. 41. Glass, A.R., Mellitt, R., Burman, K.D., Wartofsky, L., and Swerdloff, R.S.: Serum Triiodothyronine in Undernourished Rats: Dependence on Dietary Composition Rather Than Total Calorie or Protein Intake. Endocrinology 102:1925‑1928, 1978. 42. Burman, K.D., Wright, F.D., Smallridge, R.C., Green, B.J., Georges, L.P., and Wartofsky, L.: A Radioimmunoassay for 3’,5’‑Diiodothyronine. J Clin Endocrinol Metab 47:1059‑1064, 1978. 43. Thrall, J.H., Burman, K.D., Wartofsky, L., Corcoran, R.J., Johnson, M.C., and Gillin, M.T.: Discordant Imaging of a Thyroid Nodule with 131I and Technetium 99m: Concordance of 131I and Fluorescent Scans. Radiology 128:705‑706, 1978. 44. Smallridge, R.C., Wartofsky, L., Green, B.J., Miller, F.C., and Burman, K.D.: 3‑L‑Monoiodothyronine (3’T1): Development of a Radioimmunoassay and Demonstration of in vivo Conversion from 3’,5’‑Diiodothyronine. J Clin Endocrinol Metab 48:32‑36, 1979. 45. Smallridge, R.C., Wartofsky, L., and Dimond, R.C.: Inappropriate Secretion of TSH: Discordance Between the Suppressive Effects of Corticosteroids and Thyroid Hormone. J Clin Endocrinol Metab 48:700‑705, 1979. 46. Burman, K.D., Dinterman, R., Wartofsky, L., Kesler, P., and Wannemacher, R.W.: The Effect of T3 and Reverse T3 on Skeletal Muscle Catabolism During Fasting as Measured by 3‑Methylhistidine Excretion. Metabolism 28:805‑813, 1979. 47. Burman, K.D., Harvey, G.S., O’Brian, J.T., Georges, L.P., Bruton, J., Dimond, R.C., and Wartofsky, L.: Glucose Modulation of Alterations in Peripheral Thyroid Hormone Metabolism Induced by Fasting. Metabolism 28:291‑299, 1979. 48. Casterline, P.F., Jaques, D., Blom, H., and Wartofsky, L. Anaplastic Giant and Spindle Cell Carcinoma of the Thyroid: A Different Therapeutic Approach. Cancer 45:1689‑1692, 1980. 49. Boehm, T.M., McLain, J., Burman, K.D., DeShazo, R., and Wartofsky, L.: Treatment of Iodine Induced Thyrotoxicosis with Iodine. J Endocrinol Investigation 4:419‑424, 1980. 50. Burman, K.D., Latham, K.R., Djuh, Y.Y., Smallridge, R.C., Tseng, Y.L., Lukes, Y.G., Maunder, R., and Wartofsky, L.: Solubilized Nuclear T3 and T4 Receptors in Circulating Human Mononuclear Cells: Evidence for Increased Maximum Binding Capacities in Fasted Obese Subjects. J Clin Endocrinol Metab 51:106‑116, 1980. 51. Burman, K.D., Smallridge, R.C., Osburne, R., Dimond, R.C., Whorton, N.E., Kesler, P., and Wartofsky, L.: Nature of Suppressed TSH Secretion During Undernutrition: Effect of Fasting and Refeeding on TSH Responses to Prolonged TRH Infusions. Metabolism 29:46‑52, 1980. 52. Burman, K.D., Smallridge, R.C., Jones, L., Ramos, E.A., O’Brian, J.T., Wright, F.D., and Wartofsky, L.: Glucagon Kinetics in Fasting: Physiological Elevations in Serum 3,5,3’‑Triiodothyronine Increase the Metabolic Clearance Rate of Glucagon. J Clin Endocrinol Metab 51:1158‑1165, 1980. 53. Smallridge, R.C., Burman, K.D., Ward, K.E., Dimond, R.C., Wright, F.D., Latham, K.R., and Wartofsky, L.: 3’,5’‑Diiodothyronine to 3’‑Monoiodothyronine Conversion in the Rat: Enzyme Characteristics and Evidence for Two Distinct 5’‑deiodinases. Endocrinology 108:2336, 1981. 54. O’Brian, J.T., Bybee, D.E., Burman, K.D., Osburne, R.C., Ksiazek, M.R., Wartofsky, L., and Georges, L.P.: Thyroid Hormone Homeostasis in States of Relative Caloric Deprivation. Metabolism 29:721, 1980. 55. Pangaro, L., Burman, K.D., Wartofsky, L., Cahnmann, H.J., Smallridge, R.C., O’Brian, J.T., Wright, F.D., and Latham, K.R.: Radioimmunoassay for 3,5‑Diiodothyronine (3,5T2) and Evidence for Dependence on Conversion from T3. J Clin Endocrinol Metab 50:1075‑1081, 1980. 56. Boehm, T.M., Burman, K.D., Barnes, S., and Wartofsky, L.: Synergism of Lithium and Iodide in the Treatment of Thyrotoxicosis. Acta Endocrinologica 94:174‑183, 1980. 57. Becker, R.A., Wilmore, D.W., Aulick, L.H., Goodwin, C.W., Wartofsky, L., and Burman, K.D.: Thyroid Function in Burn Patients. J of Trauma 20:713‑721, 1980. 58. Wray, H.L., Burman, K.D., Smallridge, R.C., Alford, J.P., Butler, V.V., Wright, F.D., and Wartofsky, L.: Effect of T3 and Reverse T3 Administration on Serum Tri‑, Di‑, and Monoiodothyronines and Plasma Cyclic Nucleotides in Sheep. Endocrinology 107:130‑136, 1980. 59. Thompson, P., Burman, K.D., Lukes, Y.G., McNeil, J.S., Jackson, B.D., Latham, K.R., and Wartofsky, L.: Uremia Decreases Nuclear T3 Receptors in Rats. Endocrinology 107:1081‑1084, 1980. 60. Burman, K.D., Lukes, Y.G., Latham, K.R., and Wartofsky, L.: Ipodate and 8‑Anilino‑1‑Naphthalene Sulfonic Acid Block Receptor Binding of T3 in Rat Liver. Hormone and Metabolic Research 12:685‑687, 1980.
61. Burman, K.D., Lukes, Y.G., Latham, K.R., Glass, A.R., Smallridge, R.C., and Wartofsky, L.: The Effect of Dexamethasone, Diet Control, and Hyperglycemia on Murine Hepatic T3 Receptors. Life Sciences 28:1701‑1712, 1981. 62. Wartofsky, L., Latham, K.R., Djuh, Y.Y., and Burman, K.D.: Alterations in T3 and T4 Receptor Binding in Fasting and Diabetes Mellitus. Life Sciences 28:1683‑1691, 1981. 63. Smallridge, R.C., Burman, K.D., Smith, C.E., Latham, K.R., Wright, F.D., and Wartofsky, L.: Metabolic Clearance and Production Rates of 3’,5’‑Diiodothyronine in Hyperthyroidism and Hypothyroidism in Man: Comparison of Infusions Using Radiolabeled Versus Unlabeled Iodothyronine. J Clin Endocrinol Metab 52:722‑730, 1981. 64. Smallridge, R.C., Wartofsky, L., Burman, K.D.: The Effect of Experimental Hyper‑ and Hypothyroidism on 5’‑monodeiodination of Reverse T3 and 3’5’‑Diiodothyronine by Rat Liver and Kidney. Endocrinology 111:2066‑2069, 1982. 65. Thompson, P.T., Burman, K.D., and Wartofsky, L.: Iodothyronine Levels in Cerebrospinal Fluid. J Clin Endocrinol Metab 54:653‑655, 1982. 66. Burman, K.D., Bongiovanni, R., Garis, R.K., Wartofsky, L., and Boehm, T.M.: Measurement of Serum T4 Levels by High Pressure Liquid Chromatography. J Clin Endocrinol Metab 53:909‑912, 1981. 67. Chernow, B., Burman, K.D., Johnson, D.L., McGuire, R.A., O’Brian, J.T., Wartofsky, L., Georges, L.P.: T3 May Be a Better Agent Than T4 in the Critically Ill Hypothyroid Patient: Evaluation of Transport Across the Blood‑brain Barrier in a Primate Model. Critical Care Med 11:99‑104, 1983. 68. DeRuyter, H., Burman, K.D., Wartofsky, L., and Taylor, S.: Effect of Thyroid Hormones on the Insulin Receptor in Rat Liver Membranes. Endocrinology 110:1981. 69. Smallridge, R.C., Mehlman, I., Pamplin, C.L. Whorton, N.E., Dimond, R.C., Doyle, T., and Wartofsky, L.: Pituitary and Thyroid Function in the Male Cynomolgus Monkey. Laboratory Animal Science 31:693‑696, 1981. 70. Smallridge, R.C., Glass, A.R., Wartofsky, L., Latham, K.R., and Burman, K.D.: Investigations into the Etiology of Elevated Serum T3 Levels in Protein Malnourished Rats. Metabolism 31:538‑542, 1982. 71. Wartofsky, L. and Burman, K.D.: Alterations in Thyroid Function in Patients with Systemic Illness: The “Euthyroid Sick Syndrome,” Endocrine Reviews 3:164‑217, 1982. 72. Smith, C.E., Smallridge, R.C., Dimond, R.C., and Wartofsky, L.: Hyperthyroidism Due to a Thyrotropin Secreting Pituitary Adenoma. Studies of Thyrotropin and Subunit Secretion. Arch Intern Med 142:1709‑1712, 1982. 73. Jurney, T., Wartofsky, L., and Smallridge, R.C.: Propranolol Decreases Serum Thyroxine as Well as Triiodothyronine in Rats: A Protein Binding Effect. Endocrinology 112:727‑732, 1983. 74. DeRuyter, H.A., Burman, K.D., Wartofsky, L., and Smallridge, R.C.: Thyrotropin Secretion in Starved Rats is Enhanced by Somatostatin Antiserum. Hormone and Metabolic Research 16:92‑96, 1984. 75. Burman, K.D., Smallridge, R.C., Burge, J.R., Carlson, D., and Wartofsky, L.: Ipodate Restores the Fasting‑Induced Decrement in Thyrotropin Secretion. J. Clin Endocrinol 57:597‑602, 1983. 76. Burman, K.D., Ferguson, E.W., Djuh, Y.Y., Wartofsky, L., and Latham, K.: Beta Receptors in Peripheral Mononuclear Cells Increase Acutely During Exercise. Acta Endocrinologica 109:563‑568, 1985. 77. Glass, A.R., Vigersky, R.A., Rajatanavin, R., Smallridge, R.C., Pardridge, W.M., Wartofsky, L., and Burman, K.D.: Low Serum Thyroxine and High Serum Triiodothyronine in Nephrotic Rats: Etiology and Implications for Bioavailability of Protein‑Bound Hormone. Endocrinology 114:1745‑1753, 1984. 78. Wartofsky, L.: Diagnostic Indications for Free Thyroid Hormone Measurement in Thyroid and Non‑Thyroid Disorders. J. Clinical Immunoassay 7:181‑191, 1984. 79. Jurney, T.H., and Wartofsky, L.: Thyrotropin‑Releasing Hormone in an Outpatient Clinic. Southern Medical J:78:774‑781, 1985. 80. Tseng Y‑C, Burman, K.D., Baker, J.R., and Wartofsky, L: A Rapid and Sensitive Enzyme‑Linked Immunoassay (EIA) for Human Thyrotropin (TSH). Clinical Chemistry, 31:1131‑1134, 1985.
81. Hennessey, J.V., Burman, K.D., Wartofsky, L.: The Equivalency of Two L‑thyroxine Preparations. Annals Intern Med, 102:770‑773, 1985.
81a. Hennessey, J.V., Burman, K.D., Wartofsky, L.: Thyroxine bioequivalency. Annals Intern Med 103:647, 1985 (Letter). 82. Raines, K.B., Baker, J.R., Lukes, Y.G., Wartofsky, L., Burman, K.B.: Anti‑thyrotropin Antibodies in the Sera of Graves’ Disease Patients. J Clin Endocrinol Metab, 61:217‑222, 1985. 83. Hennessey, J.V., Evaul, J.E., Tseng, Y‑C., Burman, K.D., Wartofsky, L.: L‑Thyroxine Dosage: A Re‑evaluation of Therapy With Contemporary Preparations. Annals Intern Med 105:11‑15, 1986. 83a. Hennessey, J.V., Evaul, J.E., Tseng, Y‑C., Burman, K.D., Wartofsky, L.: Reevaluation of L‑thyroxine Dose. Ann Int Med 105:797‑798, 1986 (Letter). 84. Sack, J., Baker, J.R., Weetman, A.P., Wartofsky, L., Burman, K.D.: Killer Cell Activity and Antibody‑dependent Cell Mediated Cytotoxicity are Normal in Hashimoto’s Disease. J Clin Endocrinol Metab 62:1059‑1064, 1986. 85. Smallridge, R.C., DeKeyser, F.M., Van Herk, A.J., Butkus, N.E., Wartofsky, L.: Thyroid Iodine Content and Serum Thyroglobulin: Cues to the Natural History of Destruction Induced Thyroiditis. J. Clin. Endocrinol. Metab. 62:1213‑1219, 1986. 86. Burman, K.D., Smallridge, R.C., Burge, J.R., O’Brian, J.T., Wartofsky, L.: Iodide Administration Enhances Thyrotropin Responsiveness to TRH During Fasting: Evidence for Normal Pituitary Feedback Regulation. Clinical Endocrinology 26:9‑15, 1987. 87. Ahmann, A., Baker, J.R., Jr., Weetman, A.P., Wartofsky, L., Nutman, T.B., Burman, K.D.: Antibodies to Porcine Eye Muscle in Patients with Graves’ Ophthalmopathy: Identification of Serum Immunoglobulins Directed Against Unique Determinants by Immunoblotting and Enzyme‑Linked Immunosorbent Assay. J. Clin. Endocrinol. Metab. 64:454‑460, 1987. 88. Sack, J., Baker, J.R. Jr., Weetman, A.P., Wartofsky, L., Burman, K.D.: Thyrocyte Specific Killer Cell Activity is Decreased in Patients With Thyroid Carcinoma. Cancer 59:1914‑1917, 1987. 89. Tseng, Y‑C., Burman, K.D., Baker, J.R. Jr., D’Avis, J., Wartofsky, L.: Intrinsic Abnormality of Thyroid Cells From A Patient with A Brobdingnagian Goiter. J Endocrinological Investigation 10:517‑522, 1987. 90. Solomon, B., Evaul, J., Burman, K., and Wartofsky, L.: Remission Rates with Antithyroid Drug Therapy: Continuing Influence of Iodine Intake? Ann Intern Med 107:510‑512, 1987. 91. Wartofsky, L., and Schaaf M. Graves’ Disease with Thyrotoxicosis Following Subacute Thyroiditis. Amer J Med 83:761‑764, 1987. 92. Baker, J.R., Saunders, N.A., Tseng, Y‑C., Wartofsky, L., Ahmann, A., and Burman K.D.: Seronegative Hashimoto Thyroiditis with Thyroid Autoantibody Production Localized to the Thyroid. Ann Intern Med 108:26‑30, 1988. 93. Dolev, E., Deuster, P.A., Solomon, B., Trostmann, V., Wartofsky, L., Burman, K.D.: Alterations in Magnesium and Zinc Metabolism in Thyroid Disease. Metabolism 37:61‑67, 1988. 94. Nuovo, J.A., Baker, J.R. Jr., Wartofsky, L., Lukes, Y.G., Burman, K.D.: Autoantibodies to Insulin are Present in the Sera of Patients with Autoimmune Thyroid Disease. Diabetes 37:317‑320, 1988. 95. Hayslip, C.C., Baker, J.R. Jr., Wartofsky, L., Klein, T., Opsahl, M.S., Burman, K.D.: Natural Killer Cell Activity and Serum Autoantibodies in Women with Postpartum Thyroiditis. J Clin Endocrinol Metab 6:1089‑1093, 1988. 96. Sack, J., Zilberstein, D., Barile, M.F., Wartofsky, L., Lukes, Y.G., Baker, J.R. Jr., Burman, K.D.: Binding of Thyrotropin to Selected Mycoplasma Species: Detection of Serum Antibodies Against a Specific Mycoplasma Membrane Antigen in Patients with Auto‑Immune Thyroid Disease. J Endocrinol Invest 12:77‑86, 1989. 97. Sellitti, D.F., Tseng, Y‑C., and Wartofsky, L.: Receptors for Atrial Natriuretic Factor (ANP) and Regulation of Thyroglobulin Secretion by ANP in Human Thyroid Cells. Life Sciences 45:793‑801, 1989. 98. Tseng, Y‑C. L., Sellitti, D.F., Ahmann, A.J., Burman, K.D., D’Avis J.C., and Wartofsky, L.: Thyrotropin Modulates Receptors for Atrial Natriuretic Factor on Intact Human Thyroid Cells. Amer J Med Sci 298:15‑19, 1989. 99. Tseng, Y‑C. L., Schaudies, P., Ahmann, A.J., D’Avis, J.C., Burman, K.D., and Wartofsky, L.: Effects of Epidermal Growth Factor on Thyroglobulin and Cyclic AMP Production by Human Thyrocytes in Long Term Culture. J Clin Endocrinol Metab 69:771‑775, 1989. 100. Smallridge, R.C., Burman, K.D., Wartofsky, L.: Malabsorption of Thyroxine, Calcium, and Vitamin D in a Thyroparathyroidectomized Woman: Efficacy of Therapy with Medium Chain Triglyceride Oil. Military Medicine 155:156‑158, 1990. 101. Tseng, Y‑C.L., Lahiri, S., Sellitti, D.F., Burman, K.D., D’Avis, J.C., Wartofsky, L.: Characterization by Affinity Cross‑Linking of a Receptor for Atrial Natriuretic Peptide in Cultured Human Thyroid Cells Associated with Reductions in Both Adenosine 3’,5’‑Monophosphate Production and Thyroglobulin Secretion. J Clin Endocrinol Metab 70:528‑533, 1990. 102. Solomon, B., Glinoer D., Lagasse, R., Wartofsky, L.: Current Trends in the Management of Graves’ Disease. J Clin Endocrinol Metab 70:1518‑1524, 1990. 103. Burman, K.D., Anderson, J.H., Wartofsky, L., Mong, D.P., Jelinek, J.J.: Detection of Thyroid Carcinoma by Thallium‑201 Scintigraphy and Magnetic Resonance Imaging (MRI). J Nucl Med 31:1958‑1964, 1990. 104. Wartofsky, L., Glinoer, D., Solomon, B., Nagataki, S., LaGasse, R., Nagayama, Y., Izumi, M.: Differences and Similarities in the Diagnosis and Treatment of Graves’ Disease in Europe, Japan, and the United States. Thyroid 1:(2) 129‑135,1991. 105. Humphrey, M., Mosca, J., Baker, J.R., Drabick, J., Carr, F.E., Burke, D., Wartofsky, L, Djuh, Y‑Y, Burman, K.D.: Absence of Retroviral DNA Sequences in Genomic DNA Isolated from Patients with Graves’ Disease. Lancet 337:17‑18, 1991. 106. Tseng, Y‑C.L., Burman, K.D., Lahiri, S., Abdelrahim, M.M., D’Avis, J.C., and Wartofsky, L.: Thyrotropin Modulates Internalization and Processing of the Atrial Natriuretic Peptide Receptor Complex in Cultured Thyroid Cells. J Clin Endocrinol Metab 72:669‑674, 1991. 107. Brennan M.J., Duncan, W.E., Wartofsky, L., Butler, V.M., Wray, H.L.: In Vitro Dissolution of Calcium Carbonate Preparations. Calcified Tissue International 49:308-312, 1991. 108. Poth, M., Tseng, Y‑C.L., Wartofsky, L.: Inhibition of Thyrotropin Activation of Human Cultured Thyroid Cells by Tumor Necrosis Factor: An Explanation for Reduced Hormone Release in the Sick Euthyroid Syndrome? Thyroid 1(3):235-240, 1991. 109. Wartofsky, L., Glinoer D., Solomon B., LaGasse R.: Differences and Similarities in the Treatment of Diffuse Toxic Goiter in Europe and the United States. Exp Clin Endocrinol 97:243-251, 1991. 110. Francis, T., Burch, H.B. Cai, W-Y., Lukes, Y., Peele, M., Carr, F.E., Wartofsky, L., Burman, K.D.: Lymphocytes Express Thyrotropin Receptor Specific mRNA as Detected by the PCR Technique. Thyroid 1(3):223-228, 1991. 111. Gililland, J., Tseng, Y.L., Wartofsky, L.: Atrial Natriuretic Peptide Receptors in Human Endometrial Stromal Cells. J Clin Endocrinol Metab 75:547-53, 1992. 112. Burman, K.D., Wartofsky, L., Lukes, Y.G., Djuh, Y‑Y., Wortsman, J., Baker, J.R. Jr.: TSH Receptor Antibody and Anti‑Idiotypic Antibody Containing Immune Complexes in the Serum of Patients with Graves’ Disease. (1993). 113. Sack, J., Zilberstein, D., Gemski, P., Wartofsky, L., Burman, K.D.: Thyrotropin Binding Sites in Yersinia Enterocolitica. (1994). 114. Burch, H.B., Lukes, Y.G., Cai, W‑Y., Wartofsky, L., Burman, K.D.: A Unique Region of the Human Thyrotropin Receptor has Nucleotide and Amino Acid Sequence Homology With the HIV‑1 NEF Protein. Biochem Biophys Res Comm 181:498-505, 1991. 115. Cai, W‑Y., Lukes, Y.D., Burch, H.B., Djuh, Y‑Y., Carr, F., Wartofsky, L., Rhooms, P., d’Avis, J.C., Baker, J.R. Jr., Burman, K.D.: Analysis of Human TSH Receptor Gene and RNA Transcripts in Patients with Thyroid Disorders. Autoimmunity 13:43-50, 1992. 116. Wartofsky, L.: Has the Use of Antithyroid Drugs for Graves’ Disease Become Obsolete? Thyroid 3: (4) 335-344, 1993. 117. Tseng, Y.L., Burman, K.D., Lahiri, S., d’Avis, J.C., Wartofsky, L.: Thyrotropin Modulates Epidermal Growth Factor (EGF) Binding to Receptors on Cultured Thyroid Cells by Inducing Receptor‑Mediated EGF Internalization. Thyroid 2:181-187, 1992. 118. Peele, M.E., Carr, F., Baker, J.R. Jr., Wartofsky, L., Burman, K.D.: TSH Beta Subunit Gene Expression in Human Lymphocytes. Amer J Med Sci, 305:1-7, 1993. 119. Solomon, B.L., Wartofsky, L., Burman, K.D.: Adjunctive Cholestyramine Therapy for Thyrotoxicosis. Clinical Endocrinology 38:39-43, 1993. 120. Burman, K.D., Djuh, Y‑Y., Nicholson, D., Rhooms, P., Wartofsky, L., Fein, H., Usala, S.J., Hao, E‑H., Bradley, W.E.C., Berard, J., Smallridge, R.C.: Generalized Thyroid Hormone Resistance: Identification of a Mutation in Codon 315 of the C‑erb A Beta Thyroid Hormone Receptor. J Endocrinol Invest 15:573-579, 1992. 121. Burch, H.B., Nagy, E.V., Kain, K.C., Lanar, D.E., Carr, F.E., Wartofsky, L., Burman, K.D.: Expression Polymerase Chain Reaction for the In Vitro Synthesis and Epitope Mapping of Autoantigen: Application to the Human Thyrotropin Receptor. J Immunolog Methods 158:123-130, 1993. 122. Jackson, S., Tseng, Y.L., Burman K.D., Wartofsky, L.: Receptors for Endothelin in Cultured Human Thyroid Cells and Inhibition by Endothelin of Thyroglobulin Secretion. J Clin Endocrinol Metab 75:388-392, 1992. 123. Tseng, Y.L., Lahiri, S., Jackson, S., Burman, K.K., and Wartofsky, L.: Endothelin Production by Human Thyroid Follicular Cells and Its Modulation by Thyrotropin and Transforming Growth Factor Beta. J Clin Endocrinol Metab 76:156-161, 1993. 124. Burch, H.B., Wartofsky, L.: Graves’ Ophthalmopathy: Current Concepts Regarding Pathogenesis and Management. Endocrine Reviews 14:747-793, 1993. 125. Solomon BL, Wartofsky L, Burman KD: Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 3:17-23, 1993. 126. Duncan, W.E., Chang, A., Solomon, B., and Wartofsky, L: Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 4:183-190, 1994. 127. Levetan, C., and Wartofsky, L: A Clinical Guide to the Management of Graves’ disease with radioactive iodine. Endocrine Practice 1: 205-212, 1995. 128. Burch, H.B., Solomon B.L., Wartofsky, L., and Burman K.D. Discontinuing antithyroid therapy before ablation with radioiodine in Graves’ disease. Annals Internal Med 121:553-559, 1994. 128a. Burch H.B., Wartofsky L, Burman KD. Antithyroid drugs and radioiodine therapy. Annals Int Med 122:554, 1995 (Letter). 128b. Burch HB, Wartofsky L, Burman KD. Radioiodine therapy in Graves’ disease. Annals Int Med 122:555, 1995 (Letter). 129. Wartofsky, L. Graves’ ophthalmopathy: Concerns over its aggravation by radioactive iodine treatment and the utility of retrobulbar radiation therapy. In: Therapeutic Controversies - Radiation and Graves’ Ophthalmopathy, DeGroot LJ, Gorman CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel MF, Wartofsky, L. J Clin Endocrinol Metab 80:339-349, 1995. 130. Wartofsky, L. Thyroxine therapy and osteoporosis: An end to the controversy? .Archives Int Med 155:1130-31, 1995. 130a. Wartofsky, L. Thyroid hormones and osteoporosis. Archives Int Med 156:341, 1996 (Letter).
130b. Wartofsky, L. Thyroid hormone use and fractures. Archives Int Med 156:341-344, 1996 (Letter).
131. Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well-differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81:333-339, 1995. 132. Tseng, Y.L., Lahiri, S., Nicholson, D., Burman, K.D., Wartofsky, L.: Evidence of an association of Endothelin-1 Receptor Expression to the Active Growth Phase of the Cell Cycle and Identification of Endothelin-1 mRNA in FRTL-5 cells. Endocrinology and Metabolism 3:37-47, 1996.
133. Wartofsky, L. The scope and impact of thyroid disease. Clinical Chemistry 42: 121-124, 1996. 134. Lahiri S., Nicholson D.E., Burman K.D., Wartofsky, L., Tseng Y-C.L., Burch H.B. Identification of endothelin messenger RNA in human thyroid tissue and cultured human thyrocytes. (Submitted for publication). 135. Wartofsky, L. Radioiodine therapy for Graves’ disease: Case selection and restrictions recommended to patients in North America. Thyroid 7: 213-216, 1997. 136. Ayala, A., and Wartofsky, L. Minimally symptomatic (subclinical) hypothyroidism. The Endocrinologist 7 (1) 44-50, 1997. 137. Wartofsky, L. Bioequivalence of levothyroxine preparations: Shortcomings and implications of a recently published study. The Endocrinologist 7:322-333, 1997. 137a. Wartofsky, L. Bioequivalence of levothyroxine preparations: Shortcomings and implications of a recently published study. Letters to Editor incl. Dong, B. et al: The Endocrinologist 8:149-51, May 1998, and 9:(1)1999,6-7. 138. Pacak K, Sweeney DC, Wartofsky L, Mark AS, Punja U, Azzam C, Burman KD. Case report: Solitary cerebellar metastases from papillary thyroid carcinoma. Thyroid 8:327-335, 1998. 139. Prendiville S, Burman KD, Wartofsky L, Ringel M, Sessions RB. Evaluation and treatment of post thyroidectomy hypocalcemia. The Endocrinologist 8:34-40, 1998. 140. Wartofsky, L. Radioiodine in the treatment of Graves’ disease. Current Opinion Endocrin Diab 5(4): 288-295, 1998. 141. Wartofsky, L., Management of patients with scan negative, thyroglobulin positive differentiated thyroid carcinoma. In: Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID., The Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer. J Clin Endocrinol Metab 83:4195-4203, 1998. 142. Lu R, Wang P, Wartofsky L, Sutton BD, Zweier JL, Bahn RS, Garrity J, Burman KD. Oxygen free radicals in IL-1β-induced glycosaminoglycan production by retroocular fibroblasts from normal subjects and patients with Graves’ ophthalmopathy. Thyroid 9:297-303, 1999. 143. Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM. Quantitative reverse transcriptase polymerase chain reaction of circulating thyroglobulin messenger RNA for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 84:4037-42, 1999. 144. Gardner RE, Tuttle RM, Burman KD, Haddady S, Truman C, Sparling YH, Wartofsky L, Sessions RB, Ringel MD. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 126:309-312, 2000. 145. Burman KD, Wartofsky L. Iodine effects on the thyroid gland: biochemical and clinical aspects. Reviews in Endocrine and Metabolic Disorders 1:19-25, 2000. 146 Wartofsky L, Burman KD, Ringel MD. Trading one dangerous dogma for another? Thyroid hormone treatment of the “euthyroid sick syndrome”. (Letter to the Editor) J Clin Endocrinol Metab 84:1759-60, 1999. 147. Prendiville S, Burman KD,, Ringel M, Shmookler BM, Deeb ZE, Wolfe K, Azumi N, Wartofsky L, Sessions RB. The tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol-Head & Neck Surg 122:352-7, 2000. 148. Torréns JI, Bernet V, Solomon B, Mahoney K, Wartofsky L, Burman KD, Duncan WE. Cyclic etidronate prevents loss of lumbar spine bone mineral in women on levothyroxine therapy. (Submitted for publication). 149. Fadel BM, Ellahham S, Ringel MD, Lindsay J, Wartofsky L, Burman KD. Hyperthyroid heart disease. Clin Cardiol 23:402-408, 2000. 150. Iudica-Souza C, Adair C, Poth P, and Wartofsky, L. Thyrotoxicosis ectopia et eutopia: Struma ovarii and Graves’ disease. The Endocrinologist 10: 60-64, 2000. 151. Newkirk KA, Ringel MD, Wartofsky L, Burman KD. The role of radioactive iodine in salivary gland dysfunction. Ear, Nose & Throat J 49:460-68, 2000. 152. Newkirk KA, Ringel MD, Jelinek J, Mark A, Wartofsky L, Deeb ZE, Sessions RB, Burman KD. Ultrasound-guided fine-needle aspiration and thyroid disease. Otolaryngol Head Neck Surg 123:700-05, 2000. 153. Stathatos N, Levetan, C., Burman KD, and Wartofsky, L. Is there a role for thyroid hormone treatment in the sick euthyroid syndrome? Baillieres Best Practice & Research: Clinical Endocrinology & Metabolism, Van den Berghe G. (Ed.) Endocrinology in Critical Care Medicine, 15: 465-477, 2001. 154. Karl M, Ellahham S, Wartofsky L, Burman KD. Thyrotoxicosis associated with rapidly reversible low-output heart failure and dilated cardiomyopathy. (Submitted for publication). 155. Lu R, Ringel MD, Vodovotz Y, Rees J, Balducci-Silano PL, Wartofsky L, Garrity J, Bahn RS, Burman KD. Modulation of Fas expression and apoptosis in retroocular fibroblasts. Submitted for publication. 156. Wartofsky, L. Update in Endocrinology, Annals Internal Medicine 135:601-609, 2001. 157. Stathatos N, and Wartofsky, L. Management of Thyroid Storm. J Intensive Care Med 17: 1-7, 2002. 158. Van Nostrand D, Atkins F, Yeganeh F, Acio E, Bursaw R, Wartofsky, L. Dosimetrically-determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 12: (2) 121-134, 2002. 159. Stathatos N, and Wartofsky, L. Subclinical Thyroid Disease in Women. Women’s Health in Primary Care 5: 239-246, 2002. 160. Ayala A, and Wartofsky, L. The case for more aggressive screening and treatment of mild thyroid failure (“Subclinical” hypothyroidism). Cleveland Clinic Journal of Medicine, 69:313-320, 2002. 161. Wartofsky, L. Using baseline and recombinant human TSH-stimulated thyroglobulin measurements to manage thyroid cancer without diagnostic 131-I scanning. J Clin Endocrinol Metab 87: 1486-1489, 2002. 162. Stathatos N, and Wartofsky, L. Acute Presentations of Thyroid Disease: Thyroid Storm and Myxedema Coma. Emergency Medicine, February 2003, pp. 22 - 30. 163. Wartofsky L (and the rhTSH-Stimulated Thyroglobulin Study Group). Management of low-risk well- differentiated thyroid cancer based only upon thyroglobulin measurement after recombinant human thyrotropin, Thyroid 12: 583-92, 2002. 164. Wartofsky, L. Levothyroxine: Therapeutic use and regulatory issues related to bioequivalence. Expert Opin Pharmacother 3: 727-732, 2002. 165. Oertel YC, Burman KD, Boyle L, Ringel M, Wartofsky L, Shmookler B, Yeganeh F, Van Nostrand D. Integrating fine needle aspiration into a daily practice involving thyroid disorders: the Washington Hospital Center approach. Diagnostic Cytopathology 27:120-122, 2002. 166. Mazzaferri, E.L, Robbins, R.J., Spencer, C.A., Braverman L.E, Pacini, F., Wartofsky, L., Haugen, B., Sherman S.I., Cooper D.S., Braunstein, G. D., Lee, S., Davies, T.F., Arafah, B.M., Pinchera, A. A Consensus Report on the Role of Serum Thyroglobulin as a monitoring method for Low Risk Patients with Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 88:1433-1441, 2003. 166a. Mazzaferri, E.L, Robbins, R.J., Braverman L.E, Pacini, F., Haugen, B , Wartofsky, L., Braunstein, G. D., Ladenson PW, Pinchera, A. Letters to the Editor Re: “A Consensus Report on the Role of Serum thyroglobulin as a monitoring method for Low Risk Patients with Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 88:4508-4510, 2003. 167. Stathatos N, and Wartofsky, L. The euthyroid sick syndrome: Is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Investig. 26:1174-1179, 2003. 168. Wartofsky, L. Combined Levotriiodothyronine and Levothyroxine therapy for hypothyroidism: Are we a step closer to the magic formula? Thyroid 14: 247-248, 2004. 169. Wartofsky, L., Dickey R. The evidence for a lower reference range for thyrotropin (TSH) is compelling. J Clin Endocrinol Metab 90:5483-5488, 2005. 170. Wartofsky, L. Levothyroxine therapy of Hypothyroidism: Should we abandon conservative dosage titration? Archives Internal Medicine 165:1683-84, 2005. 171. Dickey RA, Wartofsky L, Feld S. Optimal TSH level: ‘normal ranges’ and ‘reference intervals’ are not equivalent. Thyroid 15: 1035-1039, 2005. 172. Wartofsky, L. Update in Endocrinology 2004-2005, Annals Internal Medicine 143: 673-682, 2005. 173. Kulkarni K, Van Nostrand D, Atkins F, Aiken M, Burman K, and Wartofsky, L. The Relative Frequency in which Empiric Dosages of Radioiodine Would Potentially “Over-” or “Under-” Treat Patients Who Have Metastatic Well-Differentiated Thyroid Cancer. Thyroid 16:1019- 1051, 2006. 174. Wartofsky L, Van Nostrand D, Burman KD. Overt and Subclinical Hypothyroidism in Women. Obstet Gynecol Survey 61:535-542, 2006. 175. Monge C, DeMarco P, Burman KD, Wartofsky, L. Autoimmune thyroid disease and Chronic Urticaria. Clinical Endocrinology 67: 473-76, 2007. 176. Duntas LH, Wartofsky, L. Cardiovascular Risk and Subclinical Hypothyroidism: Focus on Lipids and new emerging risk factors. What is the Evidence? Thyroid: 17: 1075-1084, 2007. 177. Seiboth L, Van Nostrand D, Wartofsky L, Ousman Y, Jonklaas J, Butler C, Burman K. Analysis of the role of PET/MRI digital fusion images in detection and management of recurrent or persistent thyroid cancer. Thyroid: 18: 103-111, 2008. 178. Nadkarni PJ, Sharma M, Zinsmeister B, Wartofsky L, Burman KD.. Thyrotoxicosis-Induced Ventricular Arrhythmias, Thyroid 18:1111-14, 2008. 179. Alexandrescu DT, Popoveniuc G, Farzanmehr H., Dawson N, Wartofsky L, Sunitinib-induced Lymphocytic Thyroiditis with Augmented Thyroid Hormone Release, Thyroid 18: 809-12, 2008. 180. Burman, KD, Hennessey JV, McDermott MT, Wartofsky L, Emerson CH. The FDA Revises Requirements for Levothyroxine Products, Thyroid 18: 1-4, 2008. 181. Karl M., Onumah BM, Cole J, Golding J, Burman KD, Wartofsky, L. Hypocortisolemia in Graves’ Hyperthyroidism. Endocrine Practice 15:220-224, 2009. 182. Loh J, Wartofsky L, Jonklaas J, Burman KD. Magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon etiology of the hypothyroidism. Thyroid 19:269-275, 2009. 183. Van Nostrand D, Atkins F, Moreau S, Aiken M, Kulkarni K, Wu JS, Burman KD, Wartofsky, L. The utility of the whole- body retention at 48 hours for modifying empiric activity of 131-Iodine for the treatment of metastatic well-differentiated thyroid carcinoma. Thyroid 19: 1093-98, 2009. 184. Klubo-Gwiezdzinska J, Wartofsky L. Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient. Archives Intern Med 169:1949-51, 2009. 185. Van Nostrand D, Atkins F, Bandaru VV, Chennupati SP, Moreau S, Burman K, Wartofsky L. Salivary gland protection from sialogogues: A case study. Thyroid 19:1005-1008, 2009. 186. Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, Wartofsky L. The utility of radioiodine scans prior to Iodine-131 ablation in patients with well-differentiated thyroid cancer. Thyroid 19:849-55, 2009. 187. Wartofsky L. American Thyroid Association Guidelines for patients with thyroid nodules or differentiated thyroid carcinoma: The 2009 Revision. Thyroid 19: 1139-1143, 2009. 188. Klubo-Gwiezdzinska J, Van Nostrand D, Burman KD, Vasko V, Chia S, Deng T, Kulkarni K, Wartofsky L. Salivary gland malignancy and radioiodine therapy for thyroid cancer. Thyroid 20: 647-651, 2010. 189. Wartofsky L. Rising world incidence of thyroid cancer: Increased detection or higher radiation exposure? Hormones 9 (2):103-108, 2010. 190. Klubo-Gwiezdzinska J, Morowitz D, Van Nostrand D, Wartofsky L. Metastases of papillary thyroid carcinoma to the gastrointestinal tract. Thyroid 20: 381-387, 2010. 191. Popoveniuc G, Sharma M, Devdhar M, Wexler JA, Wartofsky L, Burman KD. Graves' disease and thymic hyperplasia: The relationship of thymic volume to thyroid function. Thyroid 20:1015-1018, 2010.
192. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Diagnostic and therapeutic use of human Recombinant thyrotropin (rhTSH) (Thyrogen®) in well differentiated thyroid cancer – current indications and future perspectives. Current Pharmaceutical Analysis 6: 1-14, 2010. 193. Van Nostrand D, Moreau S, Bandaru VV, Atkins F, Chennupati S, Mete M, Burman K, Wartofsky L. 124-I positron emission tomography versus 131-I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well differentiated thyroid cancer. Thyroid 20:879-883, 2010.
194. Klubo-Gwiezdzinska J, Jensen K, Bauer A, Patel A, Costello J, Burman KD, Wartofsky L, Hardwick MJ, Vasko VV, The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. J Endocrinology DOI:10.1530/JOE-12-0081; Vol. 214: 207-216, 2012.. 195. Klubo-Gwiezdzinska J, Manes RP, Chia SH, Burman KD, Stathatos NA, Deeb AE,, Wartofsky L. Ectopic cervical thyroid carcinoma: literature review with illustrative case series. J Clin Endocrinol Metab 96:2684-2691, 2011. 196. Rao R, Boyle L, Wartofsky L, Hofer S, Burman KD. The utility of intra-operative ultrasound during thyroid surgery. Submitted for publication 2013.
197. Henderson JA, Buchwald D, Goldberg J, Sorkin J, Wartofsky L, Jacobsen C, Howard BV. Is Subclinical Hypothyroidism a Risk Factor for Coronary Heart Disease? The Strong Heart Study. Submitted for publication, 2011. 198. Stein SA, Wartofsky L. Screening for thyroid disease in high-risk populations. Expert Rev Endocrinol Metab 63-671, 2011. 199. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? Clin Endocrinology (Oxf) 74: 111-117, 2011. 200. Kulkarni K, Van Nostrand D, Mete M, Burman KD, Wartofsky L. Detectability of foci of radioiodine uptake in the thyroid bed and neck comparing pinhole with parallel-hole collimators. Nucl Med Commun 32:369-74, 2011. 201. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Wartofsky L. Levothyroxine treatment in pregnancy: Indications, efficacy and therapeutic regimen. J Thyroid Research, Volume 2011 (2011), Article ID, doi:10.4061/2011/84391 (http://www.hindawi.com/journals/jtr/2011/843591). 202. Klubo-Gwiezdzinska J, Van Nostrand D, Atkins FB, Burman KD, Jonklaas J, Mete M, Wartofsky L. Efficacy of dosimetric versus empirically determined prescribed activity of 131-I for therapy of differentiated thyroid Cancer. J Clin Endocrinol Metab 2011 jc 2011-0494; doi:10.1210/jc.2011-0494; and J Clin Endocrinol Metab 96: 3217-3225, 2011.
203. Wartofsky L. Management of subclinical hyperthyroidism. J Clin Endocrinol Metab 96: 59-61, 2011.
204. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Mete M, Jonklaas J, Wartofsky L. Radioiodine treatment of metastatic thyroid cancer: Relative efficacy and side effect profile after preparation by thyroid hormone withdrawal vs. recombinant human TSH. Thyroid 22: 310-317, 2012. 205. Van Nostrand D., Khorjekar G., O’Neil J., Moreau S., Atkins F., Kharazi P., Mete M., Chennupati S., Burman K.D., Wartofsky L. Recombinant human thyroid stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole body and 124I PET. J Nuclear Med 53: 359-362, 2012. 206. Klubo-Gwiezdzinska J, Wartofsky L. Thyroid Emergencies. Med Clinics N. Amer 96: 385-403, 2012. 207. Wartofsky L. Management of papillary microcarcinoma: Primum non nocere. J Clin Endocrinol Metab 97: 1169-1172, 2012. 208. Klubo-Gwiezdzinska J, Jensen K, Costello J, Patel A, Bauer A, Burman KD, Wartofsky L, Vasko V. Metformin Inhibits Growth and Decreases Resistance to Anoikis in Medullary Thyroid Cancer Cells. Endocrine Related Cancer 19: 447-456, 2012. 209. Biondi B, Wartofsky L. Combination treatment with T4 and T3: Toward personalized replacement therapy in hypothyroidism. J Clin Endocrinol Metab 97: 2256-2271, 2012.
210. Wartofsky L, Van Nostrand D. Radioactive iodine treatment for well differentiated thyroid cancer. Endocrine; DOI: 10.1007/s12020-012-9729-5, 26 June 2012; Volume 42, Issue 3, pp. 506-513, 2012. 211. Wartofsky L. Clinical Criteria for the Diagnosis of Thyroid Storm. Thyroid 22:659-660,2012 212. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Mete M, Jonklaas J, Wartofsky L. Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. Endocrine Practice 19:139-148, 2013. 213. Kulkarni K, Van Nostrand D, Atkins F, Mete M, Wexler J, Wartofsky L. Does lemon juice increase radioiodine re-accumulation within the parotid glands greater than if lemon juice had not been administered? Nuclear Med Commun 35:210-216, 2014.
214. Stein SA, Wartofsky L. Primary Thyroid Lymphoma; A Clinical Review. J Clin Endocrinol Metab 98: 3131- 3138, 2013.
215. Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, Wartofsky L. A diagnostic scoring system for patients with myxedema coma. Endocrine Practice 8:808-817, August 2014. 216. Klubo-Gwiezdzinska J, Costello J, Patel A, Bauer A, Jensen K, Mete M, Burman K, Wartofsky L, Vasko VV. Treatment with Metformin is Associated with Higher Remission Rate in Diabetic Patients with Thyroid Cancer. J Clin Endocrinol Metab 98: 3269-3279, 2013. 217. Wartofsky L. Combination therapy with L-triiodothyronine and L-thyroxine for hypothyroidism. Curr Opinion Endocrinol Diabetes Obes 20:460-466, October 2013 218. Grewal AK, Wartofsky L, Kumar D, Murthy N, Chia SH. Malignant thyroid teratoma: Case report and review of the literature. Case Studies American Assn Clin Endocrinologists: 2: (4)Autumn 2016; e1-e 6. 219. Khorjekar GR, Van Nostrand D, Garcia C, O’Neil J, Moreau S, Atkins F, Mete M, Orquiza M, Burman K, Wartofsky L. Do negative 124-I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict a negative 131-I post-therapy scan? Thyroid 24: 1394-1399, 2014. 220. Biondi B, Wartofsky L. Treatment with Thyroid Hormone. Endocrine Reviews, published ahead of print: doi: 101210/er.2013-1083; 35: 433-512, June 2014. 221. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov Y, Pacini F, Randolph G, Sawka A, Shepard D, Sosa J, Tuttle RM, Wartofsky L, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Available online at Thyroid 25: DOI:10.1089/thy.2015.0020; print version in Thyroid 26:1-133, 2016. 222. Atkins F, Van Nostrand D, Moreau S, Burman K, Wartofsky L. Validation of a simple thyroid cancer dosimetry model based on the fractional whole body retention at 48 hours post administration of I-131. Thyroid 25: 1347-1350, 2015. 223. Chaudhury C, Wartofsky L., Burman K.D. Evaluation of thyroid bed nodules on ultrasonography after total thyroidectomy: risk for loco-regional recurrence of thyroid cancer. Europ Thyroid J 2015;4:- (DOI: 10.1159/000431317) http://www.karger.com/DOI/10.1159/000431317.; 4: 106-114, 2015. 224. Bikas A., Van Nostrand D., Jensen K., Desale S., Mete M., Patel A., Wartofsky L., Vasko V., Burman KD. Metformin Attenuates 131-I – Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. Thyroid 26:280-286, 2016. 225. Bikas A., Van Nostrand D., Jensen K., Desale S., Mete M., Patel A., Wartofsky L., Vasko V., Burman KD. Glucose-Deprivation Increases Thyroid Cancer Cells Sensitivity to Metformin, Endocrine-Related Cancer 22:919-932, 2015. 226. Singh I, Bikas A, Garcia CA, Wartofsky L, Desale S, Burman K. 18F-FDG-PET SUV as a prognostic marker of increasing size of Lesions in Thyroid Carcinoma. DOI:10.4158/EP161390.OR; Endocrine Practice 23:182-189, 2017. 227. Burman KD, Wartofsky L. The thyroid nodule. N Engl J Med 373: 2347-2356, 2015. 228. Bikas A., Kundra P., Desale S., Mete M., O’Keefe K., Clark BG., Wray L., Barett C., Jelinek J.S., Wexler J.A., Wartofsky L., Burman K.D. Phase II Clinical Trial of Sunitinib as Adjunctive Treatment in Patients with Advanced Differentiated Thyroid Cancer. Europ J. Endocrinol 174:373-380, 2016. 229. Bikas A, Schneider M, Desale S, Atkins F, Burman KD, Wartofsky L, Van Nostrand D. Effects of Dosimetrically-Guided I-131 Therapy on Hematopoiesis in Patients with Differentiated Thyroid Cancer. Submitted for publication, J Clin Endocrinol Metab 101:1762-1769, 2016. 230. Duntas LH, Wartofsky L. There is no "universal fit": Reflections on the use of 3-triiodothyronine in the treatment of hypothyroidism. Metabolism 2016: doi: 10.1016/j.metabol.2015.11.005; print version Metabolism 65: 428-431, 2016. 231. Burman KD, Wartofsky L. Thyroid Nodules. Correspondence N Engl J Med 374: 1294-1295, 2016. 232. Luster M, Aktolun C, Amendoera I, Barczynski M, Bible KC, Elisei R, Duntas L, Handkiewicz-Junak D, Hoffmann M, Jarzab B, Leenhardt L, Mushold TJ, Newbold K, Nixon I, Sobrinho-Simões M, Smit J, Sosa JA, Tuttle RM, Verburg FA, Wartofsky L, Fűhrer D. European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid cancer. Proceedings of an Interactive International Symposium. Thyroid 29:17-26, 2019. 233. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD. The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP. Thyroid 27:481-483, 2017. 234. Baxi SS, Kurtzman R, Eaton A, Dewey E, Bickford C, Fish S, Wartofsky L, Tuttle RM. Pilot study of a web-based decision tool on post-operative use of radioactive iodine. European Endocrinology, 13: 26-29, 2017. 235. Szczepanek-Parulska E, Zybek-Kocik A, Wartofsky L, Ruchała M. Thyroid hemiagenesis: incidence, clinical significance and genetic background, J Clin Endocrinol Metab 102:3124-3137, 2017. 236. Klubo-Gwiezdzinska J, Costello Jr. J, Jensen K, Patel A, Tikavc R, Van Nostrand D, Burman KD, Wartofsky L, Vasko V. Amifostine Does Not Protect Thyroid Cancer Cells in DNA Damaging in vitro Models, Endocrine Connections, 6:469-478, 2017. 237. Rizzo LFL, Mana DL, Bruno OD, Wartofsky L. Coma Mixedematoso. Medicina 77:321-328, 2017. 238. Gomes-Lima C, Wu Di, Kharazi P, Khorjekar G, Ringel M, Vetter R, Bloom G, Burman K, Wartofsky L, Van Nostrand D. Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient 131-I Therapy for Differentiated Thyroid Cancer, Thyroid 28: 1558-1565, 2018. 239. Klubo-Gwiezdzinska J, Wartofsky L. Gene expression classifier versus targeted next-generation sequencing in the management of indeterminate thyroid nodules. J Clin Endocrinol Metab 103:3507-3510, 2018. 240. Ylli D, Burman KD, Van Nostrand D, Wartofsky L. Eliminating the age cut off in staging of differentiated thyroid cancer- the safest road. J Clin Endocrinol Metab 103: 1813-1817, 2018. 241. Wu D, Ylli D, Gomes Lima CJ, Lee W, Burman KD, Wartofsky L, Van Nostrand D. Use of 99m-Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management. Endocrine 2018 Oct;62(1):57-63. https://doi.org/10.1007/s12020-018-1636-y; Epub May 24, 2018. 242. Ylli D, Wartofsky L. Can we link thyroid status, energy expenditure, and body composition to management of subclinical thyroid dysfunction? J Clin Endocrinol Metab 104:209-212, 2019, https://doi.org/10.1210/jc.2018-01997. 243. Bikas A, Wu D, Bethancourt E, Orquiza M, Bloom G, Burman KD, Wartofsky L, Van Nostrand D. Detection at public facilities of 131-I in patients treated for differentiated thyroid cancer: the frequency, sites, management by security agents, and recommended physician documentation for patients. J Nuclear Med Oct 25, 2018. 244. Wu D, Khorjekar G, Kharazi P, Moreau S, Kulkarni K, Burman KD, Wartofsky L, Van Nostrand D. Poor patient compliance with instructions for continuous sialagogues after 131-I therapy. Oral Diseases Aug 31, 2018. 245. Ylli D, Van Nostrand D, Wartofsky L. Conventional radioiodine therapy for differentiated thyroid cancer. In Thyroid Cancer, A.G. Ioachimescu and M. Xing (Eds.), Endocrin Metab Clin N Amer, pp. 181-198, March 2019. 246. Luo H, Tobey A, Auh S, Cochran C, Zemskova M, Reynolds J, Lima C, Burman K, Wartofsky L, Skarulis M, Kebebew E, Klubo-Gwiezdzinska J. The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy. Clin Endocrinol 89: 481-488, 2018; DOI:10:1111/can.13806. 247. Klubo-Gwiezdzinska J, Auh S, Gershengorn M, Daley B, Bikas A, Burman K, Wartofsky L, Urken M, Dewey E, Smallridge R, Chindris A-M. Association of thyrotropin suppression with survival outcomes in patients with intermediate- and high-risk differentiated thyroid cancer. JAMA Network Open 2019;2 (2) e187754.doi:10.1001/jamanetworkopen.2018.7754. 248. Gomes-Lima, CJ, Wu D, Rao SN, Punukoilu S, Hritani R, Zeymo A, Deeb H, Mete M, Aulisi EF, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. Brain metastases from differentiated thyroid carcinoma: Prevalence, current therapies, and outcomes. J Endocrine Soc 3 (2):359-371, 2019. 249. Wu D, Lima CJG, Moreau SL, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van.Nostrand D. Improved survival after multimodal approach with 131I treatment in patients with bone metastasis secondary to differentiated thyroid cancer. Thyroid 29: 971-978, 2019. 250. Bikas A, Jensen K, Patel A, Costello J, Kaltsas G, Hoperia V, Wartofsky L, Burman K, Vasko V. Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. Intern J Oncology 2019, 1-14, DOI: 10.3892/ijo.2019.4802. 251. Gomes-Lima CJ, Wartofsky L, Burman KD. Can reverse T3 assay be employed to guide T4 versus T4/T3 therapy in hypothyroidism? Frontiers Endocrinol 10: 856, December 2019, doi: 10.3389/fendo.2019.00856. 252. Ylli D, Klubo-Gwiezdzinska J, Wartofsky L. Thyroid Emergencies. Polish Archives Internal Medicine, 129 (7-8): 526-534, June 2019. 253. Wu D, Lima CJG, Moreau SL, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. The spectrum of I-124 uptake in the lacrimal gland and nasolacrimal duct uptake on PET/CT imaging. Nuclear Med Commun 1; 42 (3): 292-299, 2021. 254. Shobab L, Lima C, Zeymo A, Feldman R, Jonklaas J, Wartofsky L, Burman KD. Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer, Thyroid 29:1262-1268, 2019. 255. Wu, D, Ylli D, Heimlich L, Burman KD, Wartofsky L, Van Nostrand D. I-124 Positron Emission Tomography/Computed Tomography versus conventional radioiodine imaging in differentiated thyroid cancer: a review. Thyroid 29: 1523-1535, 2019. 256. Papoian V, Ylli D, Felger EA, Wartofsky L, Rosen JE. Evaluation of Thyroid Hormone Replacement Dosing in Overweight and Obese Patients After Thyroidectomy. Thyroid 29: 1558-1562, 2019. 257. Wu D, Wu D, Gomes-Lima CJ, Kulkarni K, Burman KD, Wartofsky L, Van Nostrand D. 30 mCi exploratory scan for two-step dosimetric 131-I therapy in differentiated thyroid cancer patients: A novel approach and case report. World J Nucl Med 19:266-70, 2020. 258. Ylli D, Patel A, Jensen K, Mendoca-Torres MC, Costello J, Lima C, Wartofsky L, Burman KD, Vasko VV. Microfluidic droplet digital PCR is a powerful tool for detection of BRAF and TERT mutations in papillary thyroid carcinomas. Cancers 2019, 11, 1916; doi:10.3390/cancers11121916, 2020. 259. Wu D, Gomes-Lima CJ, Bloom G, Burman KD, Wartofsky L, Van Nostrand D. Nationwide survey on implementation of 2011 Nuclear Regulatory Commission policy on release of patients after 131-I therapy for thyroid cancer. J Nucl Med 2020; 61:397-404; DOI:10.2967/jnumed.119.230730 260. Saracyn M, Lubas A, Bober B, Kowalski L, Kapusta W, Niemczyk S, Wartofsky L, Kamiński G. Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer. Thyroid 30: 2020 https://doi.org/10.1089/thy.2019.0372; 30 (5): 653-660, 2020. 261. Gubbi S, Avadhanula S, Araque K, Filie AC, Raffeld M, Welch J, Kebebew E, Burman KD, Wartofsky L, Klubo-Gwiezdzinska J. Spindle Cells in Thyroid Biopsy – a Comprehensive Guidance on the Management of Primary Thyroid Mesenchymal Tumors. Lancet Oncology 21: November 2020, e528-e537. 262. Papoian V, Rosen JE, Lee W, Wartofsky L, Felger EA. Differentiated Thyroid Cancer and Hashimoto Thyroiditis: Utility of the Afirma Gene Expression Classifier. J Surgical Oncology 1-5, 2020: DOI:1002/jso.25875. 263. Gomes-Lima CJ, Auh S, Thakur S, Zemskova M, Cochran C, Merkel R, Filie AC, Raffeld M, Patel SB, Xi L, Wartofsky L, Burman KD, Klubo-Gwiezdzinska J. A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology – a Pilot Cohort Study. Frontiers Endocrinology 11: :53. Doi:10.3389/fendo.2020.00053 (pp. 1-13) 2020. 264. Wu D, Plyku D, Kulkarni K, Garcia C, Atkins F, Tefera E, Burman KD, Wartofsky L, Van Nostrand D. Optimal time for 124-I PET/CT imaging in metastatic differentiated thyroid cancer. World J Nucl Med 19:266-270, 2020. 265. Jensen K, Thakur S, Patel A, Mendonca-Torres MC, Costello J, Gomes-Lima CJ, Walter M, Wartofsky L, Burman KD, Bikas A, Ylli D, Vasko VV, Klubo-Gwiezdzinska J. Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy. J Clin Medicine 9:2481 (1-13), 2020; doi:10.3390/jcm9082481. 266. Ylli D, Wartofsky L, Burman KD. Evaluation and treatment of Amiodarone induced thyroid disorders. J. Clin Endocrinol Metab 106: (1) 226-236, 2021. 267. Bikas A, Jensen K, Reynolds S, Patel A, Costello J, Thakur S, Klubo-Gwiezdzinska J, Ylli D, Wartofsky L, Burman K, Vasko V. Cytochrome C Oxidase Subunit 4 (COX4): a potential therapeutic target for the treatment of medullary thyroid cancer, Accepted for publication, Cancers 2020, 12(9), E2548; https://doi.org/10.3390/cancers12092548. 268. Gomes-Lima C, Shobab L, Wu D, Ylli D, Bikas A, McCoy M, Feldman R, Lee W, Rao SN, Jensen K, Vasko V, Concalves de Castro LC, Jonklaas J, Wartofsky L, Burman KD. Do Molecular Profiles of Primary versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ? Frontiers Endocrinolo 12: 2021. Article 623182, February 2021. https://doi: 10.3389/fendo.2021.623182 269. Ylli D, Soldin SJ, Stolze B, Wei B, Nigussie G, Nguyen H, Mendu DR, Mete M, Wu D, Gomes-Lima C, Klubo-Gwiezdzinska J, Burman KD, Wartofsky L. Biotin interference in assays for thyroid hormones, TSH and thyroglobulin. Thyroid 31: 1160-1170, 2021. 269A. Ylli D, Wartofsky L, Burman KD. Response to Letter to the Editor from Sukor et al.: Evaluation and Treatment of Amiodarone-induced Thyroid Disorders. J Clin Endocrinol Metab 106: (7) e2839-2840, 2021. 270. Zheng H, Lai V, Lu J, Kang JK, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen JE. Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity. Amer J Surgery 223:617-623, 2022. 271. Fakhar Y, Khooei A, Aghaee A, Kosari HM, Wartofsky L, Zakavi SR. Bone metastasis from noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP); a case report. BMC Endocrine Disorders 21:221, 2021. https://doi.org/10.1186/s12902-021-00883-7 272. Zheng H, Lai V, Lu J, Kang JK, Chou J, Burman KD, Wartofsky L, Rosen JE. Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer Patients – A Multivariate Analysis. J Amer College Surg 234:691-700, 2022. 273. Shobab L, Burman KD, and Wartofsky L. Sex-Dimorphism in Differentiated Thyroid Cancer. Thyroid 32: 224-235, 2022. 274. Gomes-Lima C, Chittimoju S, Wehbeh L, Dia S, Pagadala P, Al-Jundi M, Jhawar S, Tefera E, Mete M, Klubo-Gwiezdzinska J, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. Survival from metastatic differentiated thyroid cancer is unaffected by mode of preparation for 131I administration. J Endocrine Soc 6: 1-8, 2022. 274A. Gomes-Lima C, Chittimoju S, Wehbeh L, Dia S, Pagadala P, Al-Jundi M, Jhawar S, Tefera E, Mete M, Klubo-Gwiezdzinska J, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. Response to Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration”, J Endocrine Soc 7 (3): 2023, Issue 3, March 2023, bvad005, https://doi.org/10.1210/jendso/bvad005. 275. Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto Thyroiditis: An Evidence-Based Guide: Etiology, Diagnosis, Treatment. Polish Archives Internal Medicine 132: 2022 Medicine 132 (3): 1-10, 2022.; doi:10.20452/pamw.16222. 276. Davies TF. Interview by Terry F. Davies.A Discussion with Leonard Wartofsky, MD: Teacher, Clinician, Investigator, Mentor of Many, a Medical Politician, and Guest Editor of Thyroid Volume 1 Number 1.Thyroid®.http://doi.org/10.1089/thy.2023.0224 277. Zheng H, Lai V, Lu J, Hu D, Kang JK, Burman KD, Wartofsky L, Rosen JE. Efficacy of Machine Learning to Identify Clinical Factors Influencing Levothyroxine Dosage After Total Thyroidectomy, Amer J Surgery 2023-04. DOI:10.1016/j.amjsurg.2022.11.025 279. Sachmechi I, Chochinov RH, Lucas KJ, Stonesifer LD, Ansley JF, Sack P, Scarsi C, Lanzi G, Wartofsky L, Burman KD. Efficacy and safety of levothyroxine sodium soft gel capsules in thyroidectomized patients taking proton pump inhibitors: An open label study. Thyroid 33: (12) 1414-1422. 280. Ghosh R, Auh S, Gubbi S, Veeraraghavan P, Cochran C, Shobab Le, Urken M, Burman K, Wartofsky L, Klubo-Gwiezdzinska, J. Association of Free Thyroxine Levels with Survival Outcomes in Patients with Intermediate and High Risk Differentiated Thyroid Cancer. J Clin Endocrinol Metab 2024-08-08. DOI: 10.1210/clinem/dgae537. 281. Zheng H, Lai V, Lu J, Burman KD, Wartofsky L, Rosen JE. Improved Sexual Function after Parathyroidectomy in Women with Primary Hyperparathyroidism. In Press, htpps://doi.org/10.1016/1.am.surg2023.12.027.Amer J Surgery 2024. 282. Kuenstner, W, Al-Souri D, Yano J, Alpeter L, Barrison, L, Mir A, Budd S, Agrawal R, Baral N, Jonklaas J, Burman K, Wartofsky L, Shobab L. "Reproductive and Mental Health Implications of Radioactive Iodine Therapy in Women of Reproductive Age with Thyroid Cancer, Thyroid 2024: in Press. 283. Plyku D, Wu D, Ylli D, Lima C, Ahuja S, Avram A, Greenspan B, Mittrra E, Tulchinsky M, Burman K, Wartofsky L, Van Nostrand D. Use of Radioiodine Dosimetry in the Selection of the Amount of Activity for 131I Therapy of Differentiated Thyroid Cancer: A Descriptive Study. Submitted 2023. 284. Zheng H, Lai V, Lu J, Kang J, Shobab L, Desale S, Chou J, Burman K, Wartofsky L, Rosen J. Multivariate Analysis of Factors Associated with Thyroid Cancer Diagnosis in Post-surgical Patients. J Surg Res. Submitted 2023 285. Shobab L, Zheng H, Jensen K, Mendonca-Torres MC, McCoy M, Hoperia V, Rosen J, Wartofsky L, Burman KD, Vasko V. Sex-Specific Expression of Histone Lysine Demethylases (KDMs) in Thyroid Cancer. Cancers 2024-03-23. DOI: 10.3390/cancers16071260. 286. Shobab L, Al-Souri D, Matthew-Kim L, Kuenstner W, Hubbard G, Kumari S, Chou J, Lee W, Rosen J, McCoy M, Klubo-Gwiezdzinska J, Atkins M, Wartofsky L, Burman KD. PD-L1 Expression Varies in Thyroid Cancer Types and Histological Subtypes of Differentiated Thyroid Cancer. Cancers 24-10. DOI: 10.3390/cancers16213632. 287. Vargus-Uricoechea H, Wartofsky L. LT4/LT3 Combination therapy vs. Monotherapy with LT4 for persistent symptoms of hypothyroidism: A Systematic Review. Intern J Molecular Sci 25:9218, 2024. https://doi.org/10.3390/ijms25179218. | BOOKS, BOOK CHAPTERS/ NON-PEER REVIEWED ARTICLES | | - Wartofsky, L., and Ingbar, S.H.: A Method for Assessing Latency, Potency, and Duration of Action of Antithyroid Agents in Man, in Further Advances in Thyroid Research, K. Fellinger and R. Hofer (eds), Verlag der Wiener Medizinischen Akademie, Vienna, Austria, 1971, p. 121‑135.
- Wartofsky, L.: A Different Approach to Hyperthyroidism. Medical Opinion 6:46‑50, 1976.
- Wartofsky, L., Dimond, R.C., Noel, G.L., Earll, J.M., and Frantz, A.G.: Estimates of Pituitary Stores of TSH and PRL in Normal Subjects and Patients With Primary Hypothyroidism by the Use of Continuous TRH Infusion,in Proceedings VII International Thyroid Conference, Boston, June 9‑13 1975, Excerpta Medica, Amsterdam, p. 268‑271.
- Burman, K.D., Vigersky, R.A., Loriaux, D.L., Djuh, Y.Y., Wright, F.D., Strum, D., and Wartofsky, L.: Investigations Concerning Thyroxine Deiodinative Pathways in Patients With Anorexia Nervosa, In “Current Concepts in Anorexia Nervosa,” Vigersky, R.A. (ed.), Raven Press, New York, 1977, p. 255‑261.
- Wartofsky, L. and Burman, K.D.: Treatment of Hypothyroidism. Current Therapy 1979 ed. by H. Conn, Saunders, Philadelphia, 1979, p.469‑473.
- Wartofsky, L.: “Thyroiditis” in Thyroid Clinics Vol 1:1‑6, 1981, Armour Pharmaceutical Co.
- Wartofsky, L.: Guidelines for the Therapy of Hyperthyroidism. American Family Physician 30:198‑210, 1984.
- Wartofsky, L., Chairman, Roundtable Discussion: Clinical Aspects of Thyroxine Metabolism, In Proceedings of An International Symposium on Peripheral Metabolism of Thyroxine, Ulm, Germany, May 1983. Hormone and Metabolic Research Supplement 14, pp. 108‑111, 1984.
- Wartofsky, L.: Physiological or Adaptive Alterations in the Deiodination of Thyroxine. Hormone and Metabolic Research Supplement 14, 66‑73, 1984.
- Wartofsky, L. and Burman, K.D.: Effects of Drugs on Peripheral Thyroxine. Hormone and Metabolic Research Supplement 14:105‑108. 1984.
- Wartofsky, L.: Diffuse Non‑Toxic and Multinodular Goiter, In Current Therapy in Endocrinology and Metabolism, Bardin C.W. and Krieger D.T. (Eds.), B.C. Decker Co., 1985, pp. 75‑79.
- Wartofsky, L.: Hyperthyroidism. In Conn’s Current Therapy 1986, W.B. Saunders Co., pp. 515‑520.
- Burman, K.D., Lukes, Y.G., Wartofsky, L., Djuh, Y‑Y, and Baker, J.R. Preparation of Biotinylated Receptor‑Purified Graves’ IgG: A Simple Technique Allowing Direct Functional Assessment of TSH Receptor Antibody Interaction With Membranes. Proceedings, Symposium Autoimmunity and the thyroid, June 29‑30, 1984, Toronto, Canada, pp. 387‑389.
- Wartofsky, L.: Thyrotoxic Storm. In The Thyroid (A fundamental and clinical text) Ingbar, S.H., and Braverman, L.E. (eds.), Fifth Edition, J.B. Lippincott, Philadelphia, 1986, pp. 974‑981.
- Wartofsky, L.: Myxedema Coma, In The Thyroid (A fundamental and clinical text) Ingbar, S.H. and Braverman, L.E. (eds.), Fifth Edition, J.B. Lippincott, Philadelphia, PA, 1986, pp. 1227‑1234.
- Sack, J., Baker, J.R. Jr., Weetman, A.P., Wartofsky, L., Burman, K.D.: The Role of Antibody‑Dependent Cytotoxicity and Natural Killer Cells in Hashimoto’s Disease. In Frontiers in Thyroidology, Volume 2, Ed. G. Medeiros‑Neto, and E. Gaitan, Plenum Publishing Co., 1986, pp. 1341‑1344.
- Burman, K.D., Djuh, Y‑Y., LaRocca, R.V., Nunes, M.E., D’Avis, J.C., Nicholson, D.E., Wartofsky, L.: C‑myc Expression in the Thyroid: I. Normal, Adenomatous and Malignant Thyroid Tissue. Horm Metab Res Suppl 17:63‑65, 1987.
- Nunes, M.E., Djuh, Y‑Y., LaRocca, R.V., Nicholson, D.E., Baker, J.R. Jr., Wartofsky, L., D’Avis, J.C., Burman, K.D.: C‑myc Expression in the Thyroid: II. Thyrocytes and Peripheral and Intrathyroidal Lymphocytes from Patients with Autoimmune Thyroid Disease. Horm Metab Res Suppl 17:66‑69, 1987.
- Wartofsky, L., Oertel, Y.: Fine Needle Aspiration of Thyroid Nodules, In Primers and Atlases of Clinical Nuclear Medicine, Van Nostrand, D. and Baum, S., (Eds.), J.B. Lippincott Co., Philadelphia, PA, 1988, pp. 193‑200 (+9 pp. color plates).
- Kushner, J.P., Wartofsky, L. Lithium Thyroid Interactions. Lithium Therapy Monographs, “Lithium and the Endocrine System,” Chapter 7, Volume II, F.N. Johnson (Ed.), Karger, Basel, 1988, pp. 74‑98.
- Peele, M., and Wartofsky, L.: A Rational Approach to the Treatment of Hyperthyroidism. Comprehensive Therapy 14:34‑41, 1988.
- Wartofsky, L.: Osteoporosis: A Growing Concern for the Thyroidologist. Thyroid Today XI(4):1‑11, December 1988.
- Wartofsky, L. Clinical Importance of Abnormal Thyroid Function Test Results in Patients with Nonthyroidal Illness. In Diagnostic Methods in Clinical Thyroidology, Hamburger, J.I. (Ed.) Springer‑Verlag, New York, 1989, pp. 27‑38.
- Wartofsky, L.: The Thyroid Gland, In Principles and Practice of Endocrinology and Metabolism, Becker K.L. (Ed.), J.B. Lippincott, Philadelphia, PA, 1990, Chapter 33, p. 264.
- Nuovo, J., Wartofsky, L.: Adverse Effects of Iodide, In Principles and Practice of Endocrinology and Metabolism, Becker, K.L. (Ed.), J.B. Lippincott Co., Philadelphia, PA, 1990, Chapter 40, p. 300.
- Ahmann, A., Wartofsky, L.: The Thyroid Nodule, In Principles and Practice of Endocrinology and Metabolism, Becker, K.L. (Ed.), J.B. Lippincott Co., Phila., PA, 1990, Chapter 42, pp. 312-319.
- Peele, M.E., Wartofsky, L.: Complications of Thyroid Surgery: Thyrotoxic Crisis. In Thyroid Disease: Endocrine, Surgery, Nuclear Medicine, and Radiotherapy, Falk, S.A. (Ed.), Raven Press, New York, 1990, pp. 625‑630.
- Wartofsky, L., Ingbar, S.H.: Diseases of the Thyroid. In Harrison’s Textbook of Medicine, 12th Edition, 1990, pp 1692‑1712.
- Wartofsky, L., Editor, A Volume Dedicated to the Life and Achievements of Dr. Sidney H. Ingbar, Introduction and Reminiscences. Thyroid Vol 1, No. 1, 1990.
- Wartofsky, L., Clinical Thyroidology (Contributions of Sidney H. Ingbar). Thyroid 1:65‑68, 1990.
- Burch, H.B., Wartofsky, L.: Treatment of Graves’ Disease, In Current Therapy in Endocrinology and Metabolism, Bardin C.W. (Ed.), B.C. Decker Co., 4th Edition, 1991, pp. 58‑64.
- Wartofsky, L.: Osteoporosis and Therapy with Thyroid Hormone. The Endocrinologist I(1):57‑61, 1991.
- Wartofsky, L.: Use of Sensitive TSH Assay to Determine Optimal Thyroid Hormone Therapy and Avoid Osteoporosis. Annual Rev Medicine, 42:341‑346, 1991.
- Wartofsky, L.: Myxedema Coma. In The Thyroid: A Fundamental and Clinical Text. Braverman, L.E., and Utiger, R.D. (Eds.), Sixth Edition, J.B. Lippincott, Philadelphia, 1991, pp 1084-1091.
- Wartofsky, L.: Thyrotoxic Storm. In The Thyroid: A Fundamental and Clinical Text. Braverman, L.E., and Utiger, R.D. (Eds.), Sixth Edition, JB. Lippincott, Philadelphia, 1991, pp 871-879.
- Jackson, S., and Wartofsky, L.: The Thyroid Nodule In Thyroid Diseases: Clinical Fundamentals and Therapy. Chapter VIIA, Monaco, F. (Ed.), CRC Press, 1993.
- Burch, H.B., and Wartofsky, L.: Life-threatening Thyrotoxicosis: Thyroid Storm. Endocrin Metab Clin N Amer 22:263-277, 1993.
- Francis, T., and Wartofsky, L.: Management of Thyroid Disorders in the Elderly. Postgraduate Medicine, Vol. 92, No. 3, Sept. 1, 1992.
- Mahoney, K., and Wartofsky, L.: Abnormal Thyroid Hormone Measurements in Acutely Ill Patients. J Intensive Care Med 7:318-327, 1992.
- Wartofsky, L.: Does Replacement Thyroxine Therapy cause Osteoporosis? In: Advances in Endocrinology and Metabolism, Mazzaferri, E.L. (Ed.), Vol. 4, 157-175, 1993.
- Becker DV, Bigos ST, Gaitan E, Morris JC, Rallison ML, Spencer CA, Sugawara M, VanMiddlesworth
L, Wartofsky L: Optimal use of blood tests for assessment of thyroid function. JAMA 269: (21) 2736-2737, June 2, 1993.
42. Spencer CA, LoPresti JS, VanMiddlesworth L, Wartofsky L, Becker DV, Bigos ST, Gaitan E, Morris JC, Rallison ML, Sugawara M. Screening for thyroid dysfunction. JAMA 270:(19) 2297-2298, Nov 17, 1993. - Burch H.B., Wartofsky, L.: Hyperthyroidism In Bardin, C.W., (Ed.): Current Therapy in Endocrinology and Metabolism, Philadelphia, B.C. Decker, Inc., 5th Edition, 1994, pp. 64-70.
- Wartofsky, L: Bone Disease in Thyrotoxicosis: Clinical Experience Series, Hospital Practice 29: 69-80, May 15, 1994.
- Wartofsky, L.: Diseases of the Thyroid. In Harrison’s Textbook of Internal Medicine, 13th Edition, McGraw Hill, 1994, Chapter 334, pp. 1930-1953.
- Wartofsky, L, and Burman KD: Alterations in thyroid function in patients with systemic illness: the “Euthyroid Sick Syndrome”. Endocrine Reviews Monographs, 3. Clinical and Molecular Aspects of Diseases of the Thyroid. Braverman LE and Refetoff S (Eds.), The Endocrine Society, 1994, pp. 210-247.
- Wartofsky, L: The Low T3 or “Euthyroid Sick Syndrome”: Update 1994. Endocrine Reviews Monographs: 3. Clinical and Molecular Aspects of Diseases of the Thyroid. Braverman LE and Refetoff S (Eds.), The Endocrine Society, 1994, pp. 248-251.
- Wartofsky, L: Myxedema Coma. In The Thyroid: A Fundamental and Clinical Text. Braverman LE and Utiger RD (Eds.), Seventh Edition, J. B. Lippincott, Philadelphia, 1996, pp. 871-877.
- Wartofsky, L: Thyrotoxic Storm. In The Thyroid: A Fundamental and Clinical Text, Braverman LE and Utiger RD (Eds.), Seventh Edition, J. B. Lippincott Co., Philadelphia, 1996, pp. 701-707.
- Wartofsky, L: The Thyroid Gland: Approach to the Patient with Thyroid Disease, In Principles and Practice of Endocrinology and Metabolism, Becker K.L. (Ed.), J. B. Lippincott, Philadelphia, PA., Second Edition, 1995, pp. 277-281.
- Wartofsky, L., and Ahmann AJ: The Thyroid Nodule, In Principles and Practice of Endocrinology and Metabolism, Becker K.L. (Ed.), J.B. Lippincott, Philadelphia, PA., Second Edition, 1995, pp. 345-353.
- Nuovo J., and Wartofsky, L: Adverse Effects of Iodine In Principles and Practice of Endocrinology and Metabolism, Becker K.L., (Ed.), J.B. Lippincott, Philadelphia, PA., Second Edition, 1995, pp. 332-338.
- Alper, M.G., and Wartofsky, L: Endocrine Ophthalmopathy In Principles and Practice of Endocrinology and Metabolism, Becker K.L., (Ed.), J.B. Lippincott, Philadelphia, PA., Second Edition, 1995, pp. 385-399.
- Wartofsky, L. Endothelin and the Thyroid Gland. Frontiers in Endocrinology - Vol. 15, Proceedings of the First International Symposium, “Endothelins in Endocrinology: New Advances”, Florence, Italy, October 6-8, 1994, Baldi, E., Maggi, M., Cameron I.T., and Dunn, M.J. (Eds.), Serono Symposia Publications, pp. 165-179, May 1995.
- Wartofsky, L. Thyroid Disorders. Primer and Videotape. Time-Life Medical Series, E.Everett Koop, Editor, Time-Life Publishers, 1995.
- Burman, K.D., Ringel M.D., and Wartofsky, L: Unusual types of thyroid neoplasms. In Thyroid Cancer II, Endocrin Clin N Amer 25: 49-68, March 1996.
- Wartofsky, L. Treatment Options for Hyperthyroidism. Hospital Practice 31:69-90, September 15, 1996.
- Wartofsky, L., and Peele, M.E. Complications of Thyroid Surgery: Thyrotoxic Crisis. In Thyroid Disease: Endocrine, Surgery, Nuclear Medicine, and Radiotherapy, Falk, S.A. (Ed.), Lippincott-Raven Press, New York, 2nd Edition, 1997, pp. 739-745
- Wartofsky, L.: Diseases of the Thyroid. In Harrison’s Textbook of Internal Medicine, 14th Edition, McGraw Hill,1997, Chapter 331, pp. 2012-2035.
- Wartofsky, L. Acute Presentations of Thyroid Disease. In Hospital Medicine, Wachter RM, Goldman L, Hollander H. (Eds.), Williams & Wilkins, Baltimore, 2000, pp. 903-912.
- Wartofsky, L. Hyperthyroidism In Atlas of Clinical Endocrinology, Korenman SG (Ed.), Volume I. Thyroid Disease, Surks MI (Ed.), Current Medicine, Philadelphia, PA., 1999, pp. 81-92.
- Wartofsky, L. Thyroid Nodules: Incidence, prevalence, clinical evaluation and cancer risk. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp. 3-8.
- Wartofsky, L. The Thyroid Nodule: Medical Management. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp.39-48.
- Wartofsky, L. Papillary Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp. 185-92.
- Wartofsky, L. Follicular Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp. 279-88.
- Wartofsky, L. Management of the radioisotope scan negative, thyroglobulin positive patient with thyroid cancer: Alternative Imaging Techniques. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp.251-62.
- White RL, Wartofsky, L. Follicular Carcinoma of the Thyroid: External Radiation Therapy. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp. 301-306.
- White RL, Wartofsky, L. Anaplastic Carcinoma of the Thyroid: External Radiation Therapy. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp.341-44.
- White RL, Wartofsky, L. Medullary Carcinoma of the Thyroid: External Radiation Therapy. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky (Editor), Humana Press, Totowa, NJ, 2000, pp.401-404.
- Bernet VJ, and Wartofsky, L. Thyroid Function and Exercise. In Contemporary Endocrinology: Sports Endocrinology, Warren MP and Constantini NW (Eds.), Humana Press, 2000, pp. 97-118.
- Wartofsky, L. Disorders of the Thyroid Gland, In Kelley’s Textbook of Internal Medicine, H.D. Humes, Editor, 4th Edition, Lippincott Williams & Wilkins,, Philadelphia, Chapter 406, pp. 2693-2719, 2000.
- Wartofsky, L., Ringel MD, and Burman KD. Therapy of Graves’ Ophthalmopathy. In Graves Disease: Pathogenesis and Treatment, Kluwer Academic Publishers, Amsterdam, Rapoport B & McLachlan S (Editors), 2000, pp. 257-278.
- Burman KD, and Wartofsky, L. Iodine Effects on the Thyroid Gland: Biochemical and Clinical Aspects. In Reviews in Endocrine and Metabolic Disorders. Le Roith D, (Ed.), Kluwer Academic Publishers, Boston, Mass., 1:19-25, 2000.
- Wartofsky, L: Annual Meeting of the American Thyroid Association (ATA) 1999: Highlights. URL:http://www.medscape.com/Medscape/endocrinology/journal/1999/v01.n10/mde1110.wart/mde110.wart-01.html; also available at: http://PrimaryCare.medscape.com/Medscape/endocrinology/ TreatmentUpdate/1999/tu02/public/toc-tu02.html
- Wartofsky, L: Myxedema Coma. In The Thyroid: A Fundamental and Clinical Text. Braverman LE and Utiger R (Eds.), Eighth Edition, J. B. Lippincott, Philadelphia, 2000, pp. 843-847.
- Wartofsky, L: Thyrotoxic Storm. In The Thyroid: A Fundamental and Clinical Text, Braverman LE and Utiger RD (Eds.), Eighth Edition, J. B. Lippincott Co., Philadelphia, 2000, pp. 679-84.
- Wartofsky, L: 12th International Thyroid Congress, Kyoto, Japan, October 22-27, 2000: Highlights. Available at: URL :http://www.medscape.com/medscape/endocrinology/journal/2001/v03.n01/mde0131.
wart/mde0131.wart-01.html - Wartofsky, L: The Thyroid Gland: Approach to the Patient with Thyroid Disease, In Principles and Practice of Endocrinology and Metabolism, Becker K.L. (Ed.), Lippincott Williams & Wilkins, Philadelphia, PA., Third Edition, 2001, pp. 306-311.
- Wartofsky, L., and Ahmann AJ: The Thyroid Nodule, In Principles and Practice of Endocrinology and Metabolism, Becker K.L. (Ed.), Lippincott Williams & Wilkins, Third Edition, 2001, pp. 374-382.
- Nuovo J., and Wartofsky, L: Adverse Effects of Iodine In Principles and Practice of Endocrinology and Metabolism, Becker K.L., (Ed.), J.B. Lippincott Williams & Wilkins, Philadelphia, PA., Third Edition, 2001, pp. 360-366.
- Alper MG, and Wartofsky, L: Endocrine Ophthalmopathy In Principles and Practice of Endocrinology and Metabolism, Becker K.L., (Ed.), J.B. Lippincott Williams & Wilkins, Philadelphia, PA., Third Edition, 2001, pp. 428-440.
- Nylen ES, Zaloga GP, Becker KL, Burman KD, Wartofsky, L, Muller B, White JC, Alarifi AA. Endocrine Therapeutics in Critical Illness, In Principles and Practice of Endocrinology and Metabolism, Becker K.L., (Ed.), J.B. Lippincott Williams & Wilkins, Philadelphia, PA., Third Edition, 2001, pp. 2108-2121.
- Stathatos N, and Wartofsky, L. Thyroid Storm In Encyclopedia of Endocrinology and Endocrine Diseases, Martini, L (Ed.), Academic Press,
- Stathatos N, and Wartofsky, L. Myxedema Coma. In Encyclopedia of Endocrinology and Endocrine Diseases, Martini, L (Ed.), Academic Press, 4: 977-982, 2004.
- Brent GA, and Wartofsky, L. Editorial: Thyroid Scientists, Clinicians and Patients gather in Los Angeles. Thyroid 12: 745-46, 2002.
- Wartofsky, L. Thyrotoxic storm. Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, First Edition, Wass JA, Shalet SM (Eds.) 2002, pp. 481-486.
- Wartofsky, L. Myxoedema coma. Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, First Edition, Wass JA, Shalet SM (Eds.) 2002, pp . 514-518.
- Stathatos N, and Wartofsky, L. Managing subclinical thyroid disease in women. Women’s Health in Primary Care: Gynecology Edition 2:487-93, November-December 2002.
- Stathatos N, and Wartofsky, L. Perioperative management of patients with hypothyroidism. Endocrin Metab Clin N Amer 32: 1-16, 2003.
- Katz M, Rosen DL, Wartofsky, L. Issues in bioequivalence and therapeutic equivalence of levothyroxine products. U. S. Pharmacist, September 2003 (Supplement) pp. 2-14.
- Brunton S, Katz M, Ridgway EC, Scherger JE, Wartofsky, L. Thyroid roundtable: the clinical implications of recent research. Available at:http://www.thyroidtoday.com/MedicalEducation/Monographs /Thyroid_RoundTable.pdf.
- Wartofsky, L. The Thyroid Gland: Basics, In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, 2004.
- Wartofsky, L. Thyroid Hormone Measurements in Blood, In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, 2004.
- Wartofsky, L. Thyroid Nodules, In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), Keystone Press, 2004
- Wartofsky, L. Well Differentiated Thyroid Cancer: Staging and Prognosis, In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky, L. (Eds), Keystone Press, 2004
- Wartofsky, L. Thyrogen (Recombinant Human TSH), In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky, L. (Eds), Keystone Press, 2004
- Stathatos N and Wartofsky, L. Effects of thyroid hormone on bone. Clin Reviews Bone & Mineral Metabolism, 2: 135-150, 2004.
- Wartofsky, L. Acute Presentations of Thyroid Disease. In Hospital Medicine, Wachter RM, Goldman L, Hollander H. (Eds.), Williams & Wilkins, Baltimore, 2005, pp. 1093-1102.
- Wartofsky, L: Myxedema Coma. In The Thyroid: A Fundamental and Clinical Text. Braverman LE and Utiger RD (Eds.), Ninth Edition, J. B. Lippincott, Philadelphia, 2005, pp.850-857.
- Wartofsky, L: Thyrotoxic Storm. In The Thyroid: A Fundamental and Clinical Text, Braverman LE and Utiger RD (Eds.), Ninth Edition, J. B. Lippincott Co., Philadelphia, 2005, pp. 651-658.
- Wartofsky, L. Thyroid Nodules: Incidence, prevalence, clinical evaluation, cancer risk and medical management. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 201-210.
- Wartofsky, L. Thyroxine therapy and TSH suppression. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006 , pp. 293-296.
- Wartofsky, L. Papillary Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 253-260.
- Wartofsky, L. Follicular Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 517-522.
- Wartofsky, L. Management of the radioisotope scan negative, thyroglobulin positive patient with thyroid cancer: Alternative Imaging Techniques. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 367-374.
- Wartofsky, L. Staging of Thyroid Cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 87-96.
- Atkins FB, Van Nostrand D, Wartofsky, L Dosimetrically-Determined Prescribed Activity of radioiodine for the treatment of metastatic thyroid carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 433-446.
- Wartofsky, L., and N. Stathatos. Thyroglossal Duct Carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 393-398.
- Wartofsky, L. Adjunctive Local Approaches to Metastatic Thyroid Cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 509-516.
- Burman KD, and Wartofsky, L. Hürthle Cell Variant of Follicular Thyroid Carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Second Edition, Humana Press, Totowa, NJ, 2006, pp. 531-536.
- Wartofsky, L. TSH targets for patients on thyroxine. Consultant 46 (12): 1309, October 2006.
- Wartofsky, L. Myxedema Coma. Endocrine & Metab Clinics N Amer 35:687-698, 2006.
- Adler SM, Wartofsky, L. The Euthyroid Sick Syndrome. Endocrine & Metab Clinics N Amer 36: (3): 657-672, September 2007. Van Nostrand D, Wartofsky, L. Radioiodine treatment of Thyroid Cancer. Endocrine & Metab Clinics N Amer 36: (3): 807-822, September 2007.
- Van Nostrand D, Wartofsky, L. Radioiodine treatment of Thyroid Cancer. Endocrine & Metab Clinics N Amer 36: (3): 807-822, September 2007.
- Wartofsky, L. Toxic tachycardia and thyrotoxicosis: An often overlooked diagnosis: Commentary on a case presentation. AHRQ WebM&M [serial online]. October 2007. Available at:http://www.webmm.ahrq.gov/case.aspx?caseID=163.
- Bahn R. Levy E. Wartofsky, L. Graves' disease. J Clin Endocrinol Metab. 92(11):2 p following 14A, Nov. 2007.
- Adler SM, Wartofsky, L. Myxedema Coma. In: Contemporary Endocrinology - Acute Endocrinology:
From Cause to Consequence, Van den Bergh, G., (Ed.) , Chapter 2, pp. 29-44, Humana Press, 2008.
- Wartofsky, L. Commentary on: Jonklaas J, et al., Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 2008; 299: 769-77; in Clinical Thyroidology, Amer Thyroid Assn., 2008.
- Wartofsky, L. Foreword: Thyroid Ultrasonography In Baskin J, Duick D, Levine R. (Eds) Thyroid Ultrasound & Ultrasound Guided FNA Biopsy, Second Edition, Springer, pp. v-vi, 2008.
- Van Nostrand D, Bloom G, Wartofsky L (Eds), Cancer de Tiroides, Guia Para Pacientes, (Spanish Language Edition) Keystone Press, 2008.
- Klubo-Gwiezdzinska, J., Wartofsky, L. Thyrotoxic storm. In Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, Second Edition, Wass JA, Stewart P. (Eds.) 2011, pp. 454-461.
- Klubo-Gwiezdzinska, J. Wartofsky, L. Myxoedema coma. In Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, Second Edition, Wass JA, Stewart P (Eds.) 2011, pp. 537-543.
- Wartofsky, L. The Thyroid Gland: The Basics, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd edition, Keystone Press, pp. 5-14, 2010.
- Wartofsky, L. Thyroid Hormone Measurements in Blood, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, pp. 15-18, 2010.
- Wartofsky, L. Thyroid Nodules, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, pp. 39-56, 2010
- Wartofsky, L. Well Differentiated Thyroid Cancer: Staging and Prognosis, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition. Keystone Press, 2010, pp. 77-88.
- Wartofsky, L. Thyrogen (Recombinant Human TSH), In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, pp. 1135-139, 2010.
- Stathatos N., Wartofsky, L. Anaplastic Thyroid Carcinoma, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, 2010, pp. 329-336.
- Wartofsky L. Editorial: A new Editor-in-Chief at the Helm! J Clin Endocrinol Metab 95: 1-2, 2010.
- Wartofsky, L. Management of the Patient with Persistent Elevated Thyroglobulin Levels and Negative Radioiodine Scans. In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, 2010, pp. 269-274.
- Van Nostrand D, Wartofsky, L. From “Nodule to Diagnosis to Therapy to Follow-up”. In Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, pp. 1-4, 2010.
- Wartofsky L. Thyrogen for Preparation for Radioiodine Ablation and Treatment. In Thyroid Cancer –A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L (Eds), 2nd Edition, Keystone Press, pp. 225-229, 2010.
- Wartofsky L. Editorial: JCEM Moves Forward into the Digital Domain. J Clin Endocrinol Metab 95: 4105, 2010.
- Wartofsky L, Handelsman DJ. Editorial: Standardization of hormonal assays for the 21st century. J Clin Endocrinol Metab 95: 5141-5143, 2010.
- Wartofsky, L: Myxedema Coma. In The Thyroid: A Fundamental and Clinical Text. Braverman LE and Cooper DS (Eds.), Tenth Edition, J. B. Lippincott, Philadelphia, 2012, pp. 600-605.
- Wartofsky, L: Thyrotoxic Storm. In The Thyroid: A Fundamental and Clinical Text, Braverman LE and Cooper DS (Eds.), Tenth Edition, J. B. Lippincott, Philadelphia, 2012, pp. 481-486.
- Klubo-Gwiezdzinska, J. Wartofsky, L. Thyroid function and exercise. In: Endocrinology of Physical Activity and Sport, 2nd Edition., Constantini N., and Hackney AC (Eds.), Humana Press/Springer, pp.85-119, 2013.
- Wartofsky L. (Editor): Diagnostic Dilemmas: Case Studies and Images in Endocrinology, The Endocrine Society Press, 2011.
- Wartofsky L. (Editor): Approaches to Endocrine and Metabolic Diseases. Volume II. The Endocrine Society Press, 2012.
- Wartofsky L, Klubo-Gwiezdzinska J. Recombinant human TSH-stimulated radioiodine uptake is approved for remnant ablation: Is it also effective for treatment of metastatic thyroid cancer? Oncolog-Hematolog.ro, in press, November 2012.
- Wartofsky L. (Editor): Diagnostic Dilemmas Volume II: Case Studies and Images in Endocrinology, The Endocrine Society Press, 2013.
- Wartofsky L. Editorial: Should patients with papillary microcarcinoma undergo radioiodine ablation? Endocrine 44: 278-279, 2013.
- Handelsman D, Wartofsky L. Editorial: Requirement of Mass Spectrometry sex steroid assays in the J Clin Endocrinol Metab 98:3971-3973, 2013.
- Gore AC, Balthazart J, Bikle D, Carpenter DO, Crews D, DeFranco DB, Grattan D, Hammes SR, Hof P, Lange C, Lee AV, Levine JE, Millar RP, Poth M, Prins G, Rissman E, Sly PD, Taylor HS, Tena-Smepere M, Wartofsky L, Watson C. Policy Decisions on Endocrine Disruptors should be based on Science across disciplines: a response to Dietrich et al., Endocrinology 154:3957-3960, 2013, and Frontiers in Endocrinology 35: 2-5, 2014.
- Wartofsky, L. Thyroid Storm In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Martini, L (Ed.), Elsevier Press, 2014.
- Wartofsky, L. Myxedema Coma. In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Martini, L (Ed.), Elsevier Press, 2014.
- Wartofsky, L. Thyroid Nodules: Incidence, prevalence, clinical evaluation, cancer risk and medical management. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 249-267, 2016.
- Wartofsky, L. Thyroxine therapy and TSH suppression. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 419-424, 2016.
- Wartofsky, L. Papillary Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 351-362, 2016.
- Wartofsky, L. Follicular Carcinoma of the Thyroid: Clinical Aspects. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 761-770, 2016.
- Wartofsky, L. Management of the radioisotope scan negative, thyroglobulin positive patient with thyroid cancer: Alternative Imaging Techniques. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 521-529, 2016.
- Wartofsky, L. Staging of Thyroid Cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 105-117, 2016.
- Atkins FB, Van Nostrand D, Wartofsky, L Dosimetrically Determined Prescribed Activity of radioiodine for the treatment of metastatic thyroid carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 627-642, 2016.
- Wartofsky, L., and N. Stathatos. Thyroglossal Duct Carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 561-564, 2016.
- Wartofsky, L. Adjunctive Local Approaches to Metastatic Thyroid Cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 737-742, 2016.
- Khorjekar G, Klubo-Gwiezdzinska, Van Nostrand D, Wartofsky L. Rare sites of metastasis secondary to differentiated thyroid carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 727-736, 2016.
- Burman KD, Wartofsky L. Hurthle cell carcinoma of the thyroid. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 779-783, 2016.
- Ball DW, Wartofsky L. Clinical aspects of medullary thyroid carcinoma. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Editors), Third Edition, Springer, New York, pp. 845-855, 2016.
- Wartofsky L, Smallridge RC. Primary lymphoma of the thyroid. In: Endocrine Cancer Handbook, Bible KC, Ryder M, Young WF (Eds.), Wiley UK, 2016, in press.
- Wartofsky L, Smallridge RC. Sarcoma of the thyroid. In: Endocrine Cancer Handbook, Bible KC, Ryder M, Young WF (Eds.), Wiley UK, 2016, in press.
- Wartofsky L, Smallridge RC. Squamous cell carcinoma of the thyroid. In: Endocrine Cancer Handbook, Bible KC, Ryder M, Young WF (Eds.), Wiley UK, 2016, in press.
- Wartofsky L. A patient with a large Hȗrthle cell cancer and nodal metastases, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 2016, pp. 207-212.
- Wartofsky L. A case of a locally advanced papillary thyroid cancer without structural evidence of disease at cross sectional imaging studies but with biochemical evidence of disease, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 2016, pp. 223-228.
- Wartofsky L. A case of a patient with follicular thyroid carcinoma with bone metastases and lesional dosimetry, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 2016, pp. 237-244.
- Van Nostrand D, Kulkarni K, Bloom G, Wartofsky L (Eds), Thyroid Cancer – A Guide for Patients, 2nd Edition, Keystone Press, Chinese Translation & Update, 2014.
- Cefalu WT, Sreekumaran N, Seaquist ER, Zierath J, Boulton AJM, LeRoth D, Harrell RM, Grnberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ. Editorial: Statement of Principle. J Clin Endocrinol Metab 99: 4376, 2014.
- Wartofsky L. Subclinical hyperthyroidism and fracture risk in women: Editorial. J Clin Endocrinol Metab 99: 2654-2656, 2014.
- Wartofsky L. Editorial: From the Editor-in-Chief: Eating with Chopsticks. J Clin Endocrinol Metab 99: 4377-4378, 2014.
| - Haugen BR, Wartofsky L. In Memoriam: E. Chester Ridgway, 1942-2014. Endocrine Rev 35:715-6, 2014; Hormones & Cancer 5:263-4, 2014; J Clin Endocrinol Metab 99:3487-3488, 2014; Endocrinology 155:3727-28, Molec Endocrinol 1587-1588, 2014.
- Wartofsky L. (Editor): Approaches to Endocrine and Metabolic Diseases. Volume III. The Endocrine Society Press, 2015.
- Wartofsky L. Endocrine Reviews: The Next Generation. Endocrine Rev 36: 347-348, August 2015.
- Wartofsky L. Anaplastic Thyroid Carcinoma and other rare thyroid malignancies. In: Thyroid Diseases:
Pathogenesis, Diagnosis and Treatment, Vitti P., and Hegedus L. (Eds.), Springer Pubs., New York, 2018;. doi:10.1007/978-3-319-29195-6_23-1) Chapter 21, pp 629-644. - Wartofsky L. A rose by any name surely does smell just as sweetly: The controversy over revised nomenclature for encapsulated follicular variant papillary carcinoma. (Editorial), J Translat Internal Med 4: 55-57, Apr-Jun 2016.
- Wartofsky, L. Thyroid Storm In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Huhtaniemi I. and Martini, L (Eds.), Elsevier Press, Second Edition, 695-697, 2018.
- Wartofsky, L. Myxedema Coma. In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Huhtaniemi I. and Martini, L (Eds.), Elsevier Press, Second Edition, 627-629, 2018.
- Gomes-Lima C, Wartofsky L. Two themes in thyroid cancer: Artful diagnosis and shortened lives. Arch Endocrinol Metab 61: 205-207, 2017.
- Wartofsky L. Cancer de Tiroides: Enfoque Clinico. Separata Montpellier 26: (4) 1-32, 2018.
- Wartofsky L. Myxedema Coma, In: Luster M, Duntas LH, Wartofsky L. The Thyroid and its Diseases: A Comprehensive Guide for the Clinician. Springer 2019, pp. 281-292.
- Wartofsky L. Thyrotoxic Crisis. In: Luster M, Duntas LH, Wartofsky L. The Thyroid and its Diseases: A Comprehensive Guide for the Clinician. Springer 2019, pp. 2357-366.
- Wartofsky, L. The Thyroid Gland: The Basics, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd edition, Keystone Press, pp. 5-14, 2019.
- Wartofsky, L. Thyroid Hormone Measurements in Blood, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 15-16, 2019.
- Wartofsky, L. Thyroglobulin (Tg) and Anti-Thyroglobulin Antibodies. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 17-22, 2019.
- Wartofsky, L. Thyroid Cancer: Active Surveillance without Surgery. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 79-82, 2019.
- Wartofsky, L. Thyroid Nodules, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 37-56, 2019.
- Wartofsky, L. Well Differentiated Thyroid Cancer: Staging and Prognosis, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D (Eds), 3rd Edition. Keystone Press, 2019, pp. 95-106.
- Wartofsky, L. Thyrogen (Recombinant Human TSH), In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 165-170, 2019.
- Stathatos N., Wartofsky, L. Anaplastic Thyroid Carcinoma, In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, 2019, pp. 361-366.
- Wartofsky, L. Management of the Patient with Persistent Elevated Thyroglobulin Levels and Negative Radioiodine Scans. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, 2019, pp. 297-302.
- Van Nostrand D, Wartofsky, L. From “Nodule to Diagnosis to Therapy to Follow-up”. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D (Eds), 3rd Edition, Keystone Press, pp. 1-4, 2019.
- Wartofsky L. Management of the Patient with Persistent Elevated Thyroglobulin Levels and Negative Radioiodine Scans. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, 2019, pp. 297-302.
- Van Nostrand D, Wartofsky, L. From “Nodule to Diagnosis to Therapy to Follow-up”. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D (Eds), 3rd Edition, Keystone Press, pp. 1-4, 2019.
- Wartofsky L. Thyrogen for Preparation for Radioiodine Ablation and Treatment. In Thyroid Cancer –A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D (Eds), 3rd Edition, Keystone Press, pp. 253-256, 2019.
- Wartofsky, L. Difference between Risk of Recurrence and Staging. In: Thyroid Cancer – A Guide for Patients, Van Nostrand D, Bloom G, Wartofsky L, Wu D. (Eds), 3rd Edition, Keystone Press, pp. 293-296, 2019.
- Burman KD, Wartofsky L: Myxedema Coma. In: The Thyroid: A Fundamental and Clinical Text. Braverman LE, Cooper DS, and Kopp P (Eds.), Eleventh Edition, J. B. Lippincott, Philadelphia, 2020, pp. 605-612.
- Wartofsky L: Burman K.D. Thyrotoxic Storm. In: The Thyroid: A Fundamental and Clinical Text, Braverman LE, Cooper DS, and Kopp P (Eds.), Eleventh Edition, J. B. Lippincott, Philadelphia, 2020, pp. 482-489.
- Ylli D, Klubo-Gwiezdzinska J. Wartofsky L. Thyroid function and exercise. In: Endocrinology of Physical Activity and Sport, 3rd Edition., Constantini N., and Hackney AC (Eds.), Humana Press/Springer, 2020; pp. 85-108.
- Ylli D, Wartofsky L. Applications of radioiodine therapy for differentiated thyroid cancer. In: Head and Neck Endocrine Surgery, Goldenberg D (Ed.), Thieme Publ., 2021. pp. 323-330.
199. Wartofsky L. A patient with a large Hurthle cell cancer and nodal metastases, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 187-193, 2020. 200. Wartofsky L. A case of a locally advanced papillary thyroid cancer without structural evidence of disease at cross sectional imaging studies but with biochemical evidence of disease, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 201-207, 2020. 201. Wartofsky L. A case of a patient with follicular thyroid carcinoma with bone metastases and lesional dosimetry, In: Thyroid Cancer: A Case-Based Approach, Cooper DC and Durante C (Eds.), Springer, Switzerland, 221-229, 2020. 202. Antonelli A, Wartofsky L, Miccoli P. Editorial: Levothyroxine therapy in patients with hypothyroidism. Frontiers Endocrinol 12:734895. Doi: 10.3389/fendo.2021.734895 | 203. Wartofsky L, Burman KD. Yolanda Castillo Oertel: Humanitarian, Diagnostician, Educator, Pathologist. Thyroid 31: 7, 2021. 204. Wartofsky L, Ylli D, Klubo-Gwiezdzinska J., Thyrotoxic storm. In Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, Third Edition, Wass JA, Stewart P. (Eds.) 2020, pp. 465-471. 205. Wartofsky L, Ylli D, Klubo-Gwiezdzinska J. Myxoedema coma. In Oxford Textbook of Endocrinology, Oxford University Press, Oxford, UK, Third Edition, Wass JA, Stewart P (Eds.) 2020, pp. 551-557. 206. Ylli D, Wartofsky L, Burman KD. Response to Letter to the Editor from Sukor et al.: Evaluation and Treatment of Amiodarone-induced Thyroid Disorders. J Clin Endocrinol Metab 106: (7) e2839-2840, 2021. 207. Ylli D, Wartofsky L. Myxedema Coma In: Endocrine Emergencies, A. Shifrin (Ed.), Elsevier Press, pp. 37 – 49, 2022. 208. Wartofsky, L. Thyroid Storm In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Huhtaniemi I. and Martini, L (Eds.), Elsevier Press, Third Edition, In Press, 2024. - Wartofsky, L. Myxedema Coma. In Encyclopedia of Endocrinology and Endocrine Diseases, Reference Module in Biomedical Sciences, Huhtaniemi I. and Martini, L (Eds.), Elsevier Press, Third Edition, In Press, 2024.
| | | | | | | | | | |
| | | |
|